Cardiovascular and respiratory effects of exposure to experimental models of obstructive sleep apnoea-related intermittent hypoxia by Griffin, Harry Sebastian
CARDIOVASCULAR AND RESPIRATORY EFFECTS OF EXPOSURE 
TO EXPERIMENTAL MODELS OF OBSTRUCTIVE SLEEP  
APNOEA-RELATED INTERMITTENT HYPOXIA  
 
By 
 
HARRY SEBASTIAN GRIFFIN 
 
 
 
A thesis submitted to the University of Birmingham for the degree of Doctor of 
Philosophy 
 
 
School of Sport and Exercise Sciences 
The College of Life and Environmental Sciences 
University of Birmingham 
Birmingham 
B15 2TT 
 
September 2012 
 
 
 
 
 
 
 
 
 
University of Birmingham Research Archive 
 
e-theses repository 
 
 
This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 
of the copyright holder.  
 
 
 
 ABSTRACT 
 
Obstructive sleep apnoea (OSA) is a common chronic condition characterised by 
repetitive nocturnal upper airway collapse that evokes intermittent hypoxia (IH). 
Although animal research has demonstrated a causal relationship between IH and 
cardiovascular disease there is a relative paucity of human research. Using a 
variety of different models of OSA we investigated the effects of IH on respiratory 
control and oxidative stress. In addition, we attempted to use Doppler ultrasound to 
investigate the effects of hypoxic airway occlusions on the pulmonary circulation 
but concluded that it is not a feasible alternative to invasive catheterisation. In a 
number of studies we showed that the expression of respiratory plasticity following 
IH is only evident when arterial levels of CO2 are raised above normal levels. 
Furthermore, in stark contrast to previous findings in animals, exposure to acute 
continuous hypoxia also evokes respiratory plasticity in humans. In addition, we 
showed that combined postprandial hyperglycaemia and hyperlipidaemia 
augments the degree of oxidative stress during IH. Finally, we demonstrated that 
IH accentuates the magnitude of postprandial hyperglycaemia. These studies 
demonstrate the complexity of respiratory control in humans and they highlight 
significant species differences. Furthermore, they highlight a fascinating synergy 
between IH and the postprandial state. 
 
THESIS OVERVIEW 
 
 
The work presented in this thesis investigates the effects of acute exposure to 
intermittent hypoxia (IH) in relation to its common occurrence in the chronic 
disease, obstructive sleep apnoea. IH appears to be a stimulus that is capable of 
eliciting cardiovascular disease through mechanisms that are currently not fully 
understood. However, in contrast with its potential to mediate disease, acute 
exposure to IH is capable of inducing respiratory plasticity that could potentially be 
harnessed to treat diseases including obstructive sleep apnoea.  
 
This thesis has investigated the possible detrimental health effects of IH and its 
ability to elicit respiratory plasticity. For simplicity, in both the general introduction 
(chapter 1) and general discussion (chapter 8) respiratory plasticity will be 
discussed separately from the detrimental health effects of IH. 
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1 CHAPTER 1 – GENERAL INTRODUCTION 
 
 
1.1 Obstructive sleep apnoea 
 
1.1.1 General 
Sleep apnoea is a common chronic disorder in which individuals experience 
frequent and abnormally long restrictions in breathing during sleep. There are two 
distinct forms of sleep apnoea: obstructive sleep apnoea (OSA) and central sleep 
apnoea. OSA is characterised by repetitive complete or partial obstruction of the 
upper airway during sleep that prevents (apnoea) or reduces (hypopnoea) airflow 
despite continued inspiratory effort. This is followed by transient incomplete arousal 
that allows restoration of upper airway patency. Central sleep apnoea like OSA 
involves both apnoeas and hypopnoeas but unlike OSA where inspiratory efforts 
continue against an occluded airway, respiratory effort is absent (apnoea) or 
diminished (hypopnoeas) in central sleep apnoea. Although sleep apnoea patients 
suffer from predominantly one of the two forms of sleep apnoea it is not uncommon 
for patients to experience a combination of obstructive and central 
apnoeas/hypopnoeas termed “complicated sleep apnoea”.  This thesis will focus 
#"
"
predominantly on OSA but due to the common overlap between the two forms and 
because both elicit IH, central sleep apnoea will be discussed where appropriate. 
 
1.1.2 Pathophysiology of OSA 
During normal breathing air is drawn into the alveoli down a pressure gradient 
generated by contraction of respiratory muscles (diaphragm and intercostals) that 
expand the thorax and lower alveolar pressure below atmospheric pressure. 
Because of this pressure gradient between the alveoli and the external 
environment the pressure inside the upper airway (e.g. mouth and throat) is 
transiently negative during inspiration. The surrounding tissue of the upper airway 
is not a rigid structure and thus, it is vulnerable to collapse during these periods of 
negative pressure. To prevent this from occurring muscles surrounding the soft 
tissue of the upper airway contract during inspiration to maintain its patency. These 
muscles receive neural activation in sync with central respiratory pattern 
generation and from mechanoreceptor feedback within the airway that responds to 
negative pressures (Edwards and White, 2011). OSA patients commonly have an 
anatomically narrow upper airway that increases resistance to airflow and 
subsequently augments the negative pressure in the upper airway during 
inspiration making it more vulnerable to collapse (Schwab et al., 2003). However, it 
has been shown that during wakefulness OSA patients demonstrate greater basal 
activity of the genioglossus muscle compared to controls. The genioglossus is the 
primary muscle of the upper airway dilator group and thus during wakefulness in 
these patients the upper airway does not collapse (Mezzanotte et al., 1992). 
$"
"
Although the mechanisms are not fully understood, during sleep the activity of the 
upper airway dilator muscles is reduced and thus the neuromuscular compensation 
present during wakefulness in OSA patients is lost and the upper airway is prone to 
collapse (Edwards and White, 2011). Upper airway patency is only restored 
following an apnoea or hypopnoea by partial arousal from sleep that increases the 
tone of these upper airway dilator muscles. It is not fully known what triggers 
arousal from sleep but it is likely to be in part a response to an increase in 
chemoreceptor drive due to increased levels of arterial partial pressure of CO2 
(PaCO2) and decreased levels of arterial partial pressure of O2 (PaO2) (Sforza et al., 
1998). Furthermore, it may also be in response to the progressive increase in 
respiratory muscle activity during the increasing frequency and magnitude of 
occluded inspiratory efforts (Sforza et al.,1998). 
 
1.1.3 Epidemiology 
In order to diagnose OSA a sleep study (polysomnography) is performed where 
numerous measurements such as airflow and arterial O2 saturation (SaO2) are 
made continuously. A standardised criterion has been developed to determine the 
number of apnoeas and hypopnoeas experienced by the patients by assessing the 
recorded measurements. Firstly, an apnoea is defined as the complete absence of 
airflow for over 10 seconds. Secondly, a hypopnoea is defined as a 50% or more 
reduction in airflow for over 10 seconds or a noticeable reduction in airflow with a 
reduction in SaO2 of more than 4%. The severity of OSA is then determined by the 
%"
"
number of apnoeas and hypopnoeas per hour (i.e. apnoea/hypopnoea index: AHI). 
An AHI of 5-15 is classed as mild OSA, an AHI of 15-30 as moderate and an AHI 
of over 30 as severe (American Academy of Sleep Medicine). 
 
OSA is now a highly prevalent condition in the developed world. A relatively 
conservative figure compared to numerous other reports is that 4% of middle-aged 
men and 2% of middle-aged women suffer from some degree of OSA (Young et 
al., 1993). However, the actual prevalence of OSA may be much higher as a study 
estimated that only 18% of men with moderate to severe OSA were clinically 
diagnosed (Young et al., 1997). The greatest risk factor for OSA is an anatomically 
narrow upper airway. This increases resistance to airflow and subsequently 
augments the negative pressure during inspiration promoting upper airway 
collapse (Schwab et al., 2003). A number of physiological characteristics such as, 
tonsillar hypertrophy, tongue shape, and a short neck can cause a narrowing of the 
upper airway and thus increase the risk of OSA (Azagra-Calero, 2012). However, 
by far the greatest risk factor for OSA is obesity. Obese individuals are prone to 
having increased adipose tissue and soft tissue edema in the neck region which 
causes a narrowing of the upper airway and a subsequent increase in upper airway 
resistance. 
 
1.1.4 Obstructive sleep apnoea and cardiovascular disease 
There is unison between large-scale epidemiology studies showing a greater 
prevalence of cardiovascular disease in OSA patients than the general population 
&"
"
(Somers et al., 2008). However, demonstrating a causal link between OSA and 
cardiovascular disease is challenging due to the high prevalence of comorbidities 
such as, obesity and diabetes. However, studies reporting reduced rates of 
mortality in OSA patients who received treatment (tracheotomy or continuous 
positive airway pressure - CPAP) vs. those that didn’t strongly suggests a 
causative link (He et al., 1988, Partinen et al., 1988). 
 
Each apnoeic event involves a complex set of acute physiological stressors and 
cardiovascular responses, all of which may chronically be capable of facilitating the 
development and progression of cardiovascular disease in OSA patients (Golbin et 
al., 2008). Figure 1.1 is an original polysomnogram from a patient with OSA and it 
illustrates a number of these different physiological events that occur during an 
apnoeic cycle. It shows that whilst the upper airway is collapsed inspiratory efforts 
continue and the development of a substantial negative intrathoracic pressure is 
associated with each such effort. The magnitude of the negative intrathoracic 
pressure that is generated with each effort gradually increases throughout the 
apnoea. The physiological effects of these negative intrathoracic pressures are 
discussed in detail in chapter 2 but in brief, they transiently increase venous return 
(Moreno et al., 1967) but simultaneously decrease stroke volume (Tolle et al., 
1983, Summer et al., 1979, Orban et al., 2008). This leads to a congestion of blood 
in the pulmonary circulation that transiently elevates pulmonary arterial pressure 
(PAP) (Marrone et al., 1994). Figure 1.1 also shows systemic BP steadily 
increases during each apnoea that peaks upon arousal. It has been shown in 
'"
"
humans that inhibiting sympathetic activity with ganglionic blockade abolishes the 
pressor response to Mueller manoeuvres and breath-holds suggesting that the 
elevation in systemic blood pressure during an apnoea is mediated completely by 
increased sympathetic activity (Katragadda et al., 1997). This increase in 
sympathetic activity is primarily, but not solely, driven by chemoreflex stimulation 
and thus may also depend on a loss of mechanoreceptor activity during occluded 
apnoeas (e.g. lung reflexes) (Chen et al., 1998). Each apnoea or hypopnoea is 
terminated by a sudden arousal from sleep that causes a further elevation in 
sympathetic activity (Odonnell et al., 1996). Immediately post apnoea there is a 
brief period of tachycardia as shown by the ECG trace in the in figure 1.1 (Stoohs 
and Guilleminault, 1992, Zwillich et al., 1982). This is likely to be in response to 
increased activation of lung reflexes as it occurs parallel to a period of 
hyperventilation and/or due to elevated sympathetic activity that peaks post 
apnoea. In addition to the aforementioned physiological events, apnoeas evoke a 
significant increase in PaCO2 that rapidly returns to or below eucapnic levels 
following the post apnoeic hyperventilation (Lanphier and Rahn, 1963). Although 
chronic exposure to all of the aforementioned physiological stressors and 
cardiovascular responses could theoretically in part mediate the development of 
cardiovascular disease the most likely stimulus is thought to be IH (Levy et al., 
2008, Foster et al., 2007b). During an apnoea the cessation in alveolar ventilation 
causes a gradual decline in SaO2 thus exposing patients to whole body hypoxia 
which can be of a significant severity and occurs simultaneous to all the other 
("
"
physiological events shown in figure 1.1. The partial pressure of arterial blood 
(PaO2) is rapidly restored during the resumption of breathing following each apnoea 
which generates the intermittent pattern of hypoxia that is unique to sleep apnoea. 
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Figure 1.1: Raw data from a polysomnography showing various physiological events during an apnoeic cycle: Channel 1, (ECG)
showing significant tachycardia immediately post apnoea; Channel 2, (Airflow) showing complete absence of airflow during
airway occlusion; Channel 3, (Intrathoracic pressure) showing negative intrathoracic pressure during continued inspiratory efforts;
Channel 4, (BP – systemic blood pressure) showing a gradual elevation in systemic BP during the apnoea that peaks during
resumption of breathing; Channel 5, (PAP - pulmonary arterial pressure) showing transient swings in PAP during each occluded
inspiratory effort and a gradual rise throughout the apnoea, and Channel 6, (SaO2 - arterial O2 saturation) showing a gradual
development of hypoxia. Adapted from Sajkov and McEvoy (2009).
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1.2 Intermittent hypoxia 
 
1.2.1 General 
Although all mammalian cells have the capability of transiently generating cellular 
energy without O2 (anaerobic respiration), survival of almost all mammalian cells is 
reliant on a continuous supply of O2 for aerobic respiration. Therefore, the human 
body has evolved to develop intricate structures and processes to transport O2 
from the atmosphere to all cells (e.g. breathing, circulation etc). Following upper 
airway collapse this highly evolved system fails at the first hurdle as O2 cannot be 
drawn into the alveoli. Therefore, the partial pressure of O2 in the alveoli (PAO2) 
gradually falls during an apnoea, resulting in a subsequent drop in PaO2. Due to 
the sigmoidal shape of the oxygen-haemoglobin dissociation curve this initially has 
little effect on SaO2 and thus tissue O2 delivery is little affected. Although, there is 
substantial variation in apnoea duration within and between individuals it is 
extremely common for apnoeas to exceed 20 seconds. During apnoeas of this 
duration PaO2 is often reported to fall as low as 40-50 mmHg equating to SaO2 of 
75-85% with nadirs in SaO2 falling into the low 50s in patients with severe OSA 
(Sforza et al., 1998). Therefore, OSA patients are frequently exposed to whole 
body hypoxia as would be experienced at a considerable altitude (i.e. ~5000 
meters). However, unlike continuous hypoxia (CH) experienced at altitude and in 
chronic conditions such as chronic obstructive pulmonary disease (COPD) the 
SaO2 is rapidly restored following each apnoea and thus OSA patients experience 
!*"
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IH. Evidence has been emerging in the last couple decades demonstrating how 
exposure to IH may evoke significant pathological effects. 
 
1.2.2 IH-mediated cardiovascular disease 
The current treatment of choice for OSA is CPAP and studies using it have been 
able to demonstrate the reversal of many health complications of OSA such as, 
systemic hypertension (Somers et al., 2008), pulmonary hypertension (Sajkov and 
McEvoy, 2009), endothelial dysfunction (Foster et al., 2007a, El Solh et al., 2007, 
Ip et al., 2004) and elevated oxidative stress (Barcelo et al., 2000, Lavie et al., 
2004, Mancuso et al., 2012). However, because CPAP inhibits upper airway 
collapse it prevents not only exposure to IH but all the other physiological events 
that occur during occluded apnoeas. Therefore, in these studies IH cannot be 
identified as the stimulus that is responsible for the development of cardiovascular 
disease in OSA patients. Thus, scientists have opted to utilise an alternative 
approach to investigate the possible pathological effects of IH. To this end, 
numerous studies have been undertaken where animals have been exposed to IH 
independently of any other OSA-related stimuli by intermittently reducing the partial 
pressure of inspired O2 (PIO2) to evoke a similar pattern and magnitude of 
hypoxaemia that is experienced during frequent apnoeas in OSA. Daily exposure 
to IH for several months evokes systemic hypertension (Brooks et al., 1997, 
Fletcher et al., 1992) pulmonary hypertension (Fagan, 2001, McGuire and 
Bradford, 2001) elevated sympathetic activity (Sica et al., 2000), atherosclerosis 
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(Savransky et al., 2007) and myocardial dysfunction (Williams et al., 2010, Chen et 
al., 2005) in animals. These animal studies have certainly highlighted the likelihood 
that IH may mediate the increased risk of cardiovascular disease in OSA. 
However, although this scientific approach benefits from separating the hypoxic 
element from other stimuli that occur in OSA so that the effects of hypoxia per se 
can be isolated, it also carries a significant limitation. Studies of this nature make 
the assumption that the body responds to intermittent reductions in PIO2 in the 
same way as it would when IH occurs during occluded apnoeas. The possible 
synergy of IH and other physiological stressors and cardiovascular responses that 
occur during an occluded apnoea are thus ignored. Although speculative it would 
seem highly likely that IH may have a more detrimental effect on health when 
exposure is simultaneous with these various physiological stressors and 
cardiovascular responses than it would have independently. For example, systemic 
blood pressure does not increase during hypoxia when it is evoked by a reduction 
in PIO2 but during an occluded apnoea hypoxia is the predominant mechanism 
responsible for causing the significant elevation in systemic blood pressure 
(Schneider et al., 2000). It is plausible that hypoxia may be more detrimental to 
cells of the cardiovascular system (specifically myocardial and endothelial cells) 
whilst simultaneously being under stress from the elevated systemic blood 
pressure. Interestingly, IH has been shown to impair endothelial function in OSA 
patients through increases in oxidative stress (El Solh et al., 2006) and it is not too 
far reached to postulate that a damaged vascular endothelium will be less able to 
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cope with apnoea-induced blood pressure elevations. Furthermore, during the 
negative intrathoracic pressure generated during each occluded inspiratory effort 
left ventricular contractility increases in order to maintain left ventricular pressure 
and prevent a fall in stroke volume (SV). Therefore, myocardial O2 consumption 
increases (Simpson et al., 2008) at a time when there is considerable arterial 
hypoxia. Indeed, in anaesthetised rats exposed to airway occlusions that"evoked 
significant negative intrathoracic pressures and hypoxia, myocardial dysfunction 
developed after as little as three hours of exposure (Simpson et al., 2008). 
Furthermore, although restoration of upper airway patency removes the burden on 
the heart of having to increase left ventricular contractility, tachycardia induced by 
the post apnoea hyperventilation and/or increase in sympathetic activity (Stoohs 
and Guilleminault, 1992, Zwillich et al., 1982) occurs simultaneous to the nadir in 
SaO2. As a result myocardial O2 consumption is again elevated during a period of 
severe hypoxia (Simpson et al., 2008). Finally, exposure to intermittent reductions 
in PIO2 is associated with enhanced ventilation and subsequent hypocapnia. In 
contrast, during an occluded apnoea the absence of alveolar ventilation elicits 
significant hypercapnia. This could have substantial implications on the effect that 
IH has on the pulmonary circulation as hypocapnia is known to cause 
vasodilatation (Balanos et al., 2003) and thus may offset the pathological effects of 
hypoxic pulmonary vasoconstriction (HPV).  
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Despite a large number of studies having been performed over the last two 
decades where animals were exposed to acute and chronic IH there is a relative 
paucity of research undertaken in humans. Although the findings from these animal 
studies goes some way to elucidating the possible detrimental health effects of 
OSA-related IH, there are well known cardiovascular, ventilatory and metabolic 
differences between species and thus there is a need for human studies to be 
performed. The methodological approach of replicating IH that occurs in OSA by 
intermittently reducing the PIO2 can easily and safely be replicated in human 
research. However, as discussed previously, evoking IH in such a way may not 
truly replicate the full extent of the pathological effects of IH as experienced in 
OSA. This is less of a limitation in animal research were animals can be exposed 
to IH for several months, but due to the ethical restraints of chronic exposures in 
humans it is important that acute studies investigate the full magnitude of any 
pathological consequence of IH. Thus, an initial aim of this thesis was to design a 
model of OSA whereby awake humans could be exposed to IH simultaneous to as 
many other components of OSA. We hoped this model could then be used in 
studies throughout and beyond this thesis to better investigate the effects of IH on 
various physiological parameters such as, ventilation, pulmonary and systemic 
haemodynamics, oxidative stress etc. A detailed description of the design of this 
model follows in chapter 3. 
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1.3 Oxidative stress 
 
1.3.1 General 
Following the initial findings from animal studies that demonstrated the 
development of cardiovascular disease following chronic exposure to IH, research 
was undertaken to investigate the responsible mechanisms. Oxidative stress has 
been associated with a considerable number of pathologies and thus it was 
considered a logical area to investigate (McCord, 2000). Furthermore, the pattern 
of hypoxia and re-oxygenation in OSA-related IH is recognised to be similar to that 
occurring during ischaemia-reperfusion injury (IRI) where oxidative stress is shown 
to play a major role in the related tissue injury. Therefore, there has been a 
considerable volume of animal research and recently a number of human studies 
to investigate whether IH elicits oxidative stress and whether this could mediate the 
development of cardiovascular disease in OSA. 
 
(Gerschman et al., 1954) first presented the theory that reduced forms of O2 called 
free radicals could be toxic to the human body. (McCord and Fridovic, 1969) later 
discovered the antioxidant enzyme superoxide dismutase (SOD) thus 
demonstrating the importance of free radicals in biological systems. Free radicals 
is an umbrella term for both reactive oxygen species (ROS, e.g. superoxide anion) 
and reactive nitrogen species (RNS, e.g. nitric oxide) which are molecules or 
fragments of molecules that have one or more unpaired electron, which makes 
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them so reactive (Halliwell and Gutteridge, 1999). Sources of free radical 
generation include the mitochondrial electron transport chain, peroxisomes and 
enzymes such as, NAD(P)H oxidase and xanthine oxidase (Valko et al., 2007).  
 
To prevent biological damage caused by the generation of excess free radicals, 
endogenous and exogenous antioxidants are required to quench and buffer free 
radicals. Enzymatic antioxidant defences include, superoxide dismutase, 
glutathione peroxidase and catalase. Non-enzymatic antioxidants include ascorbic 
acid (Vitamin C), alpha-tocopherol (Vitamin E), glutathione, carotenoids, and 
flavonoids (Valko et al., 2007). During pathological conditions such as, OSA and 
diabetes or during periods of excess stress (e.g. severe exercise) an 
overproduction of free radicals and/or insufficient antioxidants can lead to oxidative 
stress. Oxidative stress is a process where free radicals can damage cellular 
proteins (e.g. protein carbonylation), lipids (e.g. lipid peroxidation), carbohydrate 
structures and DNA, all of which can inhibit cellular function. Oxidative stress has 
been associated with a considerable number of pathologies such as all 
inflammatory diseases, diabetes, ischaemic diseases (stroke, myocardial 
infarction) and Alzheimer’s disease (McCord, 2000).  
 
Because OSA patients are often obese and have coexisting medical disorders 
such as type 2 diabetes mellitus (T2DM) studies have normally utilised CPAP 
treatment to assess whether there is a casual relationship between OSA and 
elevated oxidative stress. Studies measuring biomarkers of oxidative stress in  the 
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plasma have reported elevated levels of lipid (Barcelo et al., 2000, Lavie et al., 
2004) and protein oxidation (Mancuso et al., 2012) in OSA patients vs. controls 
and demonstrated an attenuation following CPAP treatment. Studies have also 
demonstrated that intracellular ROS production in leukocytes (Dyugovskaya et al., 
2002, Schulz et al., 2000) and oxidative stress in venous endothelial cells is 
elevated in OSA patients and restored by CPAP treatment (Jelic et al., 2010, Jelic 
et al., 2008). Finally, plasma antioxidant levels have been shown to be attenuated 
in OSA patients which would indicate a chronic overproduction of free radicals and 
CPAP treatment was also able to reverse this (Barcelo et al., 2006, Mancuso et al., 
2012). 
 
1.3.2 IH-induced oxidative stress 
Elevations in biomarkers of oxidative stress in the plasma (Christou et al., 2009) 
and urine (Yamauchi et al., 2005) of OSA patients have been shown to be 
correlated to hypoxic indices such as, the lowest and mean nadir in SaO2 following 
apnoeas and the frequency of these O2 de-saturation events. Furthermore, recent 
studies have reported increased levels of biomarkers of oxidative stress in the 
plasma of healthy humans and OSA patients following acute exposure to 
intermittent reductions in PIO2 (Pialoux et al., 2009, Lee et al., 2009). The first of 
these two studies reported an increase in DNA and lipid oxidation in healthy 
humans after a six hour cycle of two minutes hypoxia followed by two minutes 
euoxia (Pialoux et al., 2009). In the later study even much shorter durations of IH 
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(twelve cycles of four minutes hypoxia and four minutes euoxia) were capable of 
inducing DNA oxidation in OSA patients but not in healthy individuals (Lee et al., 
2009). 
 
Similar to the aforementioned findings in OSA patients and in healthy humans 
exposed to acute IH, animals exposed to chronic IH demonstrate greater levels of 
lipid and protein oxidation (Xu et al., 2004, Zhan et al., 2005) and develop an 
impaired antioxidant capacity (Chen et al., 2005). Furthermore, in one study an 
increase in lipid oxidation was significantly correlated to elevations in blood 
pressure and left ventricular dysfunction (Chen et al., 2005). There has long been 
much debate over whether free radicals and oxidative stress are causative in 
pathological conditions such as the development of atherosclerosis, or whether 
they are simply a consequence of the pathology. Indeed, although in vitro evidence 
for oxidative stress mediating atherosclerosis is strong, large scale clinical trials of 
antioxidants have had minimal to no success in attenuating atherosclerosis or 
cardiovascular events mediated by atherosclerosis (Stocker and Keaney, 2004, 
Steinberg, 2009). In contrast, a number of studies have presented strong evidence 
suggesting IH-induced oxidative stress is causative in the development of 
cardiovascular disease rather than a consequence (Burckhardt et al., 2008, 
Troncoso Brindeiro et al., 2007, Peng et al., 2006). Firstly, IH-induced oxidative 
stress would appear to mediate systemic hypertension in chronic IH rodents as 
studies have shown antioxidant treatment attenuates the rise in systemic blood 
pressure and elevated levels of circulating endothelin-1 (Troncoso Brindeiro et al., 
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2007) and plasma noradrenalin (Peng et al., 2006). Furthermore, treatment with 
the antioxidant green tea polyphenol in chronic IH animals was shown to attenuate 
the elevation in levels of lipid oxidation in the brain and improve cognitive function 
(Burckhardt et al., 2008). 
 
1.3.3 Mechanisms of IH-induced oxidative stress 
Although it is now well established that exposure to IH can evoke oxidative stress, 
the responsible mechanism(s) for increased free radical production during IH 
remain incompletely understood. As discussed earlier there are numerous sources 
for free radical production (e.g. mitochondria, enzymes etc) that have been 
identified in a range of different cells (endothelial and leukocytes) and almost all of 
these have been suggested as responsible sources of the overproduction of free 
radicals during IH (Lavie, 2003). As mentioned earlier, the cycle of hypoxia and re-
oxygenation during IH closely resembles the changing O2 tensions occurring in IRI. 
IRI is associated with organ transplantation, strokes and myocardial infarctions 
whereby the blood supply to a specific tissue/organ is blocked for a lengthy 
duration (ischaemia) causing severe hypoxia. Upon reperfusion and subsequent 
re-oxygenation there is a substantial generation of free radicals that cause 
significant oxidative stress and impair tissue/organ function. Although there are 
striking differences between the pattern of hypoxia and re-oxygenation in OSA-
induced IH and IRI (e.g. duration, hypoxic severity and number of hypoxia/re-
oxygenation cycles) the best predictions for the responsible mechanisms of free 
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radical generation in IH are based primarily on the findings from research 
investigating IRI. 
 
Figure 1.2 illustrates the proposed primary mechanisms responsible for increased 
ROS production during a cycle of hypoxia and re-oxygenation in IRI. Firstly, an 
increase in ROS generation may occur in the mitochondria during hypoxia. 
Secondly, the enzyme xanthine oxidase may increase ROS generation during re-
oxygenation and thirdly a subsequent inflammatory response may increase ROS 
production via NAD(P)H oxidase during late reperfusion and for a lengthy time 
thereafter.  
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Figure 1.2: A schematic adapted from Raedschelders et al. (2012) showing the responsible mechanisms for increased ROS
generation during IRI that may also be responsible for elevated ROS during OSA-related IH. A1: Normal oxidative
phosphorylation functioning; B1: Inhibition of electron flux beyond complex III and a reduced NADH:NAD+ ratio due to impaired
TCA cycle function during ischemia/hypoxia depletes the mitochondrial cytochrome C pool and subsequently causes a small
increase in the generation of superoxide (O2 •−); C1: Restored TCA cycle during reperfusion with a continued inhibition of electron
flux beyond complex III augments O2 •− generation; A2: Xanthine dehydrogenase activity under euoxic conditions during normal
perfusion; B2: Prolonged ischemia/hypoxia converts xanthine dehydrogenase to xanthine oxidase and increases hypoxanthine
and xanthine concentrations; C2: Xanthine oxidase couples hypoxanthine and xanthine with O2 to generate O2 •− ; C3: Stimulated
immune cells during reperfusion generate O2 •− via NAD(P)H oxidase subsequent to xanthine oxidase-induced ROS production.
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Free radical formation during ischaemia (hypoxia): Tissue injury following IRI is 
commonly regarded as resulting predominantly from an overproduction of ROS 
during reperfusion (i.e. re-oxygenation) but there are also reports of significant 
elevation in the generation of ROS during ischaemia (Becker et al., 1999, 
VandenHoek et al., 1997, Zweier et al., 1987, Zweier et al., 1989). During non 
pathological conditions, intracellular superoxide is produced primarily by the 
mitochondria during oxidative phosphorylation when electrons leak prematurely to 
O2 molecules (Valko et al., 2007). Despite hypoxia presumably reducing rates of 
oxidative phosphorylation, mitochondrial generation of ROS increases due to an 
increased “leakage” of electrons from complex III of the electron transport chain 
(Raedschelders et al., 2012, Valko et al., 2007). 
 
Free radical formation during early reperfusion (re-oxygenation): The enzyme 
xanthine oxidase was identified during early research into IRI as a likely source of 
superoxide generation during reperfusion (McCord, 1985, Schoutsen et al., 1983). 
Xanthine oxidase and xanthine dehydrogenase are inter-convertible forms of the 
same enzyme, xanthine oxidoreductase. Unlike xanthine dehydrogenase that 
catalyses the oxidation of hypoxanthine to xanthine and subsequently to uric acid 
by coupling the reaction with NAD+, xanthine oxidase does so by coupling the 
reaction with O2 and produces superoxide rather than NADH. During ischaemia 
impairment in cellular regulatory mechanisms can mediate the conversion of 
xanthine dehydrogenase to xanthine oxidase (Engerson et al., 1987, McKelvey et 
al., 1988). Furthermore, reduced oxidative phosphorylation during hypoxia results 
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in an increased cellular breakdown of energy rich metabolites and a subsequent 
increase in the availability of hypoxanthine to be catalysed by xanthine oxidase (i.e. 
adenosine triphosphate (ATP) to adenosine monophosphate (AMP) to adenosine 
to inosine and finally hypoxanthine) (Thompsongorman and Zweier, 1990, Zweier 
et al., 1994). 
 
The contribution that xanthine oxidase activity may have on oxidative stress and 
tissue damage in IRI has been investigated using the xanthine oxidase inhibitor 
allopurinol. Allopurinol preserved antioxidant capacity in myocardial tissue of dogs 
(Chambers et al., 1985, Peterson et al., 1985), improved myocardial function and 
coronary flow in rats (Thompsongorman and Zweier, 1990) and reduced tissue 
damage following open heart surgery in humans (Gimpel et al., 1995). Allopurinol 
has also been given to OSA patients and animals exposed to chronic IH to 
determine whether xanthine oxidase activity also mediates the elevation in 
oxidative stress in OSA-induced IH. Allopurinol treatment lowered oxidative stress 
and improved endothelial function (assessed by flow mediated dilatation) in OSA 
patients (El Solh et al., 2006) and reduced oxidative stress and cardiac tissue 
damage in rodents exposed to chronic IH (Williams et al., 2010).  
 
Free radical formation during a delayed inflammatory response (late 
reperfusion/re-oxygenation): Tissue damage during reperfusion evokes a large 
inflammatory response and elevated levels of ROS generation were seen for 
several hours post-reperfusion (Bolli et al., 1989, Bolli et al., 1988). Increased 
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activity of the enzyme NAD(P)H oxidase found predominantly in immune cells may 
contribute heavily to the delayed accumulation of ROS (Raedschelders et al., 
2012). The comparably brief duration of hypoxic episodes in IH that occur in OSA 
would not be expected to elicit the same magnitude of local inflammation as IRI. 
However, OSA is a chronic condition and involves several hundred re-oxygenation 
phases per night which affects the entire body rather than just a single organ. 
Indeed, evidence exists to suggest a heightened inflammatory state in OSA 
patients (Lavie and Lavie, 2009).  
 
1.4 IH-induced oxidative stress during the postprandial state 
 
Following consumption of a meal the body is in a postprandial state whereby 
digestion of food is occurring in the gastrointestinal tract and subsequently small 
molecules move into the blood and are then involved in many metabolic processes. 
Although the term postprandial is used in many contexts, it is most commonly used 
when describing the relatively rapid rise and short duration of elevated blood 
glucose levels following a meal (i.e. postprandial hyperglycaemia) and also the 
more gradual and sustained elevation in circulating lipids (i.e. postprandial 
hyperlipidaemia). Recent evidence suggests postprandial hyperglycaemia and 
postprandial hyperlipidaemia could affect the magnitude of oxidative stress during 
IH. This new evidence may be relevant to all OSA patients especially those with 
coexisting T2DM who consume meals high in glucose and lipid prior to sleep. 
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T2DM is a metabolic condition characterised by elevated blood glucose levels due 
to insulin resistance that can progress to an additional deficiency in insulin 
production. There are many risk factors for the development of T2DM such as, 
increased age and a lack of physical exercise but by far the greatest risk factor is 
excess weight. Thus, because excess weight is also the strongest predictor of OSA 
over half of patients with T2DM suffer from OSA (Einhorn et al., 2007), with a 
coexistence as high as 86% in obese patients with T2DM (Foster et al., 2009). 
Although T2DM is most commonly associated with elevated fasting blood glucose 
levels, insulin resistance also means they experience substantial augmentations in 
postprandial hyperglycaemia and hyperlipidaemia (Ceriello et al., 2002). Oxidative 
stress is believed to be heavily involved in the pathogenesis of vascular 
complications of T2DM primarily as a consequence of hyperglycaemia (Son, 2012, 
Brownlee, 2001). Indeed, it has been shown that postprandial hyperglycaemia 
causes increased oxidative stress in T2DM patients (Ceriello et al., 2002). 
Furthermore, postprandial hyperlipidaemia also causes a transient increase in 
oxidative stress in healthy individuals which is greatly augmented in T2DM and 
thus may also play a role in mediating the health complications of T2DM (Ceriello 
et al., 2002). 
 
1.4.1 Simultaneous exposure to IH and postprandial hyperglycaemia 
Following consumption of an evening meal, blood glucose levels in insulin-
sensitive individuals will normally have returned to pre-meal levels prior to sleep. 
However, because T2DM patients experience an augmentation in the magnitude 
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and also duration of postprandial hyperglycaemia blood glucose levels are likely to 
remain elevated during the initial hours of sleep. Therefore, it is likely that OSA 
patients with coexisting T2DM will experience IH simultaneously with postprandial 
hyperglycaemia.  
 
We have become aware of a line of evidence that may suggest that simultaneous 
exposure to these two stimuli could be extremely detrimental to health. As 
discussed previously (see: mechanisms for IH-induced oxidative stress) the pattern 
of cellular hypoxia and re-oxygenation during IH mimics that occurring in IRI and it 
is widely considered that the mechanisms responsible for the overproduction of 
ROS during IRI are the same as those occurring during IH (Lavie, 2003, Pack and 
Gislason, 2009). Interestingly, transient hyperglycaemia has been shown to have a 
negative effect on morbidity and mortality in humans following events characterised 
by IRI such as, stroke and myocardial infarctions (Doenst et al., 2005, Ouattara et 
al., 2005, Schmeltz et al., 2007). Furthermore, experimental studies with rodents 
have shown that transient hyperglycaemia during IRI increased liver (Behrends et 
al., 2010), kidney (Hirose et al., 2008) and cerebral tissue damage (Bemeur et al., 
2007, Tsuruta et al., 2010). During acute modest elevations in ROS production 
antioxidant defences in healthy humans and animals are capable of inhibiting or 
greatly attenuating oxidative stress. It is plausible that the greater rates of morbidity 
and mortality in humans following IRI with simultaneous hyperglycaemia (Doenst et 
al., 2005, Ouattara et al., 2005, Schmeltz et al., 2007) was a result of an additive 
effect of ROS production from hyperglycaemia and IRI independently, which 
#'"
"
overwhelmed antioxidant defences causing a substantially greater degree of 
oxidative stress. Indeed, all of the experimental animal studies investigating 
simultaneous hyperglycaemia and IRI showed greater levels of oxidative stress 
(Behrends et al., 2010), (Hirose et al., 2008, Bemeur et al., 2007, Tsuruta et al., 
2010). However, evidence from two of these animal studies strongly suggest that 
increased oxidative stress and tissue damage occurring during IRI under 
hyperglycaemic conditions and thus possibly IH are not simply a result of a 
cumulative increase in ROS production from the two ROS-producing stimuli 
(Hirose et al., 2008, Tsuruta et al., 2010). Rather, it advocates that hyperglycaemia 
can interact with and increase the activity of a pathway(s) responsible for ROS 
production during IRI. Figure 1.3 is taken from (Tsuruta et al., 2010) and it shows 
how 30 minutes of hyperglycaemia alone prior to ischaemia caused no increase in 
ROS generation but significantly increased ROS generation during ischaemia and 
especially following re-perfusion. Furthermore, (Hirose et al., 2008) showed that 24 
hours after renal IRI, oxidative stress and renal necrosis were significantly greater 
when mice were exposed to hyperglycaemia simultaneously with IRI but that 
hyperglycaemia initiated two hours after reperfusion had no effect on oxidative 
stress levels.  
 
Considering the high prevalence of coexisting OSA and T2DM and the 
aforementioned line of evidence demonstrating a synergistic interaction between 
IRI and hyperglycaemia, research is required to examine whether the same 
synergy is present with simultaneous exposure to IH and hyperglycaemia. 
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Figure 1.3: Reactive oxygen species production (!I(nA)) during cerebral ischaemia-reperfusion 
injury (IRI). Generation of ROS under hyperglycaemic (closed symbols) or euglycaemic conditions 
(open symbols). Note a lack of difference between ROS production between hyperglycaemia and 
euglycaemia during pre-ischaemia, but greater elevations under hyperglycaemia during ischaemia 
and reperfusion (Tsuruta et al., 2010). 
 
1.4.2 Simultaneous exposure to IH and postprandial hyperlipidaemia 
Postprandial hyperlipidaemia occurs more gradually than postprandial 
hyperglycaemia and thus circulating lipid levels remain above fasting levels for 
many hours longer than postprandial hyperglycaemia. Therefore, OSA patients 
who consume a high lipid evening meal within a few hours of sleeping may 
experience simultaneous exposure to postprandial hyperlipidaemia and IH. In OSA 
patients with coexisting T2DM, this simultaneous exposure may even occur when 
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meals are consumed much earlier in the evening because T2DM demonstrate 
augmented magnitude and duration of postprandial hyperlipidaemia (Ceriello et al., 
2002). 
 
In healthy humans, postprandial hyperlipidaemia causes a modest transient 
elevation in oxidative stress but in T2DM patients this response is augmented 
(Ceriello et al., 2002). It is currently unknown why oxidative stress is greater in 
T2DM patients but it is likely to be in part a result of the exaggerated magnitude of 
postprandial hyperlipidaemia and an already lower antioxidant capacity (Baynes, 
1991). We are not aware of any existing research that has examined the effects of 
simultaneous exposure to hyperlipidaemia and IH at any biological level. Therefore, 
it remains to be determined whether combined exposure to IH and postprandial 
hyperlipidaemia overwhelms the antioxidant defence system causing substantially 
greater oxidative stress than individual exposure to each stressor. 
 
In summary, OSA patients who consume evening meals shortly before sleep may 
experience postprandial hyperglycaemia and hyperlipidaemia simultaneously with 
IH. Postprandial hyperglycaemia and hyperlipidaemia are both capable of causing 
increased ROS generation but it remains to be determined what effect 
simultaneous exposure to these stimuli with IH causes. Acute hyperglycaemia 
independently does not increase ROS production in rodents but greatly augments 
ROS production during IRI and thus may also have a synergistic effect during IH. 
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This could have implications for all OSA patients but especially the high prevalence 
of those with coexisting T2DM. 
 
1.5 IH-mediated respiratory plasticity 
 
1.5.1 General 
The term neuroplasticity has no clear scientific definition and encompasses in its 
entirety any physiological adaptation of the central nervous system (from molecular 
to a change in physical structure) that can occur in response to a large range of 
different stimuli such as environment or behaviour. Neuroplasticity has long been 
recognised as being fundamental for learning and memory. In contrast the neural 
system responsible for respiratory control has conventionally been considered 
‘rigid’ even during early development where other neural systems are known to 
demonstrate their greatest capacity for neuroplasticity. This traditional belief has 
since been challenged and substantial evidence now exists to indicate the 
respiratory system is capable of considerable neuroplasticity (Mitchell and 
Johnson, 2003). The respiratory motor control system regulates the essential 
process of all mammals’ life: breathing. It is therefore logical that neuroplasticity is 
an integral component of the respiratory system that guarantees precise control of 
breathing in order to maintain blood gas homeostasis during changing conditions. 
These conditions may be physiological, such as ageing, pregnancy, ascent to 
altitude, or pathophysiological conditions such as respiratory infections and 
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lung/neural disease. Most of the changing conditions experienced throughout life 
that evoke respiratory plasticity are long lasting and develop gradually, such as 
weight gain and ageing. Their respective development of respiratory plasticity is 
also relatively gradual. However, respiratory plasticity can also develop more 
quickly in response to conditional changes, such as respiratory infection and 
ascent to altitude.  
 
Animals and humans naive to prior hypoxic exposure develop two forms of 
respiratory plasticity that appear unique to acute IH and are rapid in their onset. 
These are, respiratory long-term facilitation (LTF) and progressive augmentation of 
the hypoxic ventilatory response (HVR). HVR is the term given to the elevation in 
ventilation in response to a lowered PaO2. Respiratory LTF is a persistent and 
progressive augmentation in respiratory motor output that is initiated during euoxic 
episodes that intersperse hypoxic exposures and is sustained for minutes to hours 
beyond cessation of IH (Mitchell and Johnson, 2003). Progressive augmentation of 
the HVR is referred to as a gradual increase in the magnitude of HVR during 
sequential hypoxic episodes of identical intensity and duration that can be 
sustained for over one hour post acute IH (Mateika et al., 2004, Powell et al., 
1998). 
 
Before discussing these phenomena in greater detail it is necessary to provide 
some definitions for the various forms of neuroplasticity and indicate where 
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respiratory LTF and progressive augmentation of the HVR are positioned. 
However, because of the relative infancy of research into neuroplasticity of the 
respiratory motor control system, a clear framework of respiratory plasticity 
remains to be universally accepted. (Mitchell and Johnson, 2003) attempted to 
establish a clear set of definitions of plasticity and other related neural properties 
that affect respiratory motor control. Figure 1.4 is adapted from (Mitchell and 
Johnson, 2003) to illustrate the different forms of respiratory plasticity that are 
specific to IH. Respiratory modulation (panel A) is a neurochemically induced 
alteration in respiratory neural network function that is only active during the 
presence of the neurochemical e.g. serotonergic modulation of respiratory 
neurones during hypoxic exposure but is absent as soon as euoxia is resumed. 
Respiratory metamodulation (panel B) is an enhancement or reduction of the 
neurochemically induced alteration in respiratory neural network, e.g. progressive 
augmentation of the HVR during IH exposure. Respiratory Plasticity (panel C) is a 
sustained alteration in respiratory neural network function that is sustained beyond 
cessation of the stimulus, e.g. respiratory LTF. Respiratory metaplasticity (panel D) 
is a change in the magnitude of respiratory plasticity induced by prior or concurrent 
experience, e.g. the magnitude of respiratory LTF is enhanced in humans with 
OSA (Lee et al., 2009) or animals exposed to chronic IH (Peng et al., 2003). 
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Although progressive augmentation of the HVR clearly fits well into the 
metamodulation category described by (Mitchell and Johnson, 2003) it may be an 
extension of respiratory LTF as discussed later (see: Is progressive augmentation 
of the HVR the same phenomenon as respiratory LTF and what are the 
responsible mechanism(s)?). It is also commonly defined as a form of respiratory 
plasticity in the literature (Mateika and Narwani, 2009) and for simplicity this thesis 
will conform with the current literature and progressive augmentation of the HVR 
will be discussed as a form of respiratory plasticity. 
 
1.5.2 Why investigate IH-mediated respiratory plasticity? 
In the 32 years since (Millhorn et al., 1980a) first reported respiratory LTF in cats 
following intermittent stimulation of the carotid sinus nerve a large volume of 
research has been undertaken to investigate the mechanisms responsible for this 
phenomenon. Indeed, a recent review by (Mateika and Sandhu, 2011) reported 
that there are more than 70 published animal studies to date to have specifically 
investigated respiratory LTF and numerous human studies. Progressive 
augmentation of the HVR has received far less attention than respiratory LTF but 
there still exists a considerable number of studies that have increased our 
understanding of this phenomenon (Mateika and Narwani, 2009). In general the 
beneficial significance of respiratory plasticity is to maintain normal arterial blood 
gas levels and it has been well described for a number of conditions. For example, 
elevated ventilation induced by acclimitisation to chronic altitude exposure partly 
balances the reduction in atmospheric O2 and alterations in respiratory output 
$%"
"
during pregnancy overcome the mechanical limitations. However, our 
understanding of the possible benefits that respiratory plasticity following IH may 
have are less well understood.  
 
Could OSA-induced IH evoke respiratory plasticity and thus attenuate upper airway 
collapse?  
OSA patients experience IH on a nightly basis which theoretically could elicit 
respiratory plasticity as is demonstrated in animals and humans following exposure 
to intermittent reductions in PIO2 (Mateika and Sandhu, 2011). If OSA does elicit 
respiratory plasticity it must then be considered whether respiratory LTF and/or 
progressive augmentation of the HVR are beneficial or detrimental to upper airway 
stability in OSA patients (Mateika and Narwani, 2009). Based on our current 
understanding of the function of respiratory plasticity in other settings (e.g. 
acclimitisation to altitude) it seems logical that respiratory plasticity in OSA patients 
should serve to stabilise breathing, preventing apnoeas and thus maintaining blood 
gas homeostasis (Mahamed and Mitchell, 2007). In OSA upper airway collapse 
occurs during sleep but not wakefulness due to a reduction in neural activity to the 
pharyngeal dilator muscles during sleep. Therefore, LTF of neural activity to upper 
airway dilator muscles would be expected to increase muscle tone and thus 
attenuate upper airway collapse. Upon arousal and restoration of the upper airway 
a period of hyperventilation also occurs which can evoke hypocapnia causing a 
subsequent reduction in respiratory drive. It is well known that upper airway dilator 
muscle activity parallels the level of ventilation and thus the upper airway is prone 
$&"
"
to collapse during nadirs in ventilation. Furthermore, if PaCO2 levels are driven 
below the apnoeic threshold this greatly increases the risk of a central apnoea 
(Mateika and Narwani, 2009) which can then be followed by collapse of the upper 
airway and thus an obstructive apnoea (Badr, 1996, Badr et al., 1997, Hudgel et 
al., 1987, Onal et al., 1986). By maintaining respiratory drive during these periods 
of hypocapnia ventilatory LTF may prevent further obstructive events and thus 
attenuate OSA severity. In contrast, development of progressive augmentation of 
the HVR might elicit an unsuitably exaggerated response to apnoea-induced 
hypoxia (i.e. increased respiratory control system loop gain), such that 
considerably greater hypocapnia is elicited. This will lead to a reduction in 
ventilatory drive and a parallel reduction in upper airway dilator muscle activity 
increasing the chance of upper airway collapse. Therefore, it is believed by many 
that progressive augmentation of the HVR could destabilise the upper airway in 
OSA patients.  
 
An interesting finding is that 78% of OSA patients demonstrate long periods of 
stable breathing characterised by the absence of apnoeas (Younes, 2003). If these 
long periods of stable breathing are ascribed to IH evoked respiratory LTF it should 
also be expected that apnoea severity should lessen over the course of the night. 
However, a number of clinical studies have reported that the apnoea hypopnoea 
index (AHI) (Fanfulla et al., 1997, Sforza et al., 1998) and duration of apnoeas 
(Sforza et al., 1998, Charbonneau et al., 1994) increases rather than decreases 
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throughout the night. Furthermore, because chronic exposure to IH enhances 
respiratory LTF (i.e. metaplasticity is present) (Ling et al., 2001), it would be 
expected that OSA severity would decrease over time in OSA patients but in 
contrast it worsens. However, it remains to be determined whether this is due to 
risk factors of OSA such as, obesity increasing over time (Chamberlin and Ling, 
2011). In summary, these studies suggest that respiratory LTF is not expressed in 
OSA patients, or, if it is expressed, it is incapable of improving breathing stability.  
 
Potential benefits of artificially inducing or enhancing respiratory plasticity 
The aforementioned evidence clearly argues against any naturally developed 
respiratory LTF promoting breathing stability in OSA. However, it does not preclude 
the potential benefit to breathing stability of voluntarily inducing respiratory LTF 
prior to sleep, or enhancing the natural ability of nocturnal IH to induce respiratory 
LTF. A clearer understanding of the mechanisms responsible for respiratory LTF 
may enable the development of new therapeutic strategies to artificially induce 
respiratory LTF or enhance the inherent capacity for IH-induced respiratory LTF. 
Furthermore, an understanding of the different mechanisms (if they are different) 
between the various forms of respiratory plasticity (e.g. LTF of ventilation, 
progressive augmentation of the HVR, and upper airway dilator muscles) would 
allow therapeutic strategies to be tailored to induce only the forms of respiratory 
plasticity that are deemed beneficial to breathing stability.  
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Other potential benefits of respiratory plasticity 
Although research into respiratory plasticity has primarily been performed because 
of its perceived potential to promote breathing stability and mitigate OSA, its 
benefits may not be restricted to OSA. Indeed, a greater understanding of 
respiratory plasticity may guide the development of therapeutic interventions for the 
treatment of other conditions associated with respiratory insufficiency, such as 
chronic lung disease, sudden infant death syndrome, congenital alveolar 
hypoventilation syndrome, and neuromuscular injury (Mitchell and Johnson, 2003). 
Fascinating data from animal research is emerging to suggest that chronic 
exposure to IH may be an effective means of restoring breathing capacity following 
chronic spinal injury (Dale-Nagle et al., 2010, Lovett-Barr et al., 2012). Even if 
research aimed at increasing our understanding of respiratory plasticity does not 
lead to the development of therapeutic strategies for respiratory related illness, our 
enhanced knowledge of neuroplasticity derived from these studies may be relevant 
to other neural systems. Indeed, our current understanding of IH-induced 
respiratory plasticity has already begun to impact on the development of 
treatments for non respiratory related neuronal conditions (Trumbower et al., 
2012). (Trumbower et al., 2012) recently demonstrated that acute IH evokes 
sustained increases in somatic motor output in patients with chronic incomplete 
spinal cord injury.  
 
For the remainder of this chapter a detailed discussion regarding the findings from 
animal studies investigating respiratory LTF and the more limited research 
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performed in humans is given. Finally, a shorter discussion is presented regarding 
progressive augmentation of the HVR where findings from animal and human 
studies are combined. 
 
1.5.3 Respiratory LTF in animals 
 
Respiratory LTF was first described by (Millhorn et al., 1980a) although the term 
respiratory LTF was established later. Anaesthetised, paralysed, vagotomised and 
mechanically ventilated cats were either exposed to five 2-minute episodes of 
carotid sinus nerve stimulation with five-minute intervals, or the same 
duration/interval of rapid warming of a previously cooled carotid body (CB) in order 
to induce the same intermittent firing pattern of the carotid sinus nerve. Phrenic 
activity increased above baseline following both intermittent carotid sinus nerve 
stimulation and intermittent carotid activation and remained above baseline for 
more than 90 minutes. This sustained elevation in phrenic activity was termed 
phrenic LTF and has since been replicated in cats (Millhorn et al., 1980b, Fregosi 
and Mitchell, 1994) and rats (Hayashi et al., 1993, Ling et al., 1997). Although 
intermittent carotid sinus nerve stimulation was used to induce phrenic LTF in 
these early studies investigating respiratory LTF, it was soon demonstrated that 
exposure to acute IH was also capable of inducing phrenic LTF (Hayashi et al., 
1993, Bach and Mitchell, 1996). 
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Respiratory LTF in different respiratory motor nerves 
In addition to phrenic LTF a substantial number of studies have since reported 
acute IH-induced respiratory LTF in various other respiratory motor pools in a 
range of different species (Mateika and Sandhu, 2011, Baker-Herman and Strey, 
2011). These include LTF of hypoglossal (Bach and Mitchell, 1996), 
glossopharyngeal (Cao et al., 2010) and intercostal motor nerves (Fregosi and 
Mitchell, 1994). However, in comparison to phrenic LTF relatively little research 
has been performed on hypoglossal LTF and considerably less again on LTF of 
glossopharyngeal and intercostal motor nerves. As a result far less is understood 
about the mechanisms of LTF of these motor nerves compared with the phrenic 
nerve. Although they appear to be fundamentally very similar (i.e. require serotonin 
receptor activation and require ROS) emerging evidence suggests there may be 
distinct mechanistic differences (e.g. variations in the magnitude of LTF and 
hypoxic pattern sensitivity) (Baker-Herman and Strey, 2011).  
 
Ventilatory LTF in non-anaesthetised animals 
As discussed previously, the beneficial significance of respiratory plasticity is to 
maintain normal arterial blood gas levels during altered environmental or 
physiological conditions. Therefore, for phrenic LTF to have a significant 
physiological impact it must affect ventilatory output under non-anaesthetised 
conditions (e.g. awake or sleeping). Indeed, ventilatory LTF following acute IH has 
been reported in awake goats (Turner and Mitchell, 1997), ducks (Mitchell et al., 
2001b), rats (Olson et al., 2001, McGuire et al., 2002), mice (Kline et al., 2002, 
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Terada et al., 2008), dogs (Cao et al., 1992) and also in sleeping rats and mice 
(Nakamura et al., 2010, Terada et al., 2008). It would thus appear that the 
extensive research in anaesthetised animals focusing on respiratory motor 
neurone LTF is of potential clinical importance, as ventilatory LTF can clearly 
manifest. 
 
Requirement for CO2 
It was realised early on by investigators that reduced chemoreceptor feedback by 
hypoxia-induced hypocapnia could restrain the expression of respiratory LTF. 
Therefore, the majority of studies investigating respiratory LTF in anaesthetised 
animals would first determine the baseline PaCO2 of the apnoeic threshold. PaCO2 
levels were then raised slightly above the apnoeic threshold and maintained 
throughout the study. When PaCO2 was maintained 2-3 mmHg above the apnoeic 
threshold, anaesthetised rodents demonstrate a significant increase in phrenic 
amplitude of 63% (Bach and Mitchell, 1996), 37% (Kinkead and Mitchell, 1999), 
78% (Baker and Mitchell, 2000), and 57% (Fuller et al., 2001) above baseline at 60 
minutes following acute IH. Furthermore, the restraining effect of hypoxia-induced 
hypocapnia on ventilatory LTF is clearly evident in non-anaesthetised rats as an 
increase in ventilation of only 20% was evident 60 minutes post acute IH but 
increased to 57% when supplemental CO2 was subsequently given to return PaCO2 
to baseline levels (Olson et al., 2001). In addition, exposure to acute IH with 10% 
O2 induced ventilatory LTF in rats but exposure to acute IH with 8% O2 did not 
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(McGuire et al., 2002). The authors suggested that the inhibition of ventilatory LTF 
during the 8% O2 exposure was due to a greater HVR that produced a greater 
degree of hypocapnia. 
 
Respiratory LTF in animals is pattern sensitive 
Although there is overwhelming evidence that respiratory LTF can be evoked by 
acute IH in various anaesthetised and conscious animal species (Mateika and 
Sandhu, 2011) acute CH does not appear to be a stimulus capable of eliciting 
respiratory LTF (Turner and Mitchell, 1997, Dwinell et al., 1997, Baker and Mitchell, 
2000, Mitchell et al., 2001b, Tadjalli et al., 2007). Furthermore, respiratory LTF 
following acute IH (Bach and Mitchell, 1996) has been shown to be mediated by a 
serotonin-dependant spinal cord mechanism (see the next section for details) and 
only intermittent but not continuous application of serotonin or serotonin receptor 
(5-HT2) agonists to the spinal cord evokes phrenic (Lovett-Barr et al., 2006, 
MacFarlane and Mitchell, 2009) and hypoglossal LTF (Bocchiaro and Feldman, 
2004).  
 
Mechanisms of respiratory LTF 
Because of the potential to use respiratory LTF as a treatment for OSA and 
respiratory conditions associated with spinal cord injury, there exists a 
considerable body of research specifically investigating the mechanisms 
responsible for respiratory LTF. The majority of this research has focused on 
phrenic LTF and there is overwhelming support for a serotonin-dependent 
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mechanism initiating and maintaining it. Upon first reporting the existence of 
phrenic LTF following intermittent carotid sinus nerve stimulation (Millhorn et al., 
1980b) demonstrated that the mechanism involved activation of serotonin 
receptors because systemic pre-treatment with a serotonin receptor antagonist 
(methysergide) inhibited its development. Furthermore, (Bach and Mitchell, 1996) 
later showed that systemic methysergide administration also prevented phrenic 
LTF evoked by exposure to acute IH. Subsequent studies have since progressed 
our understanding of this serotonin-dependant mechanism for respiratory LTF and 
a well accepted model has been proposed (Mahamed and Mitchell, 2007, 
MacFarlane et al., 2008). Figure 1.5 is adapted from Mahamed & Mitchell (2007) 
demonstrating the proposed serotonin-dependant mechanism for respiratory LTF. 
Phrenic LTF requires spinal serotonin release from medullary raphe serotonergic 
neurons during hypoxic exposure (Baker-Herman and Mitchell, 2002) and 
subsequent activation of serotonin receptors (5-HT2) on respiratory motoneurons in 
the spinal cord (Kinkead and Mitchell, 1999, Fuller et al., 2001). This in turn 
initiates spinal protein synthesis of brain-derived neurotrophic factor (BDNF) that 
subsequently activates its endogenous high affinity receptor tyrosine kinase (TrkB) 
that maintains phrenic LTF (Baker-Herman et al., 2004). Far less research 
examining the mechanisms for LTF in other respiratory motor pools has been 
performed (Baker-Herman and Strey, 2011). However, studies have shown that 
intermittent application of 5-HT2 agonists on or near the respiratory motor pool 
induce hypoglossal LTF (Bocchiaro and Feldman, 2004). Furthermore, both 
hypoglossal and glossopharyngeal LTF are 5-HT2 receptor dependant (Fuller et al., 
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2001, Cao et al., 2010), suggesting LTF of all inspiratory motor pools may be 
serotonin dependant.  
 
 
Figure 1.5: Schematic demonstrating the proposed responsible mechanistic pathway for phrenic 
LTF. 5-HT2 receptors on respiratory motoneurons are activated by IH-mediated spinal serotonin 
release from medullary raphe serotonergic neurons. Subsequent spinal protein synthesis (e.g. 
brain-derived neurotrophic factor - BDNF) activates its endogenous high affinity receptor tyrosine 
kinase (TrkB) which maintains phrenic LTF. Schematic adapted from Mahamed & Mitchell (2007). 
 
1.5.4 Respiratory LTF in humans 
At present we are some way from understanding how best to utilise respiratory LTF 
as a therapeutic strategy for respiratory conditions such as OSA and if it is 
beneficial at all. However, because of the promising evidence from animal studies 
demonstrating respiratory LTF of considerable magnitude, a growing body of 
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translational human research has also been performed and is attracting increasing 
interest. 
 
The first published study to specifically investigate respiratory LTF in humans was 
16 years after the phenomenon was first reported in animals (McEvoy et al., 1996). 
Eleven awake male volunteers were exposed to ten 2-minute hypoxic episodes 
(SaO2 80%) that were separated by two-minute intervals of euoxia whilst isocapnia 
was maintained at baseline levels throughout. Minute ventilation (V˙E), 
diaphragmatic activity and genioglossus muscle activity were measured at 
baseline, during acute IH and for ten minutes during recovery. However, LTF was 
not demonstrated in any of these respiratory variables suggesting that in contrast 
to animals acute IH is not a stimulus capable of eliciting respiratory LTF in awake 
humans. Of course one negative finding does not categorically rule out the 
existence of respiratory LTF in humans and scientists continued to attempt to 
evoke respiratory LTF in numerous studies that followed. During the next decade 
the effect of gender, the duration of hypoxic exposures, the intensity of hypoxic 
exposures, duration of recovery and previous exposure to IH on the development 
of respiratory LTF were all examined without any form of respiratory LTF being 
reported in healthy awake humans (Mateika & Sandhu, 2011). There was only 
slightly more success in studies of sleeping humans where ventilatory LTF was at 
least reported in individuals with inspiratory flow limitations (Babcock and Badr, 
1998) and LTF of upper airway dilator muscle activity in OSA patients (Aboubakr et 
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al., 2001). It wasn’t until 2006 when respiratory LTF was first reported in healthy 
humans where the requirement for elevating CO2 was demonstrated (Harris et al., 
2006). 
 
Requirement for PaCO2 being above the chemoreflex threshold 
Based on previous animal studies that highlighted the importance of PaCO2 levels 
on the expression of respiratory LTF, it was postulated that previous unsuccessful 
attempts to induce respiratory LTF in awake humans may be due to PaCO2 levels 
being below the central and peripheral chemoreflex thresholds. During 
wakefulness in humans PaCO2 levels below the ventilatory threshold have little or 
no effect on ventilation. In contrast to sleep, this reduction in chemoreflex-initiated 
ventilatory drive does not lead to the abolishment of ventilation as it can be 
sustained by arousal and/or behavioural stimuli. Therefore, under normal PaCO2 
conditions during wakefulness the responsible mechanism(s) for mediating 
respiratory LTF could have been activated during acute IH but the expression of 
respiratory LTF may have been restrained because ventilation was not controlled 
by the chemoreflex. By raising the end-tidal partial pressure of CO2 (PETCO2) 5 
mmHg above normal wakefulness levels and maintaining this throughout acute IH 
and recovery, ventilatory LTF and LTF of genioglossus muscle activity was 
expressed in awake humans (Harris et al., 2006). A number of subsequent studies 
by the same group have since replicated these results and also demonstrated the 
existence of ventilatory LTF in women and OSA patients (Wadhwa et al., 2008, 
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Lee et al., 2009, Gerst et al., 2011). Prior to the study by (Harris et al., 2006) 
respiratory LTF of any form had not been demonstrated in healthy sleeping 
humans without upper airway flow limitations (e.g. snoring or OSA) despite 
numerous attempts (Mateika and Sandhu, 2011). Ventilation during sleep is 
completely controlled by the chemoreflex and thus it might be expected that 
respiratory LTF would have been expressed following exposure to IH without 
having to raise PaCO2 levels in these studies. However, exposure to hypoxia 
increases ventilation and drives down PaCO2 levels which may have impaired the 
expression of respiratory LTF. Indeed, in future studies that gave supplemental 
CO2 during hypoxic episodes to prevent the hypoxic-induced hypocapnia reported 
both ventilatory LTF (Pierchala et al., 2008) and LTF of genioglossus muscle 
activity (Chowdhuri et al., 2008) in healthy, non flow-limited individuals.  
 
Is respiratory LTF in humans pattern sensitive? 
Since the initial study by (Harris et al., 2006) demonstrated the requirement for 
supplemental CO2 for the expression of respiratory LTF, many more studies have 
reported IH-induced respiratory LTF in hypercapnic awake humans (Lee et al., 
2009, Wadhwa et al., 2008, Gerst et al., 2011, Diep et al., 2007) and in isocapnic 
sleeping humans (Pierchala et al., 2008, Chowdhuri et al., 2008). However, it has 
not been investigated if under these elevated PaCO2 conditions acute CH can also 
evoke respiratory LTF. Although animal evidence strongly suggests the 
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manifestation of respiratory LTF requires an intermittent pattern of hypoxic 
exposure it cannot be assumed that humans will respond in the same way. 
 
Mechanisms of respiratory LTF 
As a result of the invasive nature of the majority of techniques used in animal 
studies to gain mechanistic insights into the development of respiratory plasticity 
only limited translational research has been undertaken in humans. Furthermore, 
the initial demonstration of respiratory LTF in humans occurred relatively recently 
(Harris et al., 2006) in comparison to that of animals (Millhorn et al., 1980a). As a 
result the limited number of studies investigating respiratory LTF in humans have 
primarily focused on confirming its existence in different genders (Wadhwa et al., 
2008), in OSA patients (Lee et al., 2009) and examining whether time of day and 
repeated exposures alters its magnitude (Gerst et al., 2011). (Lee et al., 2009) 
exposed OSA patients and healthy controls to acute IH in order to examine 
whether ventilatory LTF was enhanced in OSA patients. Their results demonstrate 
that respiratory LTF was augmented in OSA patients and also showed that the 
augmentation was abolished by systemic administration of antioxidants. This data 
supports evidence from animal studies that have demonstrated prior exposure to 
chronic IH augments respiratory LTF and that it is mediated by ROS (Del Rio et al., 
2010, MacFarlane et al., 2008). However, because antioxidant administration only 
abolished the augmentation in respiratory LTF in OSA patients but did not affect 
that occurring in healthy controls the mechanisms responsible for initiating and 
maintaining respiratory LTF following acute IH in healthy humans remain unknown. 
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1.5.5 Progressive augmentation of the HVR 
Research into progressive augmentation of the HVR has received far less attention 
than respiratory LTF, presumably because in contrast to respiratory LTF it is widely 
considered that it may have a detrimental rather than a beneficial effect on 
breathing stability in OSA patients. The first indication of progressive augmentation 
of the HVR was reported in inspiratory intercostal nerve and phrenic activity of 
anesthetized cats during intermittent carotid sinus nerve stimulation (Fregosi and 
Mitchell, 1994). Progressive augmentation of phrenic and hypoglossal nerve 
activity of anesthetized rats has since been reported during acute IH (Fuller, 2005). 
Furthermore, progressive augmentation of V˙E during successive hypoxic episodes 
has been reported in awake goats (Turner and Mitchell, 1997) awake ducks 
(Mitchell et al., 2001b) and anaesthetized rabbits (Sokolowska and Pokorski, 
2006). However, there also exist studies that report that progressive augmentation 
of the HVR is not evident during acute IH in animals (Olson et al., 2001, McGuire et 
al., 2002). 
 
Requirement for CO2 
As is the case with respiratory LTF following IH the demonstration of progressive 
augmentation of the HVR in some studies and its absence in others may be due to 
the level of PaCO2. Indeed, all animal studies that demonstrated progressive 
augmentation of the HVR utilised supplemental CO2 to prevent hypoxia-induced 
hypocapnia (Mateika and Narwani, 2008). Furthermore, in early human studies 
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investigating respiratory plasticity PETCO2 during hypoxic exposures was kept at, or 
below normal levels, which may explain why progressive augmentation of the HVR 
as measured by V˙E and/or genioglossus activity was not demonstrated (McEvoy et 
al., 1996, Jordan et al., 2002, Mateika et al., 2004, Khodadadeh et al., 2006). 
When mild hypercapnia was sustained throughout hypoxic exposures progressive 
augmentation of both V˙E and genioglossus activity was expressed (Harris et al., 
2006) with the former having since been confirmed in other studies (Wadhwa et al., 
2008, Lee et al., 2009, Gerst et al., 2011). 
 
The relationship between the HVR and PaCO2 is important because progressive 
augmentation of the HVR may be due to alterations in either the ventilatory 
recruitment threshold or peripheral sensitivity (Duffin, 2007). Therefore, as 
ventilation in human studies was assessed during successive hypoxic exposures at 
a single level of hypercapnia (Wadhwa et al., 2008, Lee et al., 2009, Gerst et al., 
2011) it is not clear if the progressive augmentation of the HVR was due to an 
enhancement of chemosensitivity (i.e. sensitivity to PaCO2) or whether the 
ventilatory recruitment threshold (i.e. when ventilation begins to increase in a linear 
fashion to elevated PaCO2 having had little effect at lower levels of PaCO2) is 
lowered. To determine whether the recruitment threshold is altered it is necessary 
to perform a hypoxic chemosensitivity test where PaCO2 is progressively increased 
from a significantly hypocapnic level and thus the ventilatory threshold can be 
determined. Three studies on humans have been undertaken where such tests 
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were performed before and after exposure to IH (Morelli et al., 2004, Mateika et al., 
2004, Ahuja et al., 2007). In all three studies chemosensitivity during hypoxia was 
increased without a change in the ventilatory threshold. 
 
Is progressive augmentation of the HVR the same phenomenon as 
respiratory LTF and what is the responsible mechanism(s)? 
As discussed previously, it is commonly believed that respiratory LTF may mitigate 
OSA by facilitating ventilation and upper airway muscle activity, whereas 
progressive augmentation of the HVR is more likely to promote OSA by promoting 
hypocapnia and reducing ventilatory drive (Mateika and Narwani 2008). If artificially 
inducing or enhancing respiratory LTF is to be used as a successful treatment for 
OSA it will need to occur in the absence of progressive augmentation of the HVR. 
However, it has been suggested that progressive augmentation of the HVR and 
respiratory LTF could be the same form of respiratory plasticity just demonstrated 
under different O2 tensions but mediated by the same mechanism(s) (Richerson, 
2010). 
 
It is well understood in animals that respiratory LTF is mediated by a serotonin 
dependant spinal cord mechanism as discussed previously (see: mechanisms of 
respiratory LTF). Interestingly, (Fregosi and Mitchell, 1994) reported that although 
pre-treatment with a serotonergic antagonist (methysergide) abolished the 
development of respiratory LTF in cats following intermittent carotid sinus nerve 
stimulation it did not affect the expression of progressive augmentation of phrenic 
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and intercostal nerve activity. These results would suggest that progressive 
augmentation of the HVR is independent of respiratory LTF as they require 
different mechanisms for their development. Because the CB plays a predominate 
role in numerous time dependant ventilatory responses to hypoxia such as 
acclimitisation to CH (Powell et al., 1998) it seems logical that the CB would 
contribute to the progressive augmentation of the HVR following IH. However, an 
interesting finding from the study by (Fregosi and Mitchell, 1994) is that 
progressive augmentation of phrenic and intercostal nerve activity manifest during 
intermittent carotid sinus nerve stimulation independent of the CB being exposed to 
IH. This would suggest that progressive augmentation of the HVR can be evoked 
independently of a change in peripheral chemoreflex sensitivity. These findings are 
supported by (Peng et al., 2003) who demonstrated that both in and ex vivo CB 
afferent discharge did not change from the first to the last hypoxic episode during a 
pattern of IH previously shown to evoke progressive augmentation of the HVR. No 
animal study has since been undertaken to further investigate what is the 
responsible mechanism(s) for progressive augmentation of the HVR. All we can 
conclude from the available animal literature is that progressive augmentation of 
the HVR is mediated independent of a change in CB chemoreflex responsiveness 
or a serotonin dependant mechanism in the spinal cord.  
 
Even less has been learnt from human studies regarding the mechanisms for 
progressive augmentation of the HVR as invasive techniques performed in animal 
studies cannot be replicated (e.g. carotid sinus nerve stimulation and application of 
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serotonin inhibitors). The most informative method that can be used is to perform 
two different CO2 sensitivity tests. One test is performed under hypoxic conditions 
to determine the combined contribution of the central and peripheral chemoreflex 
to the HVR and the other under hyperoxic conditions to determine the independent 
contribution of the central chemoreflex. These tests have been performed in three 
separate studies on humans before and after exposure to IH (Morelli et al., 2004, 
Mateika et al., 2004, Ahuja et al., 2007). It was shown in all three studies that 
combined central and peripheral chemoreflex sensitivity was significantly increased 
following IH. A smaller independent increase in central chemoreflex sensitivity was 
shown in all studies but only in one of these studies was it statistically significant 
(Morelli et al., 2004). In Mateika’s et al. (2004) study the increase in central 
chemosensitivity was subtracted from that of the larger increase in the combined 
central and peripheral chemosensitivity. Because there remained a significant 
increase in sensitivity after the subtraction of the central component, the authors 
claim that exposure to IH has increased peripheral chemosensitivity. However, this 
assumption relies on the resulting ventilatory response of the peripheral and 
central chemoreflexes being simply additive, which is not the case. Indeed, (Blain 
et al., 2010) recently showed that in dogs there is a substantial hyperadditive 
interaction between the peripheral and central chemoreflexes. Therefore, it cannot 
be concluded that IH did not enhance this hyperadditive interaction between 
central and peripheral chemoreflexes without actually altering peripheral 
chemosensitivity. Furthermore, as a result of this substantial hyperadditive 
interaction it cannot be confirmed that the modest increase in central 
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chemosensitivity shown in all studies does not account for the majority of the 
increase in chemosensitivity when the peripheral chemoreflex is also active.  
 
1.5.6 Summary of respiratory plasticity 
The potential for harnessing or artificially evoking IH-induced respiratory LTF as a 
treatment for conditions associated with respiratory insufficiency has certainly 
attracted much interest from scientists over the last three decades. As a result of 
this extensive research it would appear that we have greatly expanded our 
understanding of the responsible mechanisms of respiratory plasticity. Indeed, 
scientists can now induce respiratory LTF in animals by administering specific 
proteins into the spinal cord (Hoffman and Mitchell, 2011) in the absence of 
exposure to IH. Therefore, it would seem likely that animal research will now focus 
on being able to administer these specific proteins intravenously and if successful 
the next step will be to test their effectiveness in humans. Sceptics of inducing 
respiratory LTF as a treatment for OSA will argue that there is no evidence to 
suggest that respiratory plasticity will be beneficial to breathing stability. Although 
this is a valid argument, it may be that the magnitude of respiratory plasticity that is 
developed during OSA may be too small to have any noticeable effect but greater 
magnitudes of artificially induced respiratory LTF may be beneficial. However, 
there also exist a number of other concerns regarding the potential benefit of 
inducing respiratory LTF via pharmaceutical aids that have been developed based 
on our understanding of respiratory LTF in animals. Overwhelming evidence has 
indicated that a central mechanism mediates respiratory plasticity in animals and 
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studies have identified the exact proteins (e.g. BDNF) in the spinal cord that are 
responsible for its manifestation. However, in contrast to the huge body of animal 
research regarding IH-induced respiratory plasticity there exists only very limited 
translational human research. Indeed, at present there is not a single study that 
has been performed to confirm that respiratory LTF is mediated by a central 
mechanism in humans. If in fact a change in CB activity maintains respiratory LTF 
in humans, then strategies to increase concentrations of proteins such as, BDNF in 
the spinal cord might not have the same effect on respiration as it does in animals. 
Furthermore, there is convincing evidence in animals that respiratory LTF is pattern 
sensitive and that only IH or intermittent serotonin receptor activation evokes 
respiratory LTF. However, since it was demonstrated in humans that elevating 
PaCO2 was a requirement for the manifestation of respiratory LTF following acute 
IH it has not been examined whether acute CH also causes respiratory LTF under 
these conditions.  
 
1.6 Aims of this thesis and proposed studies 
 
This thesis consists of one methodological chapter and five experimental chapters. 
The first aim of the thesis was to develop a new airway occlusion model of OSA 
that could be used to better investigate the effects of OSA-related IH. The 
development of this model is described in detail in chapter 2. The first experimental 
study (chapter 3) examined the success of using Doppler ultrasound to investigate 
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the effects of IH as it occurs in OSA on pulmonary haemodynamics in humans 
using the new model of airway occlusions. Also using the new model of airway 
occlusions in the second study (chapter 4), we aimed to investigate the 
manifestation of respiratory plasticity following hypoxic airway occlusions and to 
investigate whether exposure sensitises HPV in humans. By reducing the PIO2 in 
the third study (chapter 5) we aimed to investigate whether acute CH in addition to 
acute IH can induce respiratory LTF in humans and what were the responsible 
mechanisms (e.g. changes in peripheral or central chemosensitivity). In the fourth 
study (chapter 6) we examined the effects of simultaneous hyperglycaemia on 
oxidative stress during IH as induced using an airway occlusion model of OSA in 
rats. Finally, in the fifth study (chapter 7) we investigated whether simultaneous 
exposure to combined postprandial hyperglycaemia and hyperlipidaemia increased 
oxidative stress during exposure to intermittent reductions in PIO2 in humans. 
 
1.6.1 Primary questions investigated in this thesis 
1) Can a new human airway occlusion model of OSA be successfully 
implemented in experimental research investigating the cardiovascular and 
respiratory effects of IH as occurs in OSA?  
2) What is the contribution of hypoxia to the elevation in PAP during apnoeas 
and does IH sensitise hypoxic pulmonary vasoconstriction in humans? 
3) Does exposure to hypoxic airway occlusions elicit respiratory plasticity in 
humans?  
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4) During sustained mild hypercapnia does ventilatory LTF manifest in awake 
humans following acute exposure to CH? 
5) Is ventilatory LTF following acute IH and/or acute CH actively maintained by 
the CB? 
6) Does simultaneous exposure to hyperglycaemia augment oxidative stress 
during hypoxic airway occlusions in rats? 
7) Is oxidative stress during acute exposure to IH augmented by simultaneous 
exposure to combined postprandial hyperglycaemia and hyperlipidaemia in 
humans? 
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2 CHAPTER 2 – GENERAL METHODS 
 
2.1 Gas control 
 
Experiments were undertaken in this thesis to examine the effects of OSA-related 
IH on various physiological systems. The study of the effects of a gas in the body 
depends on its presence in arterial blood and in order to induce arterial hypoxia it is 
necessary to manipulate (lower) the PIO2. Therefore, in experiments studying OSA 
and the effects of the associated IH, scientists have used protocols during which 
participants breathe alternating gas mixtures of low and normal PIO2. However, 
humans vary greatly in their ventilatory response to a set PIO2 and thus the 
resulting PaO2 will also vary substantially. Furthermore, increased ventilation during 
hypoxia
 
is not accompanied by a parallel elevation in metabolic rate and thus 
hypocapnia manifests. Therefore, implicating the physiological effects to hypoxia is 
complicated by hypocapnia, which may cooperate or compete with it. Although 
increasing the PCO2 of the inspired gas mixture can be used in an attempt to 
abolish hypocapnia, the amount of inspired PCO2 that is needed for this purpose 
also depends on the individual ventilatory response to hypoxia. For this reason, 
eucapnic conditions that are maintained accurately are hard to achieve with set 
inspired gas mixtures. In order to overcome the limitations of using a set inspired 
stimuli, Swanson and Bellville 1975 developed a computer-controlled prediction-
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correction scheme, further developed by (Robbins et al., 1982) called dynamic 
end-tidal forcing (DEF). 
 
2.1.1 Dynamic end-tidal forcing 
The DEF system allows PAO2 and PACO2 to be tightly maintained at desired values 
despite the variation in respiratory responses to these respiratory stimuli between 
individuals. A fundamental principle of the DEF system is the assumption that an 
equilibration between alveolar PO2 and PCO2 and that of arterial blood returning to 
the heart is achieved. Measuring PETO2 and PETCO2 allows an indirect 
measurement of arterial PO2 and PCO2. In order to evoke the desired PETO2 and 
PETCO2 values in an individual, a formula based on models of the circulation and 
the respiratory system is used to predict the required inspired gas composition. 
During experiments the actual values of PETO2 and PETCO2 are measured for each 
breath and they are compared to the desired values. A correction scheme is then 
utilised to alter the initial prediction for the subsequent breath based on the 
difference between the actual and desired end-tidal values. 
 
In all experiments the 
prediction and correction elements of the DEF system (as described below) were 
applied using PC-based software (BreathM, Oxford, UK). 
 
Prediction: Calculations to predict the inspired gas compositions that are required 
to generate the desired end-tidal profiles are performed in advance of each 
experiment. These calculations are initially derived from the mass balance 
&)"
"
equations of O2 and CO2 in the lungs providing an equation whereby the inspired 
partial pressure (PI) of the gas in question can then be derived as shown below 
(equation 1) (Robbins et al., 1982), 
    
where V!A is alveolar ventilation, PA is the partial pressure of the gas in question in 
the alveoli, VL is the lung volume, λ is a coefficient dependent on units, Q˙   is 
pulmonary blood flow, Ca is the arterial concentration of the gas in the blood, and 
Cv–   is the concentration of the gas in question in mixed venous blood. This 
equation is then solved using a two-component model of the respiratory control 
system that includes the peripheral and central chemoreflex and a multi-
component model of the circulatory system. 
 
Correction: An integral-proportional feedback system is used to make corrections 
to the predictive inspired gas compositions based on the difference between 
desired end-tidal values and the actual values measured for each breath as shown 
below (equation 2),  
   
where PIC is the predicted inspired partial pressure, PETd is the desired end-tidal 
partial pressure, PETm is the measured end-tidal partial pressure, gp is the 
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proportional feedback gain, and gi is the integral feedback gain.  Proportional 
feedback is calculated from the difference between actual and desired end-tidal 
values from the last breath and it is used to reduce breath-to-breath variation 
whereas integral feedback is calculated from the sum of the differences from all 
previous breaths. Both gains can be adjusted manually during experiments to 
generate greater accuracy.  
 
2.2 Development of a novel airway occlusion model of OSA 
 
2.2.1 General 
Research investigating whether IH might mediate the development and 
progression of cardiovascular disease in OSA patients has predominantly been 
performed in animals. These studies have most commonly elicited IH independent 
from other stimuli occurring in OSA by simply intermittently reducing the PIO2. 
Although these studies have supplied valuable data highlighting the potential risk to 
health from exposure to IH, this approach is limited in its success in mimicking IH 
caused by OSA (see: General introduction). Therefore, recent studies have begun 
utilising a variety of airway occlusion models to investigate the pathology of OSA-
related IH (Simpson et al., 2008, Othman et al., 2010, Schoorlemmer et al., 2011). 
However, until now only limited research has been completed in humans with 
these studies evoking IH by reducing the PIO2 or using repetitive breath-holds to 
rather weakly mimic OSA. Further human research is required to better understand 
'!"
"
the pathological consequences of OSA-related IH and an accurate laboratory 
model of OSA may enhance future research. Therefore, we attempted to design a 
model of OSA whereby awake humans could be exposed to as many of the 
different components of OSA as possible with or without simultaneous hypoxia. We 
hoped that this model could then be used in future studies throughout this thesis to 
investigate the effects of OSA-related IH on various physiological variables such 
as, ventilation, oxidative stress, pulmonary and systemic haemodynamics etc. 
 
2.2.2 Existing models of OSA and identification of potential improvements 
We are not the first to attempt to develop a model of OSA in awake humans as 
scientists realised early on that exposure to reduced PIO2 may not be the best 
approach to investigate the effects of IH that occur in OSA. Indeed, a number of 
studies have previously been performed using breath-holds in awake humans to 
better mimic an apnoeic event (Cutler et al., 2004a, Cutler et al., 2004b, 
Leuenberger et al., 2007, Leuenberger et al., 2005). Cutler and colleagues were 
the first to study the effects of repetitive breath-holds and had participants perform 
them for 20 seconds on end-expiration, every minute for 20 minutes (Cutler et al., 
2004b, Cutler et al., 2004a). Each breath-hold was preceded by two breaths of 
100% N2 to augment the drop in SaO2 during the breath-hold and induce post-
apnoeic SaO2 nadirs in the range of 80-85%. The only alteration from this design 
used in subsequent studies by Leuenberger and colleagues (2005 & 2007) was 
that the two breaths of 100% N2 were replaced with 20 seconds breathing 10% O2. 
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In all four of these breath-hold studies participants were requested to briefly exhale 
following each 20-second apnoea to measure PETCO2. This demonstrates a 
significant elevation from pre breath-hold values and thus participants are exposed 
to intermittent hypercapnia in addition to IH as occurs during obstructive apnoeas 
in OSA. Furthermore, these hypoxic breath-holds induced transient elevations in 
sympathetic activity and systemic blood pressure and evoked hyperventilation and 
tachycardia immediately post breath-hold that are all known to occur during an 
apnoeic cycle in OSA. 
 
These hypoxic breath-hold models of OSA are certainly an improvement from 
simply exposing individuals to reductions in PIO2. However, during an obstructive 
apnoea patients continue to produce inspiratory attempts against the occluded 
airway that become more frequent and progressively greater in force as the 
apnoea continues. Each occluded inspiratory effort generates negative 
intrathoracic pressure that has been reported to fall as low as -65 mmHg (Malone 
et al., 1991). These brief but severe negative intrathoracic pressures have a 
number of significant haemodynamic effects on the heart. Firstly, venous return is 
augmented as a result of the large pressure gradient generated between the extra 
and intrathoracic space (Moreno et al., 1967). Secondly, studies on OSA patients 
have demonstrated reduced SV during occluded inspiratory efforts (Tolle et al., 
1983). Furthermore, a recent study in humans using echocardiography 
demonstrated that the decrease in SV during negative intrathoracic pressure is a 
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result of decreased ejection fraction and is subsequently associated with elevations 
in left ventricular afterload (Orban et al., 2008). The pathological consequences of 
these haemodynamic disturbances are not fully understood although it is known 
that the resulting repetitive congestion of blood in the pulmonary system transiently 
increases PAP (Marrone et al., 1994, Schafer et al., 1998). Furthermore, the same 
study by (Orban et al., 2008) demonstrated that left atrial volume fell during 
negative intrathoracic pressures but rapidly increased above baseline during 
resumption of normal intrathoracic pressure (Orban et al., 2008). The physiological 
effects of these frequent elevations in left atrial volume are currently unknown but 
the authors suggest that the atrial wall stretch could be significant enough to 
account for the elevated levels of atrial natriuretic peptide that OSA patients 
experience during the night.  
 
Based on the aforementioned evidence that negative intrathoracic pressures can 
cause significant swings in chamber volumes and affect PAP it is plausible that any 
detrimental effect of IH on the cardiovascular system may be augmented when 
simultaneous to these negative intrathoracic pressures. We felt that occluded 
inspiratory efforts should be incorporated into our model of OSA. 
 
Another potential improvement to existing models of OSA would be the inclusion of 
a more accurate method to control the level of hypoxia occurring during airway 
occlusions. As previously discussed, in existing models of OSA participants are 
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exposed to a brief period of reduced PIO2 immediately prior to performing a breath-
hold (Cutler et al., 2004a, Cutler et al., 2004b, Leuenberger et al., 2007, 
Leuenberger et al., 2005). This is required because a brief 20-second breath-hold 
in awake humans who were previously breathing room air evokes only a very small 
decrease in SaO2 (Leuenberger et al., 2005). In contrast, SaO2 in OSA patients 
frequently falls into the low 80s (%) and in severe cases can fall into the low 50s 
(%) (Sforza et al., 1998). This substantial difference in SaO2 nadirs between 
wakefulness and sleep may be due to a combination of the following: lower resting 
PaO2 levels during sleep vs. wakefulness; reduced airflow pre apnoea due to 
partial upper airway collapse (hypopnoea); longer duration of apnoeas than the 20 
seconds that can be performed in awake humans; and incomplete re-oxygenation 
between apnoeas.  
 
When developing our airway occlusion model of OSA we noticed that the drop in 
PETO2 (that in healthy individuals represents PaO2) following two breaths of 100% 
N2 varied greatly between and within individuals and it was influenced by the 
individual’s tidal volume (TV). Figure 2.1 shows original data from two participants 
that demonstrate very different PETO2 values following two breaths of 100% N2. 
Furthermore, the PaO2 generated from breathing a set inspiratory gas composition 
for longer periods (e.g. 20 seconds of 10% O2) is dependent not only on the gas 
composition but also on the ventilatory response that ensues which can vary 
greatly between individuals. This variation in PaO2 prior to airway occlusions could 
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have important consequences on the severity of post airway occlusion nadirs in 
SaO2. The oxygen-haemoglobin dissociation curve demonstrates a sigmoidal 
shape and thus a small change in PaO2 (± 10 mmHg) around a pre airway 
occlusion value of PaO2 of 80 mmHg has little effect on SaO2 (~3%). However, the 
same change (± 10 mmHg) around a lower post airway occlusion PaO2 of 50 
mmHg has a much greater effect on SaO2 (~12%). Therefore, to ensure post airway 
occlusion nadirs in SaO2 were similar between individuals and similar between 
repetitive airway occlusions in the same individual we felt that PETO2 should be 
clamped at an individually tailored level prior to each airway occlusion.  
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Figure 2.1: Original data showing SaO2, PETO2 and tidal volume (TV) during
exposures to 100% inspired N2 in two participants. Note how PETO2 falls to
~60 mmHg after two breaths of 100% N2 in the participant with a large TV (A)
and just ~72 mmHg in the participant with a small TV (B).
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In a previous study by (Leuenberger et al., 2005) to determine whether IH was 
responsible for any of the physiological effects caused by exposure to hypoxic 
breath-holds, participants were also exposed to breath-holds that were preceded 
by room air breathing rather than reductions in PIO2. However, as a small but 
significant drop in SaO2 still developed during these breath-holds the success of 
using these breath-holds following room air breathing as a control trial is restricted. 
Although acute exposures to this mild IH may not be sufficient to evoke any 
physiological effects independently, it should be considered that it may still greatly 
enhance the effects from other simultaneous stressors such as hypercapnia and 
haemodynamic stress during negative intrathoracic pressures. Therefore, we felt 
that airway occlusions used in any control trials should be preceded by mild 
hyperoxia to completely abolish any drop in SaO2. As with inducing mild hypoxia 
prior to airway occlusion we felt that the elevation in PETO2 during hyperoxia should 
be clamped at an individually tailored level to ensure post airway values of PETO2 
are consistent between individuals.  
 
A final point to consider in the design of a model to mimic OSA is that of PaCO2. 
During sleep PaCO2 is higher than during wakefulness and in patients with OSA 
PaCO2 may also rise further during reductions in airflow before an apnoeic event 
due to a partial collapse of the upper airway (hypopnoea). Therefore, the post-
apnoeic PaCO2 is greater during sleep than following a breath-hold of the same 
duration during wakefulness. The existing hypoxic breath-hold studies not only 
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ignored the issue of the level of hypercapnia following a breath-hold but may also 
have caused it to be even lower by using poikilocapnic hypoxia before each airway 
occlusion (Cutler et al., 2004a, Cutler et al., 2004b, Leuenberger et al., 2007, 
Leuenberger et al., 2005). Therefore, we considered introducing a small elevation 
in PaCO2 prior to airway occlusions would better mimic the magnitude of 
intermittent hypercapnia experienced in OSA. 
 
For artificially induced airway occlusions to most accurately mimic the cycle of 
apnoeas occurring in OSA these airway occlusions should be elicited during sleep. 
This would allow both the post apnoeic arousals and the subsequent transient 
elevations in sympathetic activity to be replicated. However, although occluding the 
airway during sleep could theoretically be achieved by wearing a facemask and 
briefly causing an obstruction to the external airway (tubing), we believed it would 
be unsafe and would cause complete arousal from sleep rather than the partial 
arousal that occurs in OSA. Furthermore, the ability to perform experimental 
measurements such as those of PAP using Doppler ultrasound would not be 
possible with sleeping participants. Therefore, we were restricted to developing an 
airway occlusion model of OSA in awake humans. 
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Summary of suggested improvements to existing models of OSA 
1) Addition of inspiratory efforts against an occluded airway that mimic both the 
increasing frequency and increasing negative intrathoracic pressures that 
occur during an obstructive apnoea. 
 
2) Tailor the degree of hypoxia prior to airway occlusions in each individual to 
allow tight control of post airway occlusion nadirs in SaO2.  
 
3) Elicit mild hyperoxia prior to airway occlusions and tailor the degree of 
hyperoxia to each individual in order to completely inhibit the development 
of hypoxia and thus provide a successful control for hypoxic airway 
occlusions. 
 
4) Introduce a small elevation in PETCO2 prior to airway occlusions in order to 
better mimic the degree of intermittent hypercapnia that occurs during 
apnoeas in OSA patients.  
 
2.2.3 Model design 
Participant position: Although the airway occlusions could easily be performed 
whilst sitting, having participants lie down would be more comfortable for longer 
periods and it would better reflect the body position during sleep. Furthermore we 
chose to have participants lie on their back as obstruction of upper airway is more 
common when lying in this position due to gravity pulling the tongue to the back of 
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throat (except for during ultrasound measurements when it was necessary for 
participants to turn on their side). 
 
Duration of airway occlusions: Existing human models of OSA have all used 
breath-holds lasting 20 seconds. We hoped to be able to extend the duration of the 
breath-holds in order to cause the required degree of hypoxia without having to 
reduce inspired O2 prior to airway occlusions. However, although most participants 
that were involved in the development of the model could perform 30-second 
breath-holds at end expiration, not all of them could do this without considerable 
discomfort. Therefore, to ensure we did not introduce a participant selection bias 
into studies using this model we chose to restrict airway occlusions to 20 seconds. 
 
Frequency of airway occlusions: In order to produce a sufficiently strong 
stimulus to elicit measurable physiological changes following a relatively short 
duration of airway occlusions (e.g. several hours per day) we deemed it necessary 
to mimic the frequency experienced by patients with severe OSA (apnoea 
hypopnoea index of " 30). Therefore, we chose to induce airway occlusions every 
90 seconds which equated to an apnoea hypopnoea index of 40. This selected 
frequency of airway occlusions still allowed a suitable duration of unrestricted room 
air breathing between airway occlusions to ensure adequate re-oxygenation and 
thus induced the intermittent pattern of hypoxia experienced by most OSA patients. 
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Furthermore, it provided a suitable duration to allow good control of desired PETO2 
and PETCO2 prior to the next airway occlusion. 
 
Occluding the airway: In OSA the upper airway collapses during the initial phase 
of inspiration when negative upper airway pressure is generated. However, it was 
not feasible to occlude the airway during inspiration in awake humans due to 
discomfort and thus we decided to occlude the airway at the end of expiration. To 
this end an inflatable balloon valve (Hands Rudolph, 9340 series) consisting of a 
small length of translucent tubing with a small silicone rubber balloon in the centre 
was attached to the breathing circuit near the mouthpiece (see figure 2.2 for a 
photo of the apparatus). Air flow was continuously measured by a pneumotach 
positioned beyond the balloon valve and recorded by computer software (Spike2 
version 5.21). To induce an airway occlusion at a given time the computer would 
search for zero flow at the end of the expiration and a signal would be sent to open 
a solenoid valve. Compressed air would then rapidly inflate the balloon valve which 
formed a tight seal inside the tubing. The balloon valve would remain inflated for 20 
seconds at which point a signal would automatically be sent to close the solenoid 
valve and the balloon valve would deflate rapidly.  
 
Frequency of occluded inspiratory efforts during an airway occlusion: We 
were unable to find any published literature concerning the average frequency of 
occluded inspiratory efforts during apnoeas in OSA patients, only that the 
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frequency of these efforts increases as the apnoea continues. In theory, it would be 
possible to measure resting breathing frequency in each participant and base the 
initial frequency of inspiratory efforts on this. However, it is well known that 
breathing frequency varies greatly between individuals and thus making 
comparisons between the effects of airway occlusions between individuals would 
be complicated by having a different number of occluded inspiratory efforts. 
Therefore, in the absence of any strong support for a specific number of inspiratory 
efforts against the occlusion and the increase in frequency of these efforts during 
the 20-second airway occlusions, we included five inspiratory efforts during the 20-
second airway occlusion which progressively increased in frequency as shown in 
Table 2.1.  
 
Negative intrathoracic pressures: The gold standard for estimating intrathoracic 
pressures in OSA patients is to use an oesophageal balloon-tipped pressure 
sensor. However, changes in pressure recorded at the mouth during occluded 
inspiratory efforts have previously been shown to closely correlate to changes in 
oesophageal pressure (Baydur et al., 1982). Therefore, a pressure gauge was 
positioned between the mouthpiece and the balloon valve as shown in figure 2.2. 
This enabled negative intrathoracic pressures during the occluded inspiratory 
efforts to be measured and recorded on a computer. During an obstructive apnoea 
inspiratory efforts gradually increase in force and thus so do the negative 
intrathoracic pressures that are generated. The greatest nadir in intrathoracic 
pressure generated during the end of apnoeas varies greatly between OSA 
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patients as studies have reported values to peak anywhere between -15 mmHg 
and -65 mmHg (Malone et al., 1991). During the development of this model we 
asked participants to attempt a range of different negative pressures and 
concluded that producing pressures much beyond -40 mmHg was uncomfortable. 
We therefore limited the peak desired intrathoracic pressure to -35 mmHg as 
shown in table 2.1.  
 
LED signalling panel: To ensure airway occlusions with inspiratory efforts could 
be successfully and safely performed over a long durations it was imperative that 
participants were clearly informed when the airway would be occluded and given 
assistance in producing the desired negative airway pressures during each 
occluded inspiratory effort. To achieve this, a small panel with two lines of five red 
and five green LEDs was attached to the breathing circuit as show in figure 2.2. A 
full description of how this LED panel was used to alert participants to the airway 
being occluded and help produce the desired negative intrathoracic pressures is 
described in the next section. 
 
Inspiratory efforts during airway occlusion: Three seconds prior to the desired 
time for the airway to be occluded (i.e. every 90 seconds) computer software 
(Spike2 version 5.21) searched for the next inspiration (positive flow from the 
pneumotach). At that point a signal was sent to the LED panel causing all ten LEDs 
to flash to alert the participant that at the end of the next expiration the airway will 
be occluded. Over the course of the airway occlusion red LED’s would light up to 
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indicate when occluded inspiratory efforts should be performed. The number of red 
LEDs lit at any time indicated the negative intrathoracic pressure that the 
participant had to generate. One LED indicated a negative pressure of -15 mmHg, 
two LEDs -20 mmHg, three LEDs -25 mmHg, four LEDs -30 mmHg and five LEDs -
35 mmHg. The timings of these red LEDs lighting up are summarised in Table 2.1. 
Individuals were trained to inspire against the occluded airway at a normal 
inspiratory speed. The green LEDs were used to aid participants in accurately 
generating the correct negative intrathoracic pressures and indicating when they 
should relax after each inspiratory attempt. The negative intrathoracic pressure 
required to cause each green LED to light up was matched to that of the red LED 
directly above. Thus, as soon as the number of lit green LEDs matched the number 
of red LEDs already lit, participants knew they had generated the desired level of 
negative intrathoracic pressure and could relax.   
 
After 20 seconds of the airway being occluded all of the red and green LEDs would 
flash to indicate the balloon valve had deflated and that the participant should 
briefly exhale to allow end-tidal gases to be measured. Participants then breathed 
freely until the next airway occlusion occurred. Figure 2.3 shows original data from 
one participant producing these negative intrathoracic pressures. It clearly shows 
how the magnitude and frequency of the negative intrathoracic pressures increase 
during the 20 second airway occlusions.  
 
 
Airway occluded 1 red LED 2 red LED 3 red LED 4 red LED 5 red LED Airway open
Time (sec) 0 2 7 11 14 17 20
Interval (sec) 2 5 4 3 3 3
75
Table 2.1: !"#"$%&'()'*+,$'(--./0,0'"$&1"234(25',))(24&'*,2,'4('6,'1,2)(2#,0'0/2"$%',3-+'3"2*35'(--./&"($'3$0'4+,'0,&"2,0'
$,%34"7,'"$4234+(23-"-'12,&&/2,&8
Pressure (mmHg) -15 -20 -25 -30 -35
PETO2 & PETCO2 
measured
LED signal panel
76
Figure 2.2: A photograph of the experimental setup used to induce airway occlusions.
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Figure 2.3: Original record for one participant showing air flow and intrathoracic pressure during two successive airway
occlusions. Note the absence of airflow during each twenty second airway occlusion and how the negative intrathoracic
pressures gradually increase in frequency and magnitude during the time course of the 20-second airway occlusions.
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Gas control 
Airway occlusions with hypoxia: To enhance hypoxia during airway occlusions 
we used the DEF system to lower the PETO2 prior to the occlusion. We found a pre 
occlusion PETO2 value of ~70 mmHg would result in a post-occlusion PETO2 of ~50 
mmHg in most individuals. Although PETO2 could be lowered to 70 mmHg over 
durations as brief as 10 seconds, there was an insufficient number of breaths to 
allow the correction scheme of the DEF system to gain tight control of the PETO2 at 
70 mmHg. The most successful method to achieve the desired control was to 
gradually lower PETO2 to 70 mmHg over 20 seconds. Small adjustments to the pre-
occlusion PETO2 for each individual allowed a post-airway occlusion PETO2 of 50 
mmHg to be kept consistent between individuals. Figure 2.4a is an original 
recording of a sequence of hypoxic airway occlusions in one participant. It clearly 
shows how PETO2 is clamped at ~70 mmHg prior to airway occlusions resulting in a 
subsequent post-occlusion nadir in PETO2 of 50 mmHg. 
 
Airway occlusions without hypoxia: We found that gradually increasing PETO2 
over 15 seconds to a pre-occlusion PETO2 value of around 145 mmHg ensured that 
PETO2 following airway occlusions remained in a euoxic range (~100 mmHg). 
Figure 2.4b is an original recording of a sequence of airway occlusions without 
hypoxia. It clearly shows how PETO2 is elevated to ~145 mmHg prior to airway 
occlusions and that this results in a post-occlusion PETO2 of ~100 mmHg that 
prevented any decline in SaO2. 
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Enhancing intermittent hypercapnia: In order to increase the magnitude of 
hypercapnia during airway occlusions to better mimic the magnitude experienced 
in OSA, the DEF was used to raise PETCO2 ~1 mmHg above a predetermined 
normal level. This ensured the magnitude of hypercapnia was similar between 
repetitive airway occlusions in the same individual and thus the acute effects of 
airway occlusions in the same individual could be compared over time. This small 
elevation in PETCO2 prior to hypoxic and hyperoxic airway occlusions is 
demonstrated in the original recordings in figure 2.4. 
 
2.2.4 Model evaluation and implications for future research 
In general we were encouraged by how we were able to successfully develop a 
new airway occlusion model that we feel is superior to existing models of OSA. 
However, despite the relative ease of performing individual airway occlusions, 
participants found repeatedly performing them over long periods (of more than one 
hour) to be both tiring and tedious.  
 
Benefits of the new model: With only minimal coaching and use of the LED 
display system participants were able to successfully perform occluded inspiratory 
efforts and produce the desired negative intrathoracic pressures. Furthermore, the 
DEF system provided an effective tool to enhance or inhibit hypoxia during airway 
occlusions whilst simultaneously increasing the degree of hypercapnia to a level 
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that better reflects that of OSA. Finally, we feel the model is effective in replicating 
the cardiovascular and respiratory responses that are occur during repetitive 
obstructive apnoeas in OSA. Indeed, the original recordings of various 
physiological variables during a sequence of airway occlusions with and without 
hypoxia in figure 2.4 clearly demonstrate similar cardiovascular and respiratory 
responses to those previously shown in the polysomnogram of an OSA patient in 
figure 1.1. Firstly, there are substantial elevations in ventilation immediately 
following airway occlusions. Secondly, systemic blood pressure gradually rises 
during each airway occlusion and peaks upon resumption of breathing. Finally, a 
significant degree of tachycardia occurs during post airway occlusion 
hyperventilation. 
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Figure 2.4: Original recordings from one participant showing breath-by-breath
PETO2, PETCO2, TV, SaO2 and systemic BP during a sequence of airway
occlusions with (A) and without hypoxia (B).
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Restraints of the new model: Although we opted to use relatively short airway 
occlusions of 20 seconds which could be performed by all participants, many of 
them reported feeling physically tired following long exposures to the airway 
occlusions. Furthermore, although the occluded efforts were relatively easy to 
perform (as intended by limiting the peak desired negative intrathoracic pressures 
to only -35 mmHg) many individuals reported that repetitively performing the 
occluded efforts was a primary factor that contributed to their tiredness. 
Participants also complained of boredom and they often became restless towards 
the end of each protocol. Although they were able to watch television, this activity 
was continuously interrupted due to the frequent requirement for participants to 
focus on the LED display system and failed to provide an efficient means of 
distraction.  
 
2.3 Echocardiography 
 
The use of ultrasound to non-invasively generate two-dimensional images of 
numerous organs has made it an essential tool in the hands of both radiologists 
and researchers. One of the earliest uses of ultrasound was echocardiography 
whereby cardiac morphology could be examined. Furthermore, utilising the 
principles of the Doppler effect, echocardiography is used to measure blood flow in 
various vessels in the body and additionally across valves of the heart allowing 
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estimates of systolic pulmonary arterial pressure (SPAP) and cardiac output (Q˙ ) to 
be determined. 
 
2.3.1 Two-dimensional cardiac imaging 
Two-dimensional images of the heart and other organs are most commonly 
obtained using a transducer that utilises the principles of the piezoelectricity. When 
an electric voltage is applied to piezoelectric crystals within the transducer, rapid 
vibrations from these crystals cause high frequency pressure waves (sound waves) 
to be generated which can pass through soft tissues. These piezoelectric crystals 
are also able to receive returning sound waves that are reflected off various tissues 
of the body (echoes) and convert them into an electrical signal. This electrical 
signal can then be converted into a two-dimensional image by a computer. The 
denser a tissue is, the greater the number of echoes returned to the transducer, 
the greater the voltage produced and thus the brighter the image is. This allows 
dense cardiac tissue such as, the chamber walls and valves to be distinguished 
from the less dense tissue (e.g. skin and blood). 
 
Sound waves from the transducer are sent in brief batches and between each 
batch of sound waves the transducer receives and processes returning echoes, 
(listening phase). By increasing the duration between each batch of sound waves 
the ‘listening phase’ is increased, allowing echoes from further away from the 
transducer to be received. Although this can be beneficial by increasing the depth 
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at which images can be generated, it is offset by a reduction in temporal resolution, 
an important consideration in a constantly moving organ like the heart. An 
increased depth also reduces spatial resolution. Because sound waves cannot 
pass through the ribs echocardiography requires a special transducer that is small 
enough to fit between the ribs. Sound waves emitted from the transducer spread 
out in a fan shape allowing a larger image to be produced relative to the transducer 
head size. As shown in figure 2.5 the greater the distance from the transducer the 
greater the horizontal distance between scan lines. The ability to distinguish 
between structures lying side by side horizontally (lateral resolution) is impaired as 
distance from the transducer is increased because ends of the structures may fall 
between scan lines. Therefore, when attempting to perform accurate 
measurements of the width of various structures within the heart, these should be 
performed vertically along scan lines (axial resolution). (see: Cardiac views, for an 
example of using a vertical rather than horizontal alignment to measure aortic 
diameter). 
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Figure 2.5: Illustration of the scan lines from an ultrasonography transducer. 
 
2.3.2 Doppler ultrasound 
Upon generating two-dimensional views of the heart to locate the tricuspid and 
aortic valves, the principles of the ‘Doppler effect’ can be utilised to assess the flow 
of red blood cells across these valves. The “Doppler effect” is named after 
Christian Johann Doppler who hypothesised that stars appearing red were moving 
away for the observer and stars appearing blue were moving towards the observer 
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as a result of differences in the frequency of their emitted light waves. Three years 
later Buys Ballot (1845) confirmed that the hypothesis also held true for sound 
waves. He demonstrated that received sound waves were higher in frequency than 
those being generated by the sound source as it moved towards him and lower in 
frequency when it moved away from him.  
 
Based on these principles a brief batch of sound waves of a known frequency is 
emitted by the ultrasound transducer and measuring the frequency of reflected 
sound waves from red blood cells allows the velocity of blood to be calculated. If 
red blood cells are stationary the frequency of returning sound waves will be the 
same as those first generated by the transducer. The faster the red blood cells are 
moving towards the transducer, the greater the increase in the frequency of 
returning sound waves and vice versa for red blood cells moving away from the 
transducer. Using the mathematical formula shown below the change in frequency 
of these sound waves can be converted into velocity of the red blood cells (Hatle 
and Anglesen, 1985) (equation 3), 
                  
 
where v is red blood cell velocity, ∆f is the change in frequency calculated by the 
ultrasound machine, θ is the angle between the direction of the red blood cells and 
the sound wave (assumed to be 0°), and C is the velocity that sound travels in 
tissue (1540 m/sec). 
θ cos2 f 
fC 
v
∆
= Equation 3 
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2.3.3 Doppler modes 
 
Two distinct Doppler modalities exist: pulsed wave Doppler (PWD) which is used to 
measure blood flow of slow velocities and continuous wave Doppler (CWD) which 
is used to measure fast velocities. During PWD a batch of sound waves are 
emitted and the next batch is not generated until the “listening” phase is complete. 
Increasing the pause between emitting a batch of sound waves and the ‘listening’ 
phase will increase the distance between the transducer and the point where blood 
flow velocity is measured. As a compromise of this intermittent pattern of sampling 
PWD cannot reliably assess high velocity flow (Hatle and Anglesen, 1985). In 
contrast, CWD can be used for assessing much faster velocities because sound 
waves are continuously emitted by a segment of the transducer whilst reflected 
sound waves are continuously recorded by an independent segment. A limitation of 
CWD is that the absence of pauses between batches of sound waves and the 
‘listening’ phase is that the location of echoes cannot be distinguished. It can 
therefore only be used to calculate peak velocity of blood flow at a desired location 
if this peak velocity is known to exceed the velocity of blood flow anywhere else 
along the distance of the scan line (e.g. high velocity flow through valves such as 
tricuspid regurgitation).   
 
The change in frequency of the reflected sound waves recorded in PWD and CWD 
are first separated into positive and negative changes representing flow towards 
and flow away from the transducer. These are then converted into velocity using 
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the previously mentioned equation (equation 3) and plotted on the y-axis of a graph 
with time as the x-axis providing a spectral waveform. This is accompanied by an 
ECG trace to better distinguish the varying phases of the cardiac cycle and 
respiratory trace so that measurements can be made upon end-expiration (figure 
2.6).  
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Figure 2.6: A spectral waveform of tricuspid regurgitation measured in continuous wave Doppler mode (CWD). Upper:
electrocardiogram; Middle: Doppler waveform (frequency shift converted to positive and negative velocity); Lower:
respiratory cycle. Green cross indicates peak velocity of tricuspid regurgitation.
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2.3.4 Cardiac views 
In this thesis echocardiography was used to assess SPAP and Q˙  for which three 
different cardiac views were required. For the assessment of SPAP the velocity of 
blood flow across the tricuspid valve was measured using a four-chamber apical 
view (figure 2.7A). To estimate SV in order to calculate Q˙  the velocity of blood flow 
across the aortic valve was measured using a five chamber apical view (figure 
2.7B). Apical views of the heart are performed with the transducer positioned within 
the fourth or fifth intercostal space and the participant positioned on their left side 
to allow the apex of the heart to swing closest to the transducer. In order to 
calculate Q˙ , the diameter of the aortic valve needs to be measured as well. 
Although the aortic valve can be visualised in the apical five-chamber view, 
measuring its width in this view would be inaccurate as the vessel is parallel to the 
scan lines and thus the vessel walls may fall between scan lines. For this reason, 
the aortic valve diameter is measured using a parasternal long axis view where the 
width can be measured vertically along a scan line (figure 2.7C). To this end, 
participants lay on their back and the transducer was positioned just lateral to the 
sternum within the second or third intercostal spaces.  
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Figure 2.7. (A) Apical four-chamber view: (1) right ventricle, (2) left ventricle,
(3) right atrium, (4) left atrium. (B) Apical five-chamber view: (1) right ventricle,
(2) left ventricle, (3) right atrium, (4) left atrium, (5) aorta. (C) Parasternal long-
axis view: (1) aortic valve, (2) left ventricle, (3) mitral valve, (4) left atrium.
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2.3.5 Estimation of SPAP 
In 80% of healthy individuals a small degree of regurgitation can be detected 
across the tricuspid valve during ventricular systole. This trivial volume of 
regurgitation is not pathological and can be used to indirectly estimate SPAP non-
invasively. Tricuspid regurgitation is a fast flowing jet which at its peak velocity is 
over 200 cm/s thus requiring a high sampling rate to measure the large frequency 
shift. For that reason Tricuspid regurgitation is measured using CWD in a four-
chamber view and identified in colour Doppler mode (figure 2.8).  
 
 
Figure 2.8: Apical 4-chamber view illustrating the tricuspid regurgitation jet (1) as visualised in 
colour Doppler mode. 
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Because the velocity of tricuspid regurgitation far exceeds any other flow within the 
right side of the heart the peak velocity of the spectral trace can always be 
attributed to tricuspid regurgitation. The peak velocity of the regurgitation jet is 
measured at the most distal part of the waveform as shown in figure 2.6 and is 
then converted to a peak pressure drop (∆Pmax) between right ventricle pressure 
and right atrium pressure (RAP) by a modified version of the Bernoulli’s equation 
shown below (equation 4),  
!Pmax = 4v2      
where !Pmax is the pressure drop across the orifice in mmHg and v is velocity. To 
gain accurate measurements with this equation a number of assumptions must be 
made: firstly, the velocity before the orifice (right ventricle) is low; secondly the 
orifice is short and flow through it is steady; and thirdly the Doppler scan line is well 
aligned with the flow. Because right ventricular pressure during systole is 
equivalent to SPAP the relationship can be depicted as (equation 5), 
!Pmax = SPAP-RAP        
RAP is relatively constant at a low value of ~5 mmHg and thus SPAP is assumed 
to be !Pmax +5 mmHg.  
 
2.3.6 Cardiac output 
Two separate echocardiographic measurements are required for the determination 
of cardiac output (Q˙ ). Firstly, a five-chamber view of the heart (figure 2.9) is 
obtained and the velocity of blood flow across the aortic valve is measured in order 
Equation 4 
Equation 5 
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to calculate the velocity time integral (VTI). VTI is essentially the distance that 
blood travels in the aorta with each ventricular contraction. Secondly, a parasternal 
view (figure 2.7c) is used to determine the diameter of the aortic orifice, which is 
assumed to be a circle and thus its area (A) can be calculated using the formula 
pir2.  
 
Figure 2.9: Ejection of blood through the aortic valve as visualised in colour Doppler mode using a 
five-chamber view.  
 
To determine VTI, PWD mode is used to measure the velocity of blood flow 
through the aortic valve with the gate positioned on the aortic orifice and the 
Doppler beam aligned with the flow.  Mean velocity of the PWD spectral trace is 
then calculated offline and it is automatically integrated by the ultrasound machine 
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with the duration of systole to give VTI (figure 2.10). Q˙  can then be calculated 
using the equation below, 
HRAVTIQ ××=!
  
where HR is heart rate. 
 
 
Figure 2.10: A PWD spectral trace of flow through the aortic valve. The mean velocity (VTI) is  
measured using the green trace.  
 
Equation 5 
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3 CHAPTER 3 - ASSESSING PULMONARY ARTERIAL 
PRESSURE DURING AIRWAY OCCLUSIONS USING DOPPLER 
ULTRASOUND  
 
3.1 Introduction 
 
It is generally accepted that 15-20% of all OSA patients without coexisting 
pulmonary disorders (e.g. chronic obstructive pulmonary disorder - COPD, obesity 
hypoventilation disorder etc) suffer from some degree of pulmonary hypertension 
(Kessler et al., 1996) although a recent study suggested that this may be as high 
as 20-40% (Sajkov and McEvoy, 2009). Furthermore, numerous studies have 
demonstrated that OSA is causal in the development of pulmonary hypertension 
because treatment with CPAP significantly reduces PAP without affecting other 
factors that are closely associated with OSA, such as excess weight (Sajkov and 
McEvoy, 2009).  
 
Intravascular PAP which is referenced to atmospheric pressure demonstrates an 
irregular decline during the time course of an occluded apnoea and returns to 
baseline levels upon resumption of breathing (Marrone et al., 1989). However, 
when PAP is expressed as transmural PAP (tPAP) after correcting for the negative 
intrathoracic pressure swings, it is evident that in contrast there are numerous 
transient elevations in tPAP throughout an apnoea and also a slower more gradual 
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elevation that begins mid-apnoea and peaks immediately post apnoea (Marrone et 
al., 1989, Schafer et al., 1998). It has been hypothesised that these apnoea-
induced elevations in tPAP may be responsible for the high prevalence of diurnal 
pulmonary hypertension in OSA patients (Schroeder et al., 1978).  It is plausible 
that the frequent elevations in tPAP that occur over a relatively long duration (6-8 
hours) on a nightly basis may promote vascular remodeling leading to sustained 
pulmonary hypertension. Indeed, rodents exposed to eight hours of IH per day for 
four weeks to mimic that experienced in OSA, demonstrate vascular remodeling 
and developed pulmonary hypertension (Fagan, 2001). 
 
The stimuli responsible for both the numerous rapid transient elevations and also 
the slow gradual rise in tPAP during occluded apnoeas are not fully understood but 
two primary mechanisms have been suggested (Marrone et al., 1989, Schafer et 
al., 1998). Firstly, negative intrathoracic pressure swings associated with occluded 
inspiratory efforts almost certainly mediate the multiple transient elevations in tPAP 
(Marrone et al., 1989, Schafer et al., 1998). Each of these rapid increases in tPAP 
occurs simultaneous to occluded inspiratory efforts and tPAP is correlated to the 
magnitude of negative pressure. Indeed, this relation is clearly shown in figure 3.1 
which is adapted from (Marrone et al., 1989) and shows average tPAP for a range 
of different negative intrathoracic pressures. 
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Figure 3.1: Average transmural PAP (tPAP) over a range of intrathoracic pressures in four patients 
with OSA. Adapted from (Marrone et al., 1989). 
 
Furthermore, snoring that induces negative intrathoracic pressure swings without a 
reduction in SaO2 elicits these transient elevations in tPAP (Podszus et al., 1991). It 
is thought that these negative intrathoracic pressures swings may increase tPAP 
by increasing venous return (Moreno et al., 1967) leading to greater right 
ventricular output and subsequently elevating pulmonary blood volume. This may 
occur because blood can more easily flow back towards the heart due to the 
negative pressure gradient between the extra and intrathoracic regions. In contrast, 
the positive pressure gradient between intra and extrathoracic regions makes 
pumping blood away from the heart harder. This may further augment the rise in 
tPAP because of the simultaneous reduction in SV leading to a greater left 
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ventricular afterload (Orban et al., 2008, Tolle et al., 1983) and potentially 
increasing pulmonary wedge pressure.  
 
Secondly, the appearance of hypoxia may cause HPV as studies have shown a 
significant correlation between the fall in SaO2 and the gradual increase in tPAP 
during occluded apnoeas (Marrone et al., 1989, Marrone et al., 1994, Schafer et 
al., 1998). Indeed, studies using canine models of OSA provide evidence to 
support HPV as the responsible mechanism for the gradual elevation in tPAP 
during occluded apnoeas (Schneider et al., 2000, Iwase et al., 1992). Mild 
hyperoxic exposure immediately prior to airway occlusions in anaesthetised dogs 
completely abolished the rise in tPAP in both studies. Furthermore, Schneider et al. 
(2000) also measured systemic blood pressure and showed hyperoxia caused only 
a small reduction in the rise in systemic blood pressure. In contrast, blockade of 
the autonomic nervous system completely abolished the apnoea-induced rise in 
systemic blood pressure without any attenuation in the rise in tPAP suggesting that 
a local hypoxia-mediated mechanism is responsible. These results in canines 
suggesting that the gradual elevation in tPAP during apnoeas in OSA patients is 
likely to be mediated by HPV fits well with evidence from rodent studies that show 
chronic exposure to IH independent of other OSA related stimuli induce the 
development of pulmonary hypertension (Fagan, 2001, McGuire and Bradford, 
2001). 
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As far as we are aware only one study to date has been performed to investigate 
whether the findings in dogs are also true of humans (Marrone et al., 1992). In this 
study tPAP was measured continuously via a Swan-Ganz catheter in six sleeping 
OSA patients. Each patient was exposed to three hours of O2 supplementation via 
nasal prongs at a flow rate of 4-6 L/min and three hours room air in a randomly 
assigned pattern. During both the room air and the hyperoxic phase tPAP was 
analysed in 15 consecutive apnoeas. In contrast to the findings in dogs, prior O2 
administration did not abolish or even attenuate the rise in tPAP during occluded 
apnoeas in OSA patients. Taken at face value these results would suggest that the 
rise in tPAP during OSA is mediated by a hypoxia-independent mechanism but 
after a thorough critique of the study we have noticed a number of caveats that 
may account for these unexpected results. Firstly, although the authors report that 
the prior O2 supplementation caused a significant attenuation in the decline of 
SaO2, the 4-6 l/min flow of O2 was insufficient to completely abolish the reduction in 
SaO2, which two participants demonstrated an average nadir of 92%. Furthermore, 
O2 supplementation caused the average duration of apnoeas to be lengthened, 
which presumably accounted for the reported augmentation in the post apnoea 
level of PETCO2. When it is considered that SaO2 of 92% indicates a significant 
degree of hypoxia and that hypercapnia is also known to cause pulmonary 
vasoconstriction (Balanos et al., 2003) it is maybe not surprising that there was still 
a significant increase in tPAP during occluded apnoeas with prior O2 
administration. Unlike the aforementioned study by (Marrone et al., 1992)), using 
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our newly developed airway occlusion model of OSA (chapter 2) we are able to 
clamp PETO2 at an individually tailored, pre-determined mild hyperoxic level 
immediately prior to airway occlusions to ensure that PETO2 remains in euoxic 
range (~100 mmHg) following airway occlusions. Furthermore, by using awake 
participants rather than sleeping OSA patients we are able to control the duration 
of airway occlusions and ensure an identical duration between hypoxic and mild 
hyperoxic airway occlusions. Thus, the magnitude of hypercapnia can also be kept 
similar between hypoxic and mild hyperoxic airway occlusions.  
 
Although there exists a relatively large body of human research investigating the 
time course of HPV during CH we are unaware of any study to have investigated 
PAP during exposure to IH that is independent of other stimuli (e.g. those occurring 
during occluded apnoeas in OSA patients). However, an interesting study on dogs 
suggests that HPV is sensitised during successive hypoxic exposures (Unger et 
al., 1977). (Unger et al., 1977) exposed dogs to ten cycles of hypoxia (10% 
inspired O2 for 15 minutes) interspersed by euoxia (21% inspired O2 for 15 
minutes) and reported a progressive augmentation in the peak PAP during 
successive hypoxic exposures. The first hypoxic exposure produced a 28% 
increase in PAP from euoxic baseline and the tenth produced a 99% increase. 
Interestingly, PAP returned to baseline levels during each euoxic period that 
separated hypoxic exposures. This would suggest that HPV was sensitised rather 
than the vascular tone of pulmonary arteries during euoxia having been reset to a 
!*#"
"
higher level. In contrast, after an initial rapid increase in PAP following the 
induction of CH PAP remained stable throughout a further three hours exposure 
suggesting that in dogs intermittent rather than continuous exposure to hypoxia is 
required to cause sensitisation of the HPV. Although the duration of hypoxic 
exposures was substantially greater than those experienced by OSA patients these 
findings could still have implications for OSA patients exposed to severe IH. 
However, it should also be noted that in contrast to canines other species such as 
rabbits demonstrate a substantial secondary HPV phase that lasts several hours 
during CH (Vejlstrup and Dorrington, 1993). Indeed, it has also been shown in 
humans that there is also a slow gradual phase that it is not initiated until ~40 
minutes (Talbot et al., 2005). Whether sensitisation of the HPV during 15 minute 
hypoxic exposures as shown in these dogs might also occur during more transient 
exposures of 15-45 seconds such as those occurring during OSA remains to be 
determined. Interestingly, in a study of OSA patients who undertook a 
polysomnography, patients demonstrated a gradual rise in tPAP over the time 
course of the night (Sforza et al., 1998). In contrast to the results from Unger’s 
(1977) study of dogs that showed a progressive augmentation in PAP during 
hypoxic episodes without a change in PAP during separating euoxic episodes, 
tPAP in the OSA patients gradually increased during unrestricted breathing 
between apnoeas when it was assumed that euoxia had been restored (measured 
immediately prior to apnoeas) in addition to during hypoxic episodes (measured 
during occluded apnoeas and immediately afterwards). Because the increase in 
tPAP occurred not only during the hypoxic apnoeas but also periods of unrestricted 
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breathing their data would suggest there is a gradual resetting of resting vascular 
tone rather than an augmentation in HPV. However, the average AHI in OSA 
patients in this study was 84 which is extremely high when it is considered that 30 
or more is used to diagnose severe OSA. The average apnoea length was 
relatively long at 27 seconds and the average nadir in SaO2 was severe at 77.5%. 
With such a high AHI, long duration of apnoeas and extremely low SaO2 nadirs we 
suspect that patients may have remained relatively hypoxic throughout the night 
with limited or no complete re-oxygenation phases. The hypoxic stimuli in these 
patients may thus represent exposure to CH rather than a true intermittent 
stimulus. If our assumption is correct then the gradual rise in tPAP throughout the 
time course of the night may better represent the gradual rise in PAP shown in 
humans during CH that is not initiated until ~40 minutes of sustained hypoxia 
(Talbot et al., 2005), and takes several hours before it plateaus (Dorrington et al., 
1997). We believe that our newly developed airway occlusion model of OSA 
(chapter 2) might better enable the possibility of sensitisation of the HPV during IH 
as caused by OSA to be more thoroughly investigated than can be achieved from 
the data in the study by (Sforza et al., 1998). We are able to evoke significant 
drops in SaO2 following each airway occlusion whilst utlising a lower AHI from that 
of the OSA patients in Sforza’s et al., (1998) study (40 vs. 84) that better 
resembles the AHI in most OSA patients. We are therefore able to ensure 
adequate re-oxygenation between airway occlusions that better represents the 
nightly events of most OSA patients.  
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PAP is most commonly assessed in a clinical setting using a Swan-Ganz catheter 
and has been used in all of the previously discussed studies of OSA patients and 
animals to measure PAP during apnoeas. Although Swan-Ganz catheters are 
considered the gold standard for assessing PAP as they give accurate absolute 
values the technique is highly invasive, limiting its use outside of a clinical setting. 
Assessment of SPAP in a research setting is increasingly made non-invasively 
using Doppler ultrasound. Although it cannot be claimed that Doppler ultrasound 
provides extremely accurate absolute values of SPAP it has been shown to provide 
reproducible values allowing changes in SPAP over time to be assessed (Talbot et 
al., 2005). Despite a substantial body of research having been performed using 
Doppler ultrasound to measure SPAP during exposure to CH we are not aware of 
any research using Doppler ultrasound to assess changes in SPAP during IH or 
airway occlusions. If Doppler ultrasound can be successfully used to measure 
SPAP during airway occlusions, future studies undertaken to develop our 
understanding of the effects of OSA on the pulmonary circulation could be more 
easily performed.  
 
Study aims 
Having successfully developed a new airway occlusion model of OSA as described 
previously (chapter 2) we planned to use this model in conjunction with Doppler 
ultrasound in order to investigate the effects of IH on pulmonary haemodynamics. 
The primary aim of this study was to measure SPAP during airway occlusions with 
and without hypoxia and we hypothesised SPAP would only rise during hypoxic 
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apnoeas as previously shown in animal models of OSA (Schneider et al., 2000, 
Iwase et al., 1992) but incompletely investigated in humans (Marrone et al., 1992). 
A secondary aim of the study was to investigate whether there is an augmentation 
in the rise in PAP during airway occlusions over time and to determine whether this 
is mediated by sensitisation of HPV. We hypothesised that peak SPAP during 
hypoxic airway occlusions would progressively increase over time but that there 
would be no change in SPAP during airway occlusions without hypoxia. 
Furthermore, we wished to examine SPAP during euoxic baseline and during 
euoxic recovery from airway occlusions with and without hypoxia to assess 
whether SPAP during euoxia was altered by exposure to repetitive hypoxic 
apnoeas (i.e. a resetting of resting vascular tone).  
 
3.2 Methods 
 
Ethical approval 
After receiving detailed information on the procedures and risks of the study, 
participants gave written consent to take part. The study was performed according 
to the latest revision of the Declaration of Helsinki and was approved by the local 
ethics committee (University of Birmingham ethical review committee). 
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Participants 
Five participants in whom a clear tricuspid regurgitation jet was easily detectable 
with Doppler ultrasound imaging were recruited to take part in the study. All 
participants were non-smokers, had no history of cardiovascular, respiratory or 
metabolic disease and were not taking any medication. 
 
Study protocol 
Participants visited the laboratory for two experimental trials in a randomised order 
separated by at least 24 hours. In one visit participants were exposed to one hour 
of hypoxic airway occlusions (Trial 1) and in the other they were exposed to one 
hour of mild hyperoxic airway occlusions (Trial 2). Prior to experimental visits 
participants also undertook a preliminary visit to familiarise themselves with the 
instrumentation and exposure to airway occlusions. For all experimental trials 
participants were asked to refrain from alcohol consumption and moderate to 
vigorous exercise for 24 hours and caffeine intake for 12 hours prior to arriving at 
the laboratory. In addition, all experimental trials were performed at least three 
hours after food consumption. All trials were performed at the same time of day 
and were performed in a randomised order.  
 
Preliminary visit 
Participants were instrumented in an identical way to both experimental visits. To 
measure ventilation, induce airway occlusions and control PETO2 and PETCO2 for 
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brief periods prior to airway occlusions, participants breathed through a 
mouthpiece whilst wearing a nose clip. The mouthpiece was directly connected to 
a balloon valve (Hands Rudolph, 9340 series, USA) used to occlude the airway, 
which was in turn connected to a pneumotach (Pneumo Hans Rudolph 
pneumotach amplifier 1, Shawnee, USA) and turbine (Interface Associates, Irvine, 
CA, USA) to assess flow and volume, respectively. End-tidal gas was sampled 
continuously from a catheter placed immediately after the balloon valve and it was 
analysed using a mass spectrometer (AirSpec 2000, Case Scientific, London, UK). 
End-tidal profiles were generated using a computerised dynamic end-tidal forcing 
system, with end-tidal gas composition recorded for each breath and compared 
with desired values by a computer-controlled, fast gas-mixing system as described 
previously (chapter 2). Inspired gases were heated and humidified. Respiratory 
volumes were measured by the turbine and ventilation is reported in BTPS. 
Pressure at the mouth was continuously assessed with a pressure transducer 
positioned between the balloon valve and the mouth and used as an index of 
intrathoracic pressure. Throughout all trials SaO2 was continuously measured using 
a pulse oximeter, worn on the participant’s ear lobe (Datex-Ohmeda 3900) and 
heart rate (HR) was continuously assessed via ECG.  
 
After becoming accustomed to breathing through the mouthpiece participants were 
exposed to a number of airway occlusions and coached to successfully perform 
occluded inspiratory efforts as previously described in detail (chapter 2). In brief, 
during each airway occlusion the balloon valve was rapidly inflated in the breathing 
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circuit at the end of expiration and remained inflated for 20 seconds. During these 
20 seconds participants performed five occluded inspiratory efforts separated by 
gradually shortening intervals (i.e. inspiratory efforts increased in frequency during 
the 20-second airway occlusion) with each inspiration requiring increasing effort to 
generate the desired peak negative intrathoracic pressures of -15, -20, -25, -30 
and -35 mmHg. Prior to each airway occlusion participants were briefly exposed to 
mild hypoxia or mild hyperoxia. PETO2 was clamped at a variety of hypoxic and mild 
hyperoxic values to identify the desired level of PETO2 for each participant required 
to produce a post airway occlusion PETO2 nadir of 50 mmHg to be used in Trial 1 or 
100 mmHg to be used in Trial 2. During these brief hypoxic and hyperoxic 
exposures PETCO2 was maintained ~1 mmHg above each participant’s normal 
level. 
 
Experimental trials 
Following instrumentation that was identical to that described above for the 
preliminary visit, participants positioned themselves on a couch in the left lateral 
position so that Doppler ultrasound measurements could be made when required. 
Participants then breathed room air for approximately ten minutes to establish 
stable resting cardiovascular and respiratory parameters before baseline 
measurements were recorded. Following completion of baseline measurements, in 
Trial 1 participants were then exposed to forty 20-second airway occlusions each 
separated by 70 seconds unrestricted breathing resulting in an AHI of 40. Each 
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airway occlusion was preceded by 20 seconds of mild hypoxia at the individually 
tailored PETO2 previously determined in the preliminary visit, whilst PETCO2 was 
maintained ~1 mmHg above baseline levels. In Trial 2 participants were exposed 
to forty 20-second airway occlusions again with 75 seconds unrestricted breathing 
separating them. However, in contrast each airway occlusions was preceded by 15 
seconds of mild hyperoxia at the individually tailored PETO2 previously determined 
in the preliminary visit, whilst PETCO2 was also maintained ~1 mmHg above 
baseline levels. Following completion of the forty airway occlusions (one hour) in 
both trials participants breathed room air during a 15-minute recovery period. 
 
Doppler ultrasound assessment of SPAP and cardiac output 
SPAP and cardiac output (Q˙ ) were assessed using a Philips Sonos 5500 
ultrasound machine with an S3 two-dimensional transducer (1-3 MHz) as 
previously described in detail (chapter 2). In brief, for assessment of SPAP the 
tricuspid regurgitation jet was visualised using a four-chamber view and using 
continuous wave Doppler mode a spectral trace of the jet’s velocity profile was 
recorded. SPAP was estimated offline at a later date from the peak velocity of the 
tricuspid regurgitation jet. Once several clear spectral waveforms of the tricuspid 
regurgitation jet had been recorded the transducer was quickly repositioned to 
allow a five-chamber view of the heart. Pulse wave Doppler mode was then used 
to generate a spectral trace of the velocity of blood flow through the aortic valve at 
the level of the aortic orifice. The mean velocity over the course of each cardiac 
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cycle was calculated offline at a later date and in simple terms it represented the 
distance that the blood travelled in the aorta, termed velocity time integral (VTI). SV 
could then be calculated using the formula VTI•pir2 where r is the radius of the 
aortic orifice that was measured at the start of each experimental trial. Q˙  could 
finally be calculated by the formula Q˙  = SV•HR where HR was taken from the 
recorded ECG trace.  
 
To investigate the contribution of hypoxia in any elevation in SPAP during airway 
occlusions and determine whether there is a progressive augmentation in the 
increase in SPAP during airway occlusions over time we aimed to make several 
measurements of SPAP throughout an apnoea cycle. This included making a 
number of measurements immediately prior to airway occlusions, throughout 
airway occlusions and for a short period following airway occlusions. We hoped 
that this would allow generation of a clear time line of changes in SPAP during 
airway occlusions with and without hypoxia. Measuring Q˙  and SPAP require a 
change in transducer placement and thus could not be performed during the same 
airway occlusion. Thus, we aimed to assess SPAP and Q˙  during alternating airway 
occlusions. To examine whether there was a change in the response of SPAP to 
hypoxic and/or mild hyperoxic airway occlusions over the course of one hour we 
aimed to perform these measurements during a number of airway occlusions at the 
start, middle and end of the one hour exposures. To determine whether SPAP 
would remain elevated above euoxic baseline levels following one hour of hypoxic 
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and/or mild hyperoxic airway occlusions, SPAP and Q˙  were assessed at euoxic 
baseline and during euoxic recovery. To this end, SPAP and Q˙  were assessed 
during the final two minutes of room air breathing prior to airway occlusions and the 
final two minutes of each five minute period of the fifteen minute room air recovery 
period in both trials.  
 
Statistical analysis  
A two-way analysis of variance (ANOVA) with repeated measures was used to 
assess whether there was time-by-trial interaction for each haemodynamic 
measurement (SPAP, HR, SV and Q˙ ). One-way ANOVA with repeated measures 
was also performed separately for each trial to better determine the effect of time 
on these haemodynamic measurements. Values are expressed as mean ± 
standard error and differences were considered significant if P # 0.05. 
 
3.3 Results 
 
Participants  
Four male and one female participant completed the experiment with an average 
age of 23.6 ± 1.9 years, weight of 72.4 ± 6.3 kg, height of 176.4 ± 5.7 cm and a 
BMI of 23.2 ± 0.89. All values are mean ± standard deviation. 
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Haemodynamic measurements during airway occlusions 
Our primary aim was to assess SPAP during airway occlusions that closely 
mimicked occluded apnoeas in OSA with or without hypoxia and thus determine 
the contribution of hypoxia to any elevation in SPAP. The modest reduction in 
PETO2 prior to each airway occlusion in Trial 1 was successful in eliciting a 
significant degree of hypoxia post airway occlusion as PETO2 dropped to an 
average nadir of 50.57 ± 0.51 mmHg. However, we quickly realised that it was not 
feasible to perform Doppler ultrasound measurements of SPAP during airway 
occlusions with continued inspiratory efforts. This was because assessment of 
SPAP requires a high level of transducer control that was compromised by 
substantial rib cage movement during each occluded inspiratory effort. Therefore, 
participants were asked not to perform occluded efforts during a number of airway 
occlusions at the start, middle and end of the hour when SPAP and Q˙  were to be 
assessed. However, despite this compromise we were still unable to record reliable 
measurements of SPAP at regular enough time points over the time course of an 
airway occlusion. Furthermore, recording SPAP in the first ~5 seconds immediately 
post airway occlusion was extremely difficult due to substantial hyperventilation 
and thus considerable rib cage movement. Therefore, we were unable to describe 
an accurate time course of changes in SPAP during hypoxic or mild hyperoxic 
airway occlusions. 
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Haemodynamic measurements during room air breathing 
In contrast to the difficulty in attaining haemodynamic measurements using 
Doppler ultrasound during airway occlusions, clear and reliable measurements 
were made during unrestricted room air breathing at baseline and recovery. Figure 
3.2 shows SPAP at baseline and during 5, 10 and 15 minutes of recovery following 
one hour of hypoxic airway occlusions (Trial 1) or mild hyperoxic airway occlusions 
(Trial 2). SPAP did not change from baseline to recovery in either trial (Trial 1: P = 
0.792; Trial 2: P = 0.746). Figure 3.3 shows Q˙  at baseline and during 5, 10 and 15 
minutes of recovery following one hour of hypoxic airway occlusions (Trial 1) and 
mild hyperoxic airway occlusions (Trial 2). As was the case for SPAP, there was no 
notable change in Q˙  from baseline to recovery (Trial 1: P = 0.428; Trial 2: P = 
0.747). Figure 3.4 and 3.5 show that HR and SV did not change from baseline to 
recovery in either trial (Trial 1: P = 0.419; Trial 2: P = 0.608 and Trial 1: P = 0.940; 
Trial 2: P = 0.667 respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Systolic pulmonary arterial pressure (SPAP) at baseline, 5, 10,
and 15 minutes of recovery, following one hour of airway occlusions with
(closed symbols) and without hypoxia (open symbols).
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Figure 3.3: Cardiac output at baseline, 5, 10, and 15 minutes of recovery,
following one hour of airway occlusions with (closed symbols) and without
hypoxia (open symbols).
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Figure 3.4: !"#$% $#%" &!'( at baseline, 5, 10, and 15 minutes of recovery,
following one hour of airway occlusions with (closed symbols) and without
hypoxia (open symbols).
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Figure 3.5: )%$*+" ,*-./" &)0( at baseline, 5, 10, and 15 minutes of recovery,
following one hour of airway occlusions with (closed symbols) and without
hypoxia (open symbols).
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3.4 Discussion 
 
With the prevalence of pulmonary hypertension being high in the OSA population 
(Kessler et al., 1996, Sajkov and McEvoy, 2009) and with recent evidence 
demonstrating that OSA is causal in its development (Sajkov and McEvoy, 2009) it 
is of paramount importance that the responsible mechanisms are determined. Only 
then can therapeutic strategies be developed to prevent its development and 
progression in OSA patients. It has long been known that hypoxia causes 
vasoconstriction of the pulmonary vasculature and that chronic HPV can cause 
pulmonary hypertension in a range of pathophysiological conditions (COPD, 
obesity hypoventilation disorder etc) and indeed in rats exposed to chronic IH 
(Fagan, 2001, McGuire and Bradford, 2001). Therefore, it is logical that 
researchers have attempted to examine the possibility that hypoxia mediates the 
rise in PAP that occurs during apnoeas in OSA patients. All published studies to 
date that have measured PAP during obstructive apnoeas have used Swan-Ganz 
catheters. Although this technique is considered the gold standard for assessing 
PAP it is highly invasive. Indeed, the relatively limited number of studies 
undertaken to examine the effects of OSA and specifically IH on pulmonary 
haemodynamics is no doubt predominantly a result of the invasive nature of this 
technique. However, in recent years Doppler ultrasound has been increasingly 
used as an alternative non-invasive approach to estimate SPAP and produces 
comparable results to Swan-Ganz catheters when assessing changes in SPAP 
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over time (Talbot et al., 2005). Therefore, we attempted to use this technique to 
determine the contribution of hypoxia in the rise in PAP during airway occlusions 
that previous studies of OSA patients have been unable to answer. In doing so we 
also hoped we would demonstrate the potential use of Doppler ultrasound in future 
research into the effects of IH in humans.  
 
Prior to undertaking this study we were aware that it would be extremely 
challenging to accurately measure SPAP during airway occlusions. We screened a 
large number of volunteers and we recruited only participants with a clear tricuspid 
regurgitation jet that could be recorded quickly and consistently. However, having 
attempted to assess changes in SPAP during airway occlusions in awake humans 
we have had to conclude that Doppler ultrasound is not a viable technique to make 
these measurements. Consequently, we have been unable to assess what is the 
contribution of hypoxia to the rise in SPAP during airway occlusions or whether 
there is an augmentation in this rise in SPAP during a prolonged exposure to 
repetitive airway occlusions. The most challenging period to measure SPAP was 
immediately following the airway occlusion when participants hyperventilated 
heavily. This was important as SPAP is known to gradually increase during 
apnoeas, starting at the middle of the apnoea and reaching a maximum several 
breaths post apnoea (Podszus et al., 1994).  
 
During unrestrained room air breathing at baseline and recovery we were able to 
take accurate measurements of SPAP. Although, we are tentative to draw 
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conclusions based on such a small study population, none of the five participants 
involved in the study demonstrated any notable elevation in SPAP during the 
fifteen minutes recovery following hypoxic or mild hyperoxic airway occlusions. 
(Sforza et al., 1998) previously demonstrated that PAP gradually increased during 
the night over the entire apnoea cycle (i.e pre, during and post apnoeas). Because 
PAP increased during pre apnoea periods it would suggest that PAP was greater 
during periods of euoxia. However, the AHI was very high, apnoeas were long and 
average SaO2 nadirs were very low, thus we speculated that euoxia may not have 
been restored during the brief intervals between apnoeas. The gradual rise in PAP 
during these pre-apnoea periods may better represent the gradual elevation in 
HPV magnitude seen during CH as previously shown in humans (Talbot et al., 
2005, Dorrington et al., 1997) rather than an increase in PAP under euoxic 
conditions. In our study, hypoxic airway occlusions were limited to just one hour in 
our study based on previous testing of the model showing that it was too 
uncomfortable to maintain for longer. It remains to be determined whether a longer 
exposure to the hypoxic airway occlusions such as the 6-8 hours that occur during 
sleep in OSA patients might cause a notable sustained elevation in PAP under 
euoxic conditions.  
 
Another limitation to using Doppler ultrasound in this study was that participants 
complained of being uncomfortable due to having to remain on the couch 
positioned in the left lateral position for the entire protocol (~90 minutes). It is 
possible that participant discomfort could confound results such as systemic BP, 
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HR and ventilation. This therefore needs to be considered in the design of all future 
studies using this airway occlusion model. 
 
Summary 
Although Doppler ultrasound can be used to investigate changes in SPAP during 
unrestricted breathing it is not a suitable tool to assess changes in SPAP during 
airway occlusions. Therefore, we were unable to determine what contribution 
hypoxia may have on elevated SPAP during airway occlusions and whether there 
is an augmentation in this response over a prolonged period of airway occlusions. 
In the small study population SPAP was not elevated above euoxic baseline levels 
during fifteen minutes of euoxic recovery following airway occlusions with or 
without hypoxia.  
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4 CHAPTER 4 - MANIFESTATION OF RESPIRATORY 
PLASTICITY  FOLLOWING HYPOXIC AIRWAY OCCLUSIONS IN 
AWAKE HUMANS 
 
4.1 Introduction 
 
LTF of ventilation is a sustained elevation in V˙E that is initiated upon resumption of 
normal inspired O2 levels following acute IH. An additional form of respiratory 
plasticity evoked by IH is a progressive augmentation of the HVR. Both forms of 
respiratory plasticity have attracted a significant amount of interest primarily 
because of the possible implications they may have on upper airway stability in 
OSA patients as previously described in detail (General introduction: Could OSA-
induced IH evoke respiratory plasticity and thus attenuate upper airway collapse?). 
 
Although airway obstructions in OSA evoke a significant magnitude of IH that 
would be expected to evoke respiratory plasticity, to date there exists no 
conclusive evidence demonstrating the manifestation of ventilatory LTF and/or 
progressive augmentation of the HVR. Indeed, OSA severity during the night does 
not appear to reduce as might be expected if ventilatory LTF had developed. 
However, this can’t be taken as conclusive evidence for the absence of ventilatory 
LTF as the development of progressive augmentation of the HVR might negate any 
benefit of ventilatory LTF (Mateika and Narwani, 2009). The assessment of 
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whether respiratory plasticity manifests during a night’s sleep in OSA or not, is 
complicated by the absence of suitable intervals of unrestricted breathing to assess 
normal ventilation. Additionally, the fact that changes in sleep stages induce rapid 
changes in ventilation may confound this assessment further. An alternative 
approach is to model OSA in awake humans where these variables can be better 
controlled. Indeed, a number of studies have exposed awake humans to an acute 
bout of repetitive hypoxic breath-holds to mimic OSA (Cutler et al., 2004b, Cutler et 
al., 2004a, Leuenberger et al., 2007, Leuenberger et al., 2005) and have measured 
ventilation. Ventilation during a prolonged room air recovery period following 
exposure to hypoxic breath-holds has been compared to baseline room air 
breathing but none of these studies were able to demonstrate any sustained 
elevation in ventilation. Furthermore, in one study participants were exposed to five 
minutes of poikilocapnic hypoxia before and after hypoxic breath-holds but also 
failed to demonstrate any augmentation in the HVR (Leuenberger et al., 2007). 
However, an important factor to consider in these studies is that ventilation was 
assessed at baseline and during recovery from the hypoxic breath-holds under 
poikilocapnic conditions. During wakefulness, ventilation can be sustained by 
arousal and/or behavioural stimuli even when PaCO2 levels are below the 
ventilatory threshold. Thus under poikilocapnic conditions in these studies the 
responsible mechanism(s) for mediating respiratory LTF may have been activated 
during exposure to the repetitive hypoxic breath-holds but the expression of 
respiratory LTF may have been restrained because ventilation was not controlled 
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by the chemoreflex. Indeed, (Harris et al., 2006) exposed participants to 
intermittent reductions in PIO2 and demonstrated the appearance of ventilatory LTF 
and progressive augmentation of the HVR when PETCO2 was raised by 5 mmHg 
above normal levels but not during poikilocapnic conditions.  
 
Using our newly developed airway occlusion model of OSA (chapter 2) in awake 
humans, we aim to further investigate whether respiratory plasticity might be 
evoked in OSA. Following exposure to the hypoxic airway occlusions a recovery 
period of room air breathing will allow results to be compared to the previous 
hypoxic breath-hold studies. In addition, following room air recovery, raising 
PETCO2 slightly above normal levels will allow the possible manifestation of 
ventilatory LTF when ventilation is driven by the chemoreflex to be investigated. 
Furthermore, by maintaining the PETCO2 slightly above normal levels during a brief 
hypoxic exposure it may be possible to determine whether progressive 
augmentation of the HVR can also be expressed. 
 
Although we were unable to use Doppler ultrasound to assess the contribution of 
hypoxia to changes in SPAP during airway occlusions this technique has 
previously been used to accurately measure the magnitude and the time course of 
HPV during longer hypoxic exposures (Talbot et al., 2005). Using a similar protocol 
would allow us to investigate whether HPV is augmented following exposure to 
hypoxic airway occlusions. Although this would not give any indication of the 
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intensity of HPV during airway occlusions, showing that HPV is sensitised following 
a period of hypoxic airway occlusions could have serious implications for the high 
number of OSA patients with coexisting respiratory conditions such as chronic 
obstructive pulmonary disease (COPD) (Owens and Malhotra, 2010).  
 
Study aims 
The primary aim of this study was to determine whether exposure to an acute bout 
of hypoxic airway occlusions is capable of evoking ventilatory LTF and/or a 
progressive augmentation of the HVR in awake humans. A secondary aim of this 
study was to assess whether HPV during a prolonged hypoxic exposure is 
augmented by prior exposure to an acute bout of hypoxic airway occlusions.  
 
4.2 Methods 
 
Ethical approval  
After receiving detailed information on the procedures and risks of the study 
participants gave written consent to take part. The study was performed according 
to the latest revision of the Declaration of Helsinki and was approved by the local 
ethics committee (University of Birmingham ethical review committee). 
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Participants  
Eleven healthy participants were recruited to take part in the study. In five of these 
participants a clear tricuspid regurgitation jet could be visualised and thus 
additional Doppler ultrasound measurements during hypoxic exposures were 
possible. All participants were non-smokers, had no history of cardiovascular, 
respiratory or metabolic disease and were not taking any medication. 
 
Study protocol 
Participants visited the laboratory for two experimental trials separated by at least 
24 hours. In one visit participants were exposed to one hour of hypoxic airway 
occlusions (Trial 1) and in the other they were exposed to one hour of unrestricted 
room air breathing (Trial 2). Prior to experimental visits participants also undertook 
a preliminary visit to firstly assess whether tricuspid regurgitation could be 
measured and to familiarise themselves with the instrumentation and exposure to 
airway occlusions. For all experimental trials participants were asked to refrain 
from alcohol consumption and moderate to vigorous exercise for 24 hours and 
caffeine intake for 12 hours prior to arriving at the laboratory. In addition all 
experimental trials were performed at least 3 hours after food consumption. Both 
trials were performed at the same time of day and were performed in a randomised 
order.  
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Preliminary visit  
The preliminary visit involved the exact same procedures as previously described 
in chapter 3 except for one change. As this study did not involve a hyperoxic 
airway occlusion trial, during the preliminary visit participants were only exposed to 
hypoxic airway occlusions.  
 
Experimental trials 
In both experimental trials instrumentation was identical to that of the preliminary 
visit (see: chapter 3). Participants then breathed room air for approximately 15 
minutes to establish stable resting cardiovascular and respiratory parameters. 
Participants were then exposed to forty 20-second hypoxic airway occlusions in 
Trial 1 lasting a total of one hour as previously described in chapter 3. In contrast, 
in Trial 2 participants breathed room air freely for one hour. Following hypoxic 
airway occlusions (Trial 1) or unrestricted room air breathing (Trial 2) participants 
breathed room air during a ten-minute recovery period.  
 
In both trials participants were then exposed to an acute hypoxic ventilatory 
response test (AHVR) with the five participants who were undergoing Doppler 
ultrasound measurements re-positioning themselves into a left lateral position. For 
the AHVR test, participants were first exposed to five minutes of isocapnic euoxia 
(PETO2 = 100 mmHg and PETCO2 ~ 1 mmHg above normal), followed by 20 minutes 
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of isocapnic hypoxia (PETO2 = 50 mmHg and PETCO2 ~ 1 mmHg above normal) and 
finally a further five minutes of isocapnic euoxia.  
 
Ventilatory analysis 
In both trials, V˙E, PETCO2, PETO2 and SaO2 were recorded continuously. In both 
trials, baseline measurements were achieved by averaging the last three minutes 
of the room air baseline period. Likewise, in both trials, measurements were 
averaged during the final three minutes of the first and second five minutes of the 
ten minute room air recovery period that followed one hour of hypoxic apnoeas 
(Trial 1) or one hour unrestricted room air breathing (Trial 2). In addition, 
measurements during the AHVR test were achieved by averaging the final three 
minutes of the five minute isocapnic euoxic baseline period, of each of the five 
minute quarters of isocapnic hypoxia and of the final five minutes of isocapnic 
euoxic recovery.   
 
Haemodynamic analysis 
In the five participants whom Doppler ultrasound measurements were made SPAP 
and Q˙  was assessed as previously described in detail in chapter 3. In order to 
measure both SPAP and Q˙  during the AHVR test it was necessary to quickly 
switch between the two different echocardiographic views required (i.e. four and 
five chamber views respectively). This was achieved by holding a four chamber 
view of the heart for assessment of tricuspid regurgitation for ~90 seconds allowing 
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SPAP measurements during the first half of each minute. After ~90 seconds the 
view was changed to a five chamber view of the heart for ~30 seconds allowing Q˙  
assessments for the second half of every two minutes. To determine an isocapnic 
euoxic baseline value for SPAP, Q˙ , HR and SV and a value during isocapnic 
hypoxia once a plateau had been reached, values were averaged for all five 
minutes of isocapnic euoxic baseline and the last ten minutes of the isocapnic 
hypoxic exposure.  
 
Statistical analysis 
A two-way ANOVA with repeated measures in conjunction with post hoc LSD test 
was used to assess whether there was an interaction between trial and time for all 
ventilatory measurements (V˙E, PETCO2, PETO2 and SaO2) under room air conditions 
(three time points) and also separately during the AHVR test (six time points). One 
way repeated-measures ANOVA in conjunction with post hoc LSD test was also 
performed separately for each trial to better determine the effect of time on 
ventilatory measurements. For five of the participants who had Doppler ultrasound 
assessments a two-way ANOVA with repeated measures was used to assess 
whether there was an interaction between trial and time for SPAP, Q˙ , HR and SV. 
One way repeated-measures ANOVA was also performed separately for each trial 
to better determine the effect of time on these variables. Values are expressed as 
mean ± standard error and differences were considered significant if P # 0.05. 
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4.3 Results 
 
Participants 
Eleven healthy male participants completed the experiment with an average age of 
23.3 ± 1.7 years, weight of 77.1 ± 9.6 Kg, height of 180.1 ± 8.0 cm and a BMI of 
23.7 ± 2.2. Of these eleven participants the five who were assessed for SPAP had 
an average age of 23.2 ± 1.8 years, their weight and height was 70.0 ± 6.0 kg and 
175.0 ± 4.4 cm and they had a BMI of 22.8 ± 1.2. All values are mean ± SD. 
 
Hypoxic airway occlusions 
The modest reduction in PETO2 prior to each airway occlusion in Trial 1 was 
successful in eliciting a significant degree of hypoxia post airway occlusion as 
PETO2 dropped to an average nadir of 50.61 ± 0.68 mmHg. 
 
Room air breathing 
Table 4.1 lists the average PETO2, PETCO2 and SaO2 during room air baseline and 
room air recovery in both trials. Analysis showed a significant trial-by-time 
interaction in PETCO2 (P = 0.001). Indeed, PETCO2 significantly decreased from 
baseline to recovery in Trial 1 (P = 0.003) but not in Trial 2 and thus PETCO2 was 
significantly lower in Trial 1 than Trial 2 during the end of recovery. There was also 
a significant trial-by-time interaction in PETO2 (P = 0.043) as a result of a small but 
significant decrease in PETO2 from baseline to recovery in Trial 1 (P = 0.014) but 
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not in Trial 2. Thus, PETO2 was significantly lower in Trial 1 than Trial 2 during early 
recovery but had returned to a similar value by late recovery.  
 
Figure 4.1 shows V˙E during room air baseline and room air recovery in both trials. 
V˙E demonstrated a small but significant decrease from baseline to recovery in both 
trials (Trial 1: P = 0.004; Trial 2: P = 0.008) that was not significantly different 
between trials.  
 
AHVR test 
Gas control: Figure 4.2 shows the PETO2 and PETCO2 that were achieved during 
every minute of the AHVR test in both trials which were not different between trials. 
Furthermore, Table 4.2 lists the average PETO2, PETCO2 and SaO2 for the same 
time periods that ventilation was averaged over during each of the different phases 
of the AHVR test (i.e. isocapnic euoxic baseline, each quarter of the isocapnic 
hypoxic exposure and isocapnic euoxic recovery).  
 
Ventilation: Figure 4.3 shows average V˙E during all phases of the AHVR test in 
Trial 1 and Trial 2. As was expected V˙E during the AHVR test in both trials  
significantly increased from isocapnic euoxic baseline to isocapnic hypoxia and 
remained elevated for the entire 20 minute exposure before returning to baseline 
levels during isocapnic euoxic recovery (Trial 1: P = 0.003; Trial 2: P = 0.006). 
Analysis was unable to demonstrate a significant trial-by-time interaction in V˙E 
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during the entire AHVR test but there was a significant overall trial effect (P = 
0.003) with post hoc tests showing V˙E was greater in Trial 1 vs. Trial 2 during 
isocapnic euoxic baseline and all four quarters of the isocapnic hypoxic exposure 
but not isocapnic euoxic recovery where there was greater variation. 
 
The greater V˙E during both baseline isocapnic euoxia and isocapnic hypoxia in 
Trial 1 vs. Trial 2 would suggest the manifestation of ventilatory LTF and 
progressive augmentation of the HVR following the hypoxic airway occlusions in 
Trial 1. The manifestation of ventilatory LTF was further supported by analysis that 
showed a significant trial-by-time interaction when V˙E during room air baseline was 
compared to isocapnic euoxic baseline of the AHVR test (P = 0.013). Indeed, 
elevating PETCO2 of ~1 mmHg above room air baseline levels increased V˙E 
significantly more in Trial 1 than Trial 2 (Trial 1: 3.84 ± 0.94 vs. Trial 2: 1.53 ± 0.47 
l/min) as shown in figure 4.4. 
 
Haemodynamics 
Figure 4.5 shows SPAP for Trial 1 and Trial 2 during every minute of the AHVR 
test. In both trials SPAP significantly changed over time (Trial 1: P = 0.006, Trial 2: 
P = 0.001) but was not different between trials. Indeed, the increase from isocapnic 
euoxic baseline to a stable value during isocapnic hypoxia was by a similar 
magnitude in both trials (Trial 1: 22.8 ± 0.58 vs. 29.7 ± 0.95 mmHg; Trial 2: 22.8 ± 
0.83 vs. 29.5 ± 0.90 mmHg). Figure 4.6a shows Q˙  for Trial 1 and Trial 2 during 
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every minute of the AHVR test. Both trials demonstrated a significant change over 
time (Trial 1: P = 0.002, Trial 2: P = 0.019) but this was not different between trials 
as indicated by a similar increase from isocapnic euoxic baseline to a stable value 
during isocapnic hypoxia (Trial 1: 4.23 ± 0.09 vs. 5.00 ± 0.20 l/min; Trial 2: 4.29 ± 
0.32 vs. 4.98 ± 0.31 l/min). In both trials the change in Q˙  was a product of a 
significant increase in HR (Trial 1: P = 0.001, Trial 2: P = 0.004) which was again 
not different between trials as shown in Figure 4.6b. Indeed, there was a similar 
increase from isocapnic euoxic baseline to a stable value during isocapnic hypoxia 
(Trial 1, 50.4 ± 1.4 vs. 59.6 ± 3.4 bpm; Trial 2, 49.7 ± 2.3 vs. 58.6 ± 4.0 bpm). 
Figure 4.6c shows SV for both trials which did not change over time in either trial 
(Trial 1, 84.0 ± 1.6 vs. 84.4 ± 1.8 ml; Trial 2, 86.6 ± 5.4 vs. 85.7 ± 3.5 ml).   
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Table 4.1: PETCO2 , PETO2 and SaO2 values during room air baseline and room
air recovery following one hour of hypoxic airway occlusions (Trial 1) or
unrestricted room air breathing (Trial 2). * significantly lower than baseline, †
significantly lower than the same time point in Trial 2 (P ! 0.05).
Time Baseline Rec 5 min Rec 10 min Baseline Rec 5 min Rec 10 min
PETCO2 (mmHg) 40.4 ± 0.7 39.2 ± 0.8 * 39.3 ± 0.7 *† 40.4 ± 0.6 40.2 ± 0.5 40.4 ± 0.5
PETO2 (mmHg) 100.2 ± 0.5 95.5 ± 1.4 *† 98.3 ± 0.8 * 101 ± 1.2 99.5 ± 0.9 99.4 ± 0.8
SaO2 (%) 97.2 ± 0.1 96.6 ± 0.2 96.6 ± 0.1 97.1 ± 0.2 96.8 ± 0.2 96.8 ± 0.2
Trial 1 Trial 2
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Figure 4.1: Minute ventilation during room air baseline, and room air recovery,
following one hour of hypoxic airway occlusions in Trial 1 (closed symbols) or
unrestricted room air breathing in Trial 2 (open symbols). * significantly lower
than baseline (P ! 0.05).
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Figure 4.2: PETCO2 and PETO2 averaged for every minute during the AHVR test in Trial 1 (closed symbols) and Trial 2
(open symbols).
35
40
* **
*
Trial 1 
Time Baseline Hypoxia 5 min Hypoxia 10 min Hypoxia 15 min Hypoxia 20 min Recovery
PETCO2 (mmHg) 41.4 ± 0.6 41.0 ± 0.5 41.2 ± 0.5 41.2 ± 0.5 41.2 ± 0.6 40.9 ± 0.6
PETO2 (mmHg) 100.1 ± 0.2 50.0 ± 0.1 * 49.9 ± 0.1 * 49.9 ± 0.0 * 50.0 ± 0.0 * 100.7 ± 0.2
SaO2 (%) 96.9 ± 0.2 86.6 ± 0.4 * 86.3 ± 0.5 * 86.3 ± 0.5 * 86.3 ± 0.4 * 96.8 ± 0.1
Trial 2
Time Baseline Rec 5 min Rec 10 min Rec 10 min Rec 10 min Recovery
PETCO2 (mmHg) 41.7 ± 0.5 41.4 ± 0.5 41.5 ± 0.5 41.4 ± 0.5 41.4 ± 0.5 41.4 ± 0.6
PETO2 (mmHg) 100.2 ± 0.1 49.6 ± 0.2 * 49.7 ± 0.1 * 49.8 ± 0.1 * 50.0 ± 0.1 * 100.6 ± 0.2
SaO2 (%) 97.0 ± 0.2 86.5 ± 0.4 * 86.3 ± 0.4 * 86.5 ± 0.5 * 86.6 ± 0.4 * 96.9 ± 0.1
Table 4.2: Averaged PETCO2, PETO2 and SaO2 values for isocapnic euoxic
baseline, each quarter of isocapnic hypoxia and isocapnic euoxic recovery of
the AHVR test. * significantly lower than baseline (P ! 0.05).
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Figure 4.3: Minute ventilation during isocapnic euoxic baseline (5 min), each
quarter of isocapnic hypoxia (10,15,20,25 min) and isocapnic euoxic recovery
(30 min) of the AHVR test in Trial 1 (closed symbols) and Trial 2 (open
symbols). * significantly greater than Trial 2 (P ! 0.05). Thick black line
indicates hypoxic exposure.
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Figure 4.4: Minute ventilation in Trial 1 (closed symbols) and Trial 2
(open symbols) during room air baseline and isocapnic euoxic baseline of
the AHVR test where PETCO2 was ~1 mmHg greater than room air
baseline. * significantly greater than Trial 2 (P ! 0.05).
SP
AP
 
(m
m
Hg
)
24
26
28
30
32
34
136
Figure 4.5: Averaged systolic pulmonary arterial pressure (SPAP) during 5 minutes isocapnic euoxic baseline, 20
minutes isocapnic hypoxia and 5 minutes isocapnic euoxic recovery during the AHVR test in Trial 1 (circles) and Trial 2
(triangles). Filled symbols indicate recordings were taken during hypoxia.
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Figure 4.6: Averaged cardiac output (A), heart rate (B) and stroke volume (SV)
during 5 minutes isocapnic euoxic baseline, 20 minutes isocapnic hypoxia and 5
minutes isocapnic euoxic recovery in Trial 1 (circles) and Trial 2 (triangles).
Filled symbols indicate the measurement was taken during hypoxia.
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4.4 Discussion 
 
The primary findings of this study are threefold: 1) following exposure to one hour 
of hypoxic airway occlusions, ventilatory LTF is expressed when PETCO2 is 
elevated by ~1 mmHg above normal levels but not during poikilocapnic conditions. 
Secondly, under the same mildly elevated PETCO2 conditions augmentation of the 
HVR is also demonstrated. Thirdly, exposure to hypoxic airway occlusions for one 
hour does not augment HPV during a subsequent sustained hypoxic exposure. 
 
Respiratory plasticity 
Despite a brief period of hyperventilation immediately following the final hypoxic 
airway occlusion in Trial 1, V˙E quickly returned to baseline levels (< one minute) 
and then fell lower than baseline levels for the remaining ten minutes of recovery, 
presumably in response to the hyperventilation-induced hypocapnia. The absence 
of ventilatory LTF under these poikilocapnic conditions following hypoxic airway 
occlusions supports the results from previous studies that were unable to 
demonstrate ventilatory LTF following repetitive hypoxic breath-holds (Cutler et al., 
2004b, Cutler et al., 2004a, Leuenberger et al., 2007, Leuenberger et al., 2005). 
(Harris et al., 2006) postulated that the absence of ventilatory LTF in these studies 
and numerous other studies of awake humans using intermittent reductions in PIO2 
(Mateika and Sandhu, 2011) may have been a result of PaCO2 levels being below 
the central and peripheral chemoreflex thresholds. Indeed, they were able to 
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demonstrate the expression of ventilatory LTF in awake humans following an acute 
bout of IH when PETCO2 was raised above eucapnic baseline levels by 5 mmHg but 
not during room air breathing. PETCO2 during recovery from the airway occlusions 
was significantly lower than baseline in Trial 1 and thus even if PaCO2 was above 
the central and peripheral chemoreflex threshold at baseline it may not have been 
during recovery. 
 
To assess whether PETCO2 levels affected the expression of ventilatory LTF 
following hypoxic airway occlusions we aimed to elevate PETCO2 by ~1 mmHg 
above room air baseline levels during the AHVR test. The increase in ventilation 
during isocapnic euoxic baseline of the AHVR test compared with that of room air 
baseline in both trials (i.e. prior to exposure of one hour hypoxic airway occlusions 
in Trial 1 or unrestricted room air breathing in Trial 2) suggests that raising PETCO2 
by ~1 mmHg was sufficient to ensure PaCO2 was above the chemoreflex threshold. 
Importantly, although PETCO2 was elevated by a similar degree in both trials, V˙E 
was increased significantly more in Trial 1 than Trial 2 and thus was significantly 
greater in Trial 1 during the iscocapnic euoxic baseline of the AHVR test. Although 
we did not expose participants to this ~1 mmHg increase in PETCO2 at baseline and 
thus cannot compare with that of recovery in each trial, we take the significant trial-
by-time interaction to indicate the existence of ventilatory LTF.  
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Furthermore, V˙E during the following 20-minute hypoxic exposure was significantly 
greater in Trial 1 than Trial 2. The greater V˙E during the sustained hypoxia is 
indicative of progressive augmentation of the HVR, which is demonstrated in 
humans exposed to IH during mild hypercapnia but not during eucapnia (Harris et 
al., 2006). The only study to previously assess whether hypoxic breath-holds 
caused augmentation of the HVR in awake humans was unable to show any 
increase during a five-minute exposure to poikilocapnic hypoxia (Leuenberger et 
al., 2007). As previously discussed in detail (General introduction: Is progressive 
augmentation of the HVR the same phenomenon as respiratory LTF and what is 
the responsible mechanism(s)) progressive augmentation of the HVR and 
ventilatory LTF may simply be the same form of respiratory plasticity just 
demonstrated under different O2 tensions but we are unaware how our data can be 
used to support or refute this hypothesis. 
 
We are aware that a major limitation of our study was the absence of a trial that 
included airway occlusions without hypoxia, such as was performed in chapter 3. 
Therefore, it remains a possibility that other aspects of the airway occlusions (e.g. 
intermittent hypercapnia, lung receptor mechanical feedback and negative 
intrathoracic pressure) could have mediated ventilatory LTF and/or progressive 
augmentation of the HVR independently of IH. It would seem unlikely that 
hypercapnia occurring during each airway occlusion could have mediated the 
respiratory plasticity as previous animal evidence demonstrates it is not a stimulus 
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capable of inducing respiratory plasticity (Baker et al., 2001). It should be noted 
however, that we are unaware of any study that has examined whether exposure 
to intermittent hypercapnia evokes respiratory LTF in humans. Furthermore, it 
would seem unlikely that respiratory plasticity is the result of enhanced inspiratory 
activation (i.e. post airway occlusion hyperventilation). Postnatal rats demonstrate 
substantial hypoxic ventilatory decline and thus during hypoxic exposures they do 
not experience a notable increase in ventilation but still develop a significant 
magnitude of respiratory LTF (Tadjalli et al., 2007). During lung inflation sensory 
information from lung mechanoreceptors are relayed to the respiratory control 
centre in the brainstem via the vagus nerve (Ezure et al., 2002, Vanlunteren et al., 
1984, Kubin et al., 2006). Interestingly, (Tadjalli et al., 2010) recently demonstrated 
in rats that a reduction in vagal feedback activity during airway occlusions evoked 
LTF of hypoglossal nerve activity but had no sustained effect on diaphragm 
activity. Therefore, it would seem unlikely that intermittent reduction in vagal 
activity from lung mechanoreceptors during each airway occlusion in our study 
would have mediated the ventilatory LTF. However, this remains to be investigated 
in humans and thus remains a possibility. Furthermore, (Ryan and Nolan, 2009b) 
exposed anaesthetised rats to repetitive, five second episodes of negative upper 
airway pressure without concurrent hypoxia and was able to demonstrate the 
manifestation of LTF of diaphragm activity. Therefore, it is possible that the 
negative intrathoracic pressures generated during each occluded inspiratory effort 
may have mediated the ventilatory LTF independent of hypoxia in our study. 
Neither (Tadjalli et al., 2010) nor (Ryan and Nolan, 2009b) examined whether 
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exposure to airway occlusions or intermittent negative upper airway pressures 
caused progressive augmentation of the HVR. Therefore, it is not known whether 
either an intermittent reduction in vagal activity or negative upper airway pressures 
could have mediated the progressive augmentation shown in our study. 
 
Hypoxic pulmonary vasoconstriction 
It has previously been shown in humans that prior exposure to eight hours of 
sustained hypoxia sensitises the HPV response to a subsequent brief (25 minutes) 
hypoxic exposure (Smith et al., 2008a). HPV is known to be in part regulated by 
hypoxia-inducible factor (HIF) that controls the expression of a multitude of 
proteins, some of which may affect the response of the pulmonary vasculature to 
hypoxia (Smith et al., 2008b). It would appear that HIF plays a primary role in 
mediating the increased HPV sensitivity following prior exposure as iron 
supplementation abolished the augmentation in HPV and furthermore, iron 
depletion with infusion of desferrioxamine in the absence of hypoxia was able to 
mimic the effect of eight hours exposure to sustained hypoxia (Smith et al., 2008a). 
It remains unknown whether exposure to IH as occurs in OSA is capable of 
activating the HIF pathway and sensitising HPV to a subsequent hypoxic exposure 
as no human study has been performed to examine HPV during or after IH. 
Interestingly, in anaesthetised dogs HPV has been shown to gradually increase 
during successive intermittent exposures to 15 minutes of hypoxia, each 
interspersed by 15 minutes euoxia (Unger et al., 1977). Hypoxic exposures during 
airway occlusions in our study were brief compared to the 15 minute episodes 
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used in Unger’s et al., (1977) study and the total duration of the hypoxic exposures 
was far shorter than the eight hours used by (Smith et al., 2008a). However, we 
thought it was still possible that HPV during a 20-minute hypoxic exposure would 
be greater following one hour of hypoxic airway occlusions than following one hour 
of unrestrained room air breathing.  
 
Having only performed measurements of SPAP in five of the eleven participants in 
this study we must be conservative with our conclusions. However, in none of the 
five participants was there an indication for any augmentation in SPAP during the 
AHVR test following hypoxic airway occlusions. In humans, HPV consists of two 
distinct phases, a relatively rapid phase that reaches a plateau within several 
minutes and a second more gradual phase that is not initiated for ~40 minutes 
(Talbot et al., 2005) and does not reach a plateau for several hours (Dorrington et 
al., 1997). The initial rapid phase of HPV is clearly shown in our data and the 
plateau is similar between the two trials. Furthermore, in both trials this steady 
state plateau remains until the end of the 20 minute hypoxic exposure. Therefore, it 
is clear that the prior exposure to hypoxic airway occlusions did not cause any 
sensitisation of HPV. It is likely that the duration of airway occlusions in our study 
was too brief and that a longer exposure similar to what OSA patients experience 
nightly could have caused a notable augmentation of HPV. 
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Summary 
In summary, ventilatory LTF was not evident during ten minutes of room air 
recovery following one hour of hypoxic airway occlusions but did manifest when 
PETCO2 levels were increased above baseline levels by ~1 mmHg. Furthermore, V˙E 
during the 20 minute hypoxic exposure following one hour of hypoxic airway 
occlusions was enhanced compared with prior room air breathing suggesting the 
expression of progressive augmentation of the HVR. Future studies are required to 
determine whether hypoxia per se or negative pressures and/or reduction in lung 
mechanoreceptor feedback during airway occlusions mediates this respiratory 
plasticity. HPV during a 20 minute exposure to sustained hypoxia was unaltered by 
prior exposure to one hour of hypoxic airway occlusions. Future studies are 
required to see if longer exposures to OSA-related IH are capable of sensitising the 
HPV response as this may have implications for OSA patients with COPD. 
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5 CHAPTER 5 - LONG-TERM FACILITATION OF VENTILATION 
FOLLOWING ACUTE CONTINUOUS HYPOXIA IN AWAKE 
HUMANS DURING SUSTAINED HYPERCAPNIA 
 
5.1 Introduction 
 
A great number of studies have been undertaken during the last three decades 
which have contributed to our understanding of the mechanisms that may be 
involved in initiating and maintaining IH-induced respiratory LTF in animals. In 
contrast, despite a number of studies demonstrating the development of respiratory 
LTF in humans following intermittent reductions in PIO2 (Harris et al., 2006, 
Wadhwa et al., 2008, Lee et al., 2009, Gerst et al., 2011) and following hypoxic 
airway occlusions (chapter 4) there has been almost no research conducted to 
investigate the responsible mechanisms in humans. 
 
The carotid body (CB) is the primary O2 sensor in mammals and increased afferent 
discharge during hypoxia is considered as a logical initiating step in the 
development of respiratory LTF. Indeed, episodic stimulation of the cut carotid 
sinus nerve of rodents can initiate respiratory LTF (Millhorn et al., 1980a, Hayashi 
et al., 1993). However, respiratory LTF is sustained long after cessation of carotid 
sinus nerve stimulation suggesting that it is a central mechanism(s) that maintains 
respiratory LTF rather than CB afferent discharge (Hayashi et al., 1993, Millhorn et 
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al., 1980a). Furthermore, direct recordings of rodent (in and ex vivo) CB discharge 
show a return to baseline levels immediately upon each re-oxygenation following 
acute IH (Peng et al., 2003) and respiratory LTF is evident in rodents following 
acute IH despite CB inhibition with hyperoxia (Bach and Mitchell, 1996, Xing and 
Pilowsky, 2010, Baker and Mitchell, 2000). Thus, although strong evidence exists 
to suggest CB afferent discharge plays a primary role in initiating respiratory LTF 
during acute IH in rodents, it is generally accepted that it does not have an active 
role in maintaining respiratory LTF beyond hypoxic cessation. 
 
In humans, elevated sympathetic nervous activity during acute IH or acute CH is 
sustained for up to three hours following resumption of normal inspired O2 levels 
(Morgan et al., 1995, Xie et al., 2001, Xie et al., 2000, Tamisier et al., 2005, Cutler 
et al., 2004b, Cutler et al., 2004a, Querido et al., 2010, Leuenberger et al., 2005). It 
has recently been demonstrated that this sympathetic LTF following acute CH is 
transiently attenuated during brief inhibition of CB afferent discharge with hyperoxia 
(Querido et al., 2010). Because the pattern of sympathetic activity in humans 
(Seals et al., 1993) and rodents (Dick et al., 2004) is tightly coupled to that of the 
central respiratory drive we hypothesised that in awake humans, the CB discharge 
necessary for maintaining the full expression of sympathetic LTF may also 
maintain respiratory LTF following acute CH and acute IH. Currently, there is no 
available data to specifically link CB activity in the maintenance of ventilatory LTF 
in humans and this remains to be determined. The absence of ventilatory LTF 
following acute CH may simply be because acute CH is a stimulus that does not 
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elicit respiratory LTF in awake humans. This would be in agreement with previous 
animal research that has failed to link acute CH with respiratory LTF (Baker and 
Mitchell, 2000, Mitchell et al., 2001b, Turner and Mitchell, 1997, Dwinell et al., 
1997, McKay et al., 2004). Alternatively, ventilatory LTF following acute CH may 
not have been evident in previous human studies (Querido et al., 2010, Tamisier et 
al., 2005, McEvoy et al., 1996, Morgan et al., 1995, Xie et al., 2001) because 
PaCO2 levels were not maintained above eucapnic levels. Indeed, ventilatory LTF is 
not expressed in humans following acute IH (McEvoy et al., 1996, Jordan et al., 
2002, Mateika et al., 2004, Khodadadeh et al., 2006, Diep et al., 2007) unless CO2 
levels are elevated and maintained above eucapnic levels (Harris et al., 2006, 
Wadhwa et al., 2008, Lee et al., 2009, Gerst et al., 2011). Furthermore, we have 
previously shown in chapter 4 that ventilatory LTF is only expressed in awake 
humans following one hour of hypoxic airway occlusions when PETCO2 was 
elevated above normal levels.  
 
Study aims 
We aimed to examine whether acute CH of the same total duration of hypoxia as 
acute IH was able to elicit ventilatory LTF when CO2 levels were maintained above 
eucapnic levels. In addition, by transiently inhibiting CB discharge with brief 
hyperoxic exposures we aimed to investigate whether CB discharge was involved 
in the maintenance of ventilatory LTF following acute IH and acute CH.  
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5.2 Methods 
 
Ethical approval 
After receiving detailed information on the procedures and risks all participants 
gave written consent to take part. The study was performed according to the latest 
revision of the Declaration of Helsinki and was approved by the local ethics 
committee (University of Birmingham ethical review committee). 
 
Participants 
Twelve healthy male subjects participated in the study. All subjects were non-
smokers, had no history of cardiovascular, respiratory and metabolic disease and 
they were not taking any medication.  
 
Protocol 
Participants visited the laboratory for three experimental trials more than 24 hours 
apart; Trial 1 - acute IH, Trial 2 - acute CH, and Trial 3 - Control. Prior to 
experimental visits participants also undertook a preliminary visit to familiarize 
themselves with the instrumentation and exposure to the various gas mixtures. For 
all experimental trials participants were asked to refrain from alcohol consumption 
and moderate to vigorous exercise for 24 hours and caffeine intake for 12 hours 
prior to arriving at the laboratory. In addition all experimental trials were performed 
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at least three hours after food consumption. All trials were performed at the same 
time of day and were performed in a randomised order.  
 
Preliminary visit 
On arrival at the laboratory participants positioned themselves comfortably on a 
couch in the supine position where they were exposed to two 4-minute episodes of 
hypoxia during elevations in CO2 as would be experienced in Trial 1 and described 
in the next section. Instrumentation for this visit was identical to all other 
experimental visits as described below (Instrumentation). 
 
Trial 1: Once positioned comfortably on the couch participants breathed room air 
(RA) for 15 minutes in order to make eucapnic baseline measurements, followed 
by one minute exposure to hyperoxia. Subsequently, PETCO2 was elevated by 4-5 
mmHg above eucapnic levels and it was maintained at this level until the start of 
eucapnic recovery as described below. During the elevation in PETCO2, PETO2 was 
maintained at a euoxic level (100 mmHg), except for during hypoxic and hyperoxic 
exposures. After 20 minutes of acclimatisation to the newly elevated PETCO2 
(hypercapnic baseline), participants were exposed to one minute of hyperoxia 
followed by an additional two minutes recovery to restore euoxia. Subsequently, 
participants experienced eight, 4-minute episodes of hypoxia each separated by 4-
minute periods of euoxia. Following the final hypoxic episode, hypercapnic 
recovery consisted of four 5-minute periods, (R1-R4), each followed by one minute 
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of hyperoxia. After an additional two-minute recovery to restore euoxia following 
the final hyperoxia, inspired CO2 was removed to enable 15 minutes of eucapnic 
recovery, followed by a final one-minute exposure to hyperoxia. See Figure 5.1 for 
an illustration of the protocol. 
 
Trial 2: Trial 2 was identical to that of Trial 1, except the eight, 4-minute hypoxic 
episodes were substituted with one continuous hypoxic episode of the same total 
duration (32 minutes). See Figure 5.1 for an illustration of the protocol. 
 
Trial 3: In Trial 3 euoxia was maintained throughout the entire protocol and was 
otherwise identical to Trial 1, thus serving as a control for the sustained elevation in 
PETCO2 experienced in Trial 1 and Trial 2. See Figure 5.1 for an illustration of the 
protocol. 
 
Instrumentation 
Participants wore a comfortable face mask that allowed breathing through either 
the mouth or the nose (Hans Rudolph 7450 Series V2 oro-nasal mask, total dead 
space 100-125 ml depending on facemask size). The facemask was connected to 
the gas supply with a short flexible tube that allowed small head movements 
without lifting of the facemask seal. A good seal was ensured at all times by careful 
observation of gas waveforms on the computer monitor. End-tidal gas was 
sampled continuously from a catheter within the facemask. Ventilation was 
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measured and PETO2 and PETCO2 were controlled in an identical fashion to that 
previously described in chapter 3.  
 
During hypoxia in Trial 1 and Trial 3, PETO2 was rapidly reduced to 50 mmHg. 
Upon completion of each of the eight hypoxic episodes in Trial 1 and the 32 
minutes of continuous hypoxia in Trial 2, PETO2 was rapidly returned to 100 mmHg. 
The gas inspired during the exposures to hyperoxia consisted of 100% O2 with 
additional CO2 to maintain PETCO2 at the desired hypercapnic level. Hyperoxic 
exposures during eucapnic baseline and eucapnic recovery involved 100% 
inspired O2 without any additional CO2. 
 
Throughout all trials arterial O2 saturation (SaO2) was continuously measured using 
a pulse oximeter, worn on the participant’s ear lobe (Datex-Ohmeda 3900). 
 
Ventilatory analysis 
In all experimental trials, V˙E, SaO2, PETCO2 and PETO2 were recorded continuously. 
In all trials, baseline ventilatory measurements were made during both the 
eucapnic and hypercapnic periods by averaging V˙E for the last three minutes of 
each period. Likewise, in all trials, ventilatory measurements were made every five 
minutes during both the hypercapnic and eucapnic recovery periods by averaging 
V˙E for the last three minutes of each five-minute segment. Ventilatory 
measurements during the intervention period in Trial 1 (acute IH) were made for 
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each hypoxic and euoxic interval by averaging V˙E for the last two minutes of each 
interval. In Trial 2 and Trial 3 ventilatory measurements during the intervention 
periods (ACH and euoxia, respectively) were made every four minutes to match 
the measurement points in Trial 1.  
 
To assess the effect of inhibition of CB afferent discharge, ventilatory 
measurements were averaged over the entire minute of each hyperoxic exposure 
and compared with the ventilatory measurements made during the immediately 
preceding period of euoxia. The initial two breaths of 100% inspired O2 were 
excluded from the analysis to account for lung-to-CB circulation delay. 
 
Statistical analysis 
A two-way analysis of variance (ANOVA) with repeated measures in conjunction 
with post hoc LSD test was used to assess whether ventilatory measurements (V˙E, 
PETCO2, PETO2 and SaO2) during eucapnic and hypercapnic recovery were 
significantly different from their respective baselines within each trial and whether 
there were significant differences between trials. In addition, the same statistical 
approach was used to assess whether the hyperoxia-induced reduction in V˙E 
during hypercapnic recovery was significantly different from that during 
hypercapnic baseline within and between each trial. Finally, in Trial 1 a one-way 
ANOVA with repeated measures was used to assess whether there were 
significant differences between ventilatory measurements during the eight hypoxic 
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episodes and also during the eight immediately preceding euoxic episodes. Values 
are expressed as mean ± standard error and differences were considered 
significant if P # 0.05. 
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Figure 5.1: Schematic demonstrating protocols performed in Trial 1, 2 and
3. Arrows denote one-minute exposures to 100% inspired O2.
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5.3 Results 
 
Participants 
Twelve healthy male participants completed the experiment with an average age of 
23.5 ± 0.42 years, weight of 77.3 ± 2.4 Kg, height of 180.8 ± 1.8 cm and BMI of 
23.6 ± 0.56. All values are mean ± standard deviation. 
 
Gas control 
Figure 5.2 shows the PETO2 and PETCO2 that were achieved during all trials. The 
elevation in PETCO2 above eucapnic levels during the periods of hypercapnia in all 
trials was near identical (Trial 1: 4.6 ± 0.2, Trial 2: 4.6 ± 0.2, Trial 3: 4.4 ± 0.2 
mmHg). PETCO2 was controlled with considerable precision during all hypercapnic 
periods including when ventilation was altered due to superimposed hypoxia or 
hyperoxia. PETO2 was maintained at 100 mmHg during all periods of euoxia and at 
50 mmHg during all periods of hypoxia. Inspiration of 100% O2 was successful in 
elevating PETO2 well above the threshold that is required to inhibit CB afferent 
discharge. Tables 5.1-4 list the average end-tidal partial pressures achieved in all 
trials. 
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Ventilation 
 
Euoxia: In Trial 1, V˙E was significantly elevated above hypercapnic baseline during 
the entire hypercapnic recovery period (Figure 5.3). Intriguingly, in Trial 2, V˙E 
during the entire hypercapnic recovery period was also significantly elevated above 
baseline of an equivalent magnitude to that of Trial 1 (Figure 5.4). Furthermore, in 
both trials, V˙E continued to increase during hypercapnic recovery and was 
significantly greater during the final quarter than in the initial quarter (Figure 5.3 
and 5.4). 
 
However, in Trial 3 where participants were exposed to hypercapnia without 
hypoxia, V˙E during the hypercapnic recovery period was also significantly greater 
than hypercapnic baseline (Figure 5.5). Unlike Trial 1 and Trial 2, V˙E did not 
increase further during the hypercapnic recovery period but remained constant in 
Trial 3 (Figure 5.5). The magnitude of the increase in V˙E from baseline to the final 
quarter of the recovery period was significantly greater in Trial 1 and Trial 2 (Figure 
5.6).  
 
In trial 1, V˙E during the later hypoxic episodes began to increase and the final 
hypoxic episode was significantly greater than that of the first (Figure 5.3). V˙E 
during each euoxic episode that immediately preceded the eight hypoxic episodes 
did not change over time. 
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In all trials V˙E during eucapnic recovery had returned to eucapnic baseline levels 
within the first or second minute and remained at this level throughout the entire 
15-minute period (Figures 5.3-5.5). 
 
Hyperoxia: In all trials each exposure to hyperoxia significantly reduced V˙E 
(Figures 5.3-5.5). The hyperoxia-induced reduction in V˙E was greater during 
concurrent hypercapnia, when CB activity would be expected to be elevated above 
that of room air breathing (Figures 5.3-5.5).   
 
In contrast to our hypothesis that CB afferent discharge would be actively involved 
in maintaining ventilatory LTF, inhibition of the CB with hyperoxia did not abolish or 
even attenuate the apparent ventilatory LTF. Hyperoxia reduced ventilation to the 
same extent before and following the intervention in each trial (e.g. acute IH, acute 
CH or Control) (Figure 5.7) meaning that the increase in V˙E observed in all trials in 
the period following acute IH, acute CH or Control was independent of CB 
discharge (Figure 5.6).   
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Figure 5.2: Minute averages for PETO2 and PETCO2 for each trial. Filled
symbols indicate hyperoxic exposures.
Table 5.1: Averaged PETCO2, PETO2 and SaO2 values during eucapnic
baseline (EB) and eucapnic recovery (ER). * significantly different from
eucapnic baseline.
Time EB ER 5 min ER 10 min ER 15 min
PETCO2 (mmHg) 38.8 ±  0.6 37.1 ± 0.5 * 37.4 ± 0.5 * 37.4 ± 0.5 *
PETO2 (mmHg) 104 ± 0.8 109 ± 0.7 * 105 ± 0.6 105 ± 0.6 
SaO2  (%) 97.5 ± 0.2 97.5 ± 0.2 97.3 ± 0.2 97.3 ± 0.2
Time EB ER 5 min ER 10 min ER 15 min
PETCO2 (mmHg) 38.9 ± 0.5 36.6 ± 0.5 * 37.0 ± 0.5 * 37.1 ± 0.6 *
PETO2 (mmHg) 103 ± 0.9 106 ± 0.7 * 104 ± 0.6 104 ± 0.8
SaO2 (%) 97.3 ± 0.2 97.4 ± 0.1 97.1 ± 0.8 97.3 ± 0.2
Time EB ER 5 min ER 10 min ER 15 min
PETCO2 (mmHg) 39.4 ± 0.5 37.6 ± 0.4 * 38.1 ± 0.4 * 38.3 ± 0.4 *
PETO2 (mmHg) 103 ± 1.0 107 ± 0.7 * 104 ± 0.8 104 ± 0.8
SaO2  (%) 97.8 ± 0.2 97.6 ± 0.2 97.4 ± 0.2 97.3 ± 0.2
Trial 1 - (acute IH)
Trial 2 - (acute CH)
Trial 3 - (control)
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Table 5.2: Averaged PETCO2, PETO2 and SaO2 values for hyperoxic
exposures during eucapnic baseline (EB) and eucapnic recovery (ER).
* significantly lower than EB.
Time EB ER 
PETCO2 (mmHg) 39.7 ± 0.6 38.0 ± 0.5 *
PETO2 (mmHg) 433 ± 10 420 ± 11.9
SaO2  (%) 99.0 ± 0.2 98.8 ± 0.2
Time EB ER 
PETCO2 (mmHg) 39.4 ± 0.6 37.3 ± 0.6 *
PETO2 (mmHg) 418 ± 11 428 ± 10
SaO2 (%) 98.8 ± 0.2 98.9 ± 0.2
Time EB ER 
PETCO2 (mmHg) 39.8 ± 0.7 38.4 ± 0.5 *
PETO2 (mmHg) 434 ± 14 420 ± 18
SaO2  (%) 99.1 ± 0.1 98.9 ± 0.2
Trial 1 - (acute IH)
Trial 2 - (acute CH)
Trial 3 - (control)
Table 5.3: Averaged PETCO2, PETO2 and SaO2 values during hypercapnic
baseline (HB) and hypercapnic recovery (HR).
Time HB HR 5 min HR 10 min HR 15 min HR 20 min
PETCO2 (mmHg) 43.4 ± 0.5 43.4 ± 0.5 43.4 ±  0.5 43.4 ± 0.5 43.4 ± 0.5 
PETO2 (mmHg) 100 + 0.1 100 ± 0.18 100 ±  0.04 100 ± 0.1 100 ± 0.05
SaO2  (%) 97.5 ± 0.1 97.5 ±  0.2 97.3 ±  0.2 97.2 ± 0.2 97.3 ± 0.2
Time HB HR 5 min HR 10 min HR 15 min HR 20 min
PETCO2 (mmHg) 43.4 ± 0.4 43.3 ± 0.4 43.4 ± 0.4 43.4 ± 0.4 43.3 ± 0.4 
PETO2 (mmHg) 100 ± 0.1 100 ± 0.1 100 ± 0.04 100 ± 0.05 100 ± 0.03 
SaO2 (%) 97.3 ± 0.2 97.5 ± 0.2 97.6 ± 0.2 97.5 ± 0.2 94.5 ± 0.2
Time HB HR 5 min HR 10 min HR 15 min HR 20 min
PETCO2 (mmHg) 43.7 ± 0.4 43.7 ± 0.4 43.7 ± 0.5 43.7 ± 0.4 43.7 ± 0.4 
PETO2 (mmHg) 100 ± 0.1 100 ± 0.05 100 ± 0.1 100 ± 0.1 100 ± 0.1 
SaO2  (%) 97.3 ± 0.1 97.6 ± 0.1 97.4 ± 0.1 97.6 ± 0.2 97.6 ± 0.2
Trial 1 - (acute IH)
Trial 2 - (acute CH)
Trial 3 - (control)
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Table 5.4: Averaged PETCO2, PETO2 and SaO2 values for minute hyperoxic
exposures during hypercapnic baseline (HB) and hypercapnic recovery (HR).
Time HB HR 5 min HR 10 min HR 15 min HR 20 min
PETCO2 (mmHg) 43.5 ± 0.5 43.5 ± 0.5 43.4 ± 0.5 43.4 ± 0.5 43.5 ± 0.5
PETO2 (mmHg) 526 ± 14 544 ± 10 544 ± 11 545 ± 12 547 ± 11
SaO2  (%) 99.2 ± 0.2 98.9 ± 0.1 98.9 ± 0.1 98.8 ± 0.2 98.7 ± 0.1
Time HB HR 5 min HR 10 min HR 15 min HR 20 min
PETCO2 (mmHg) 43.6 ± 0.5 43.6 ± 0.4 43.5 ± 0.4 43.4 ± 0.4 43.6 ± 0.4
PETO2 (mmHg) 504 ± 11 507 ± 12 524 ± 12 529 ± 9 532 ± 11
SaO2 (%) 98.8 ± 0.2 98.9 ± 0.2 99.1 ± 0.1 99.0 ± 0.2 99.0 ± 0.2
Time HB HR 5 min HR 10 min HR 15 min HR 20 min
PETCO2 (mmHg) 43.8 ± 0.5 43.8 ± 0.5 43.9 ± 0.5 43.8 ± 0.4 43.7 ± 0.4
PETO2 (mmHg) 509 ± 13 515 ± 15 522 ± 17 521 ± 16 521 ± 12
SaO2  (%) 99.1 ± 0.2 98.9 ± 0.2 99.1 ± 0.1 99.1 ± 0.2 99.2 ± 0.2
Trial 1 - (acute IH)
Trial 2 - (acute CH)
Trial 3 - (control)
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Figure 5.3: (Trial 1) Black circles indicate average values for minute ventilation during hypercapnic baseline, each hypoxic and
euoxic interval during IH and hypercapnic recovery. Grey circles indicate average values for ventilation during eucapnic
baseline and during eucapnic recovery. White circles indicate average ventilation during hyperoxic exposures which
immediately followed that of the euoxic time point positioned above (as indicated by a black circle). * significantly greater than
respective baseline (i.e. euoxic or hyperoxic). † significantly greater than during the corresponding hyperoxic exposure. ‡
significantly greater than the start of hypercapnic recovery. § significantly greater than the first hypoxic episode.
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Figure 5.4: (Trial 2) Black circles indicate average values for minute ventilation during hypercapnic baseline, continuous
hypoxia and hypercapnic recovery. Grey circles indicate average values for ventilation during eucapnic baseline and
during eucapnic recovery. White circles indicate average ventilation during hyperoxic exposures which immediately
followed that of the euoxic time point positioned above (as indicated by a black circle). * significantly greater than
respective baseline (i.e. euoxic or hyperoxic). † significantly greater than during the corresponding hyperoxic exposure. ‡
significantly greater than the start of hypercapnic recovery.
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Figure 5.5: (Trial 3) Black circles indicate average values for minute ventilation during hypercapnic baseline, continuous
euoxia and hypercapnic recovery. Grey circles indicate average values for ventilation during eucapnic baseline and during
eucapnic recovery. White circles indicate average ventilation during hyperoxic exposures which immediately followed that
of the euoxic time point positioned above (as indicated by a black circle). * significantly greater than respective baseline
(i.e. euoxic or hyperoxic). † significantly greater than during the corresponding hyperoxic exposure.
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Figure 5.6: Change in minute ventilation from hypercapnic baseline to the
final quarter of recovery, during euoxia (black columns) and hyperoxia (white
columns). * significantly greater than control trial during euoxia, † significantly
greater than control trial during hyperoxia.
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Figure 5.7: Hyperoxia-induced reduction in minute ventilation during
hypercapnic baseline (black columns) and during the final quarter of
hypercapnic recovery (white columns).
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5.4 Discussion 
 
The primary findings of this study are three fold: 1) in awake humans, exposure to 
acute CH during hypercapnia induces a similar sustained elevation in ventilation to 
that of exposure to acute IH, 2) approximately half of this elevation in ventilation 
may be attributed to ventilatory LTF as exposure to sustained hypercapnia causes 
a gradual increase in ventilation that is independent of hypoxic exposure, 3) 
hyperoxia reduced ventilation to the same extent before and following acute IH and 
acute CH suggesting the CB is not actively involved in maintaining ventilatory LTF 
in awake humans. 
 
Hypercapnia and respiratory LTF 
Although respiratory LTF has been repeatedly demonstrated in a range of animal 
species using various preparations since the first publication in 1980 (Millhorn et 
al., 1980a), evidence for its existence in awake humans remained elusive until 
relatively recently despite the completion of numerous studies designed to 
investigate this phenomenon (Mateika and Sandhu, 2011). As discussed 
previously, (chapter 1 and 4) ventilatory LTF may be restrained in these studies of 
awake humans because PaCO2 may have been below the chemoreflex threshold. 
By raising PETCO2 5 mmHg above eucapnic levels and maintaining this throughout 
acute IH and recovery, (Harris et al., 2006) was able to demonstrate the 
manifestation of LTF in awake humans. Furthermore, in chapter 4 we were able to 
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demonstrate ventilatory LTF in awake humans following one hour of hypoxic 
airway occlusions during room air breathing when PETCO2 was elevated ~ 1 mmHg 
above normal levels but not during room air breathing. 
 
Using an almost identical acute IH protocol and a similar level of elevated PETCO2 
as used by (Harris et al., 2006) we demonstrated the appearance of ventilatory 
LTF of a similar magnitude in a population of young males. Furthermore, to the 
best of our knowledge we are the first to investigate whether acute CH also evokes 
ventilatory LTF during elevated PETCO2 levels in awake humans. In contrast to a 
substantial body of evidence in animal research showing that only acute IH 
produces respiratory LTF we demonstrated an equivalent magnitude of ventilatory 
LTF with acute CH to that following acute IH. However, our results from Trial 3 
(Control) also demonstrated a gradual but significant rise in ventilation during 
sustained elevations in PETCO2 that was independent of the exposure to hypoxia. 
Although the increase in V˙E was considerably less, at approximately half of the 
increase demonstrated in Trial 1 and Trial 2 following acute IH and acute CH, we 
believe that the increase in ventilation due to sustained hypercapnia must account 
for part of the apparent ventilatory LTF following both acute IH and acute CH. 
 
The possibility that the apparent ventilatory LTF following acute IH is not 
exclusively dependent on the exposure to IH but also on the gradual increase in 
ventilation to sustained hypercapnia was also considered by (Harris et al., 2006). In 
!'("
"
their study, a subset of their population was exposed to sustained hypercapnia 
without exposure to hypoxia, but in contrast to our results, ventilation remained 
constant after baseline measurements suggesting that it was indeed acute IH that 
mediated ventilatory LTF. However, a more recent paper has demonstrated that 
ventilation can also be significantly elevated in OSA patients following a slightly 
longer but lower intensity of sustained elevation in PETCO2 without hypoxic 
exposure (Gerst et al., 2011). The significant increase in V˙E due to hypercapnia 
alone in our study occurred even though we extended the duration of the 
hypercapnic acclimatisation phase by seven minutes from that used by (Gerst et 
al., 2011) in order to allow longer for ventilation to plateau following the step 
increase in PETCO2. The exact mechanism(s) responsible for this gradual rise in 
ventilation due to mild hypercapnia remains to be determined, although our data 
showing hyperoxia reduced ventilation to the same extent at baseline and recovery 
suggest a central mechanism is responsible. 
 
Respiratory LTF following acute IH and acute CH 
Despite our results demonstrating that there is a significant gradual increase in 
ventilation to sustained hypercapnia that is independent of hypoxic exposure (Trial 
3), this increase is significantly less than that occurring following the addition of 
acute IH or acute CH (Trial 1 and Trial 2). We believe these results demonstrate 
that in awake humans ventilatory LTF does manifest following exposure to both 
acute IH and acute CH during sustained hypercapnia albeit by a smaller magnitude 
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than previously documented. Furthermore, we have previously demonstrated that 
in awake humans ventilation was significantly greater during a brief five minute 
period of elevated PETCO2 (~1 mmHg above normal levels) following hypoxic 
airway occlusions vs. room air breathing. Therefore, the ventilatory LTF in chapter 
4 could not have been mediated by hypercapnia per se as the duration and level of 
hypercapnia were the same in both cases. 
 
Our findings are in contrast to animal research that suggests that intermittent but 
not continuous exposure to hypoxia can evoke respiratory LTF. Respiratory LTF 
following acute IH has been demonstrated in various anaesthetised and conscious 
animal species (Mateika and Sandhu, 2011) but not following acute CH (Baker and 
Mitchell, 2000, Mitchell et al., 2001b, Turner and Mitchell, 1997, Dwinell et al., 
1997, McKay et al., 2004, Tadjalli et al., 2007). 
  
The magnitude of ventilatory LTF following acute IH and acute CH in our study was 
equivalent and comparable to that of previous studies demonstrating ventilatory 
LTF following acute IH in healthy awake humans (Harris et al., 2006, Lee et al., 
2009, Wadhwa et al., 2008). Small differences in the magnitude of ventilatory LTF 
between studies are inevitable due to differences in protocols such as the total 
number of hypoxic episodes, level of sustained CO2, duration of recovery and 
differences in the participant population. However, one noticeable difference worth 
discussing is that the time course of ventilatory LTF development following acute 
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IH and acute CH in our study is different to that previously demonstrated in studies 
following acute IH (Lee et al., 2009, Harris et al., 2006, Wadhwa et al., 2008, Gerst 
et al., 2011). In these previous studies, V˙E does not change during hypercapnic 
recovery but remains stable and elevated above baseline having progressively 
increased during each euoxic episode that follows hypoxic exposures. In contrast 
the increase in V˙E during euoxic episodes was more modest in our study, with only 
a noticeable increase following the first hypoxic exposure and then again during 
the final two hypoxic exposures. Furthermore, there was a gradual rise in V˙E during 
hypercapnic recovery following both acute IH and acute CH and thus V˙E was 
significantly greater during the final quarter of hypercapnic recovery compared with 
the first. No change in V˙E during hypercapnic recovery in Trial 3 suggests the 
increase in V˙E during hypercapnic recovery following acute IH and acute CH is due 
to hypoxic exposure rather than a continued increase in V˙E to the sustained 
hypercapnia. Interestingly, OSA patients have been shown to both demonstrate 
(Lee et al., 2009) and not demonstrate this increase in V˙E (Gerst et al., 2011) 
during hypercapnic recovery. Although the pattern of increasing ventilatory LTF 
during hypercapnic recovery shown in our study is different to that of previous 
studies demonstrating ventilatory LTF development in healthy humans, this pattern 
is more common in animals that express respiratory LTF following acute IH. In 
anaesthetised rats phrenic and hypoglossal nerve and diaphragmatic muscle LTF 
as well as ventilatory LTF demonstrate a progressively augmenting pattern during 
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recovery from acute IH (Mitchell et al., 2001a, Ryan and Nolan, 2009a, Bach and 
Mitchell, 1996, Baker and Mitchell, 2000, Olson et al., 2001).  
 
In addition to the expression of ventilatory LTF following acute IH the significant 
increase in V˙E during the last hypoxic episode compared with the initial exposure is 
indicative of progressive augmentation of the HVR.  As previously discussed in 
detail, progressive augmentation of the HVR and ventilatory LTF may simply be the 
same form of respiratory plasticity and they are just demonstrated under different 
O2 tensions. However, as was also concluded in chapter 4 where augmentation of 
the HVR was shown following hypoxic airway occlusions, we do not have enough 
evidence to support or refute this theory.  
  
The role of the CB in maintaining ventilatory LTF 
We hypothesised that CB afferent discharge during recovery from acute IH and 
acute CH is actively involved in maintaining ventilatory LTF in awake humans. In 
contrast to this hypothesis, hyperoxia reduced ventilation to a similar extent during 
hypercapnic baseline and recovery in both trials suggesting that the CB does not 
contribute to ventilatory LTF as shown by the increase in ventilation following acute 
IH and acute CH.  
 
Our results suggest that mechanisms independent to the CB maintain ventilatory 
LTF in awake humans and accordingly, agree with a substantial body of evidence 
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from animals. The demonstration of respiratory LTF following acute IH during CB 
inhibition with hyperoxia as shown in our study has previously been demonstrated 
in rats (Bach and Mitchell, 1996, Baker and Mitchell, 2000, Xing and Pilowsky, 
2010). Although these studies were not designed specifically to investigate the 
involvement of the CB in maintaining respiratory LTF, rats were exposed to 50% 
(Bach and Mitchell, 1996, Baker and Mitchell, 2000) or 100% (Xing and Pilowsky, 
2010) inspired O2 throughout baseline and recovery, which would be expected to 
inhibit CB afferent discharge. However, despite this, phrenic discharge was shown 
to increase progressively during recovery and remained elevated for > 1 hr. This 
does not preclude the possibility of a stimulus to the CB that arises during acute IH, 
but is not inhibited by hyperoxia. To date, however, there is no evidence of any 
such residual, oxygen-independent, component arising during acute IH. Of course, 
if such a stimulus did exist then a role for the CB cannot be excluded. In addition, 
the possibility of a necessary input from the CB in LTF development is further 
eroded by the finding that episodic stimulation of the cut carotid sinus nerve to 
mimic episodic activation of the CB during acute IH initiates phrenic LTF which is 
maintained for > 30-90 minutes, following the total absence of any CB input to the 
central nervous system (CNS) (Millhorn et al., 1980a, Hayashi et al., 1993).  
 
Direct recordings of in and ex vivo CB afferent discharge in rats not previously 
exposed to acute IH demonstrated the elevated afferent discharge during hypoxic 
episodes promptly returned to baseline levels upon re-oxygenation and remained 
constant throughout recovery (Peng et al., 2003). However, rodents previously 
!(#"
"
exposed to chronic IH aimed to mimic nightly IH experienced by OSA patients 
evoked a progressive increase in CB afferent discharge during successive hypoxic 
episodes which stayed elevated for > 1 hr in recovery. This sustained elevation in 
CB afferent discharge following acute IH that is only evident in chronic IH rats has 
been termed sensory LTF and is reactive oxygen species dependant as antioxidant 
treatment inhibits its manifestation (Peng et al., 2003). All participants in our study 
reported no current or previous history of sleep apnoea and thus can be 
considered naïve to previous IH exposure. Our healthy participants would therefore 
not be expected to develop sensory LTF following acute IH. Using an almost 
identical acute IH protocol as used in our study, (Lee et al., 2009) demonstrated 
that OSA patients produced greater ventilatory LTF than healthy controls. 
Interestingly, antioxidant treatment attenuated this augmentation in ventilatory LTF 
back to the same level of ventilatory LTF as the healthy controls where antioxidant 
treatment had no effect. Presumably this was consequent to the abolishment of 
sensory LTF by antioxidant treatment in OSA patients that did not manifest in 
healthy controls who had previously not been exposed to chronic IH. However, the 
contribution that sensory LTF has on ventilatory LTF remains unknown and 
requires future studies utilising techniques such as hyperoxic inhibition of the CB. 
 
CB afferent discharge may reach the presympathetic neurons without intermediate 
communication in the respiratory network (Guyenet, 2000). Thus, it is possible that 
augmented CB afferent discharge (sensory LTF) or enhanced integration of CB 
afferent discharge at the CNS could mediate sympathetic LTF as previously shown 
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by (Querido et al., 2010) but not mediate a parallel increase in ventilation 
(respiratory LTF). We did not record sympathetic activity in our study and therefore 
we cannot conclude whether the hyperoxic exposures that failed to attenuate 
ventilatory LTF also attenuated sympathetic LTF. 
 
CB independent mechanisms maintaining ventilatory LTF in acute IH and 
acute CH 
Our findings that the CB does not actively maintain respiratory LTF suggest that a 
central mechanism may be involved. Whilst there is no evidence to suggest that an 
increase in cerebral blood flow (CBF) due to relatively short, acute exposures to 
hypoxia and/or hypercapnia adapts towards control levels (Poulin et al., 1996) 
causing a relative accumulation of CO2 in the cerebral circulation, a possible 
stimulus could be a lower pH in the cerebrospinal fluid caused by impaired 
regulation of [H+] during hypoxia (Duffin, 2005). Thus, ventilatory LTF may reflect 
the time course of central pH recovery following exposure to systemic hypoxia. 
Whilst we have no data to support or refute this possibility, this would be an 
important consideration for any mechanistic explanation of ventilatory LTF.  
 
It has long been believed that ventilation is not simply an additive product of 
peripheral and central chemoreflex input and recently a fascinating study by (Blain 
et al., 2010) presented strong evidence demonstrating that CB afferent discharge 
expresses a substantial hyperadditive interaction on the ventilatory response to 
central hypercapnia in dogs. The authors suggest that this significant interaction 
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may influence acclimitisation to continuous hypoxia and also other clinical 
conditions such as altered ventilatory control following chronic IH in OSA. 
However, because hyperoxia did not inhibit the ventilatory LTF in our study we can 
be confident that the ventilatory LTF following acute IH and/or acute CH is not due 
to an enhancement of this hyperadditive interaction.  
 
Animal studies provide evidence for a serotonin-dependent mechanism initiating 
and maintaining respiratory LTF (Mahamed and Mitchell, 2007, MacFarlane et al., 
2008). Phrenic LTF requires spinal serotonin release (Baker-Herman and Mitchell, 
2002) and activation of serotonin receptors (5-HT2) on respiratory motoneurons in 
the spinal cord (Kinkead and Mitchell, 1999, Fuller et al., 2001) which initiate the 
synthesis of spinal proteins such as brain-derived neurotrophic factor (BDNF) that 
subsequently maintains phrenic LTF (Baker-Herman et al., 2004). As stimulation of 
the cut carotid sinus nerve initiates the same serotoninergic-dependant pathway of 
phrenic LTF as acute IH (Millhorn et al., 1980b, Bach and Mitchell, 1996), the 
above model for serotonin-dependant respiratory LTF does not imply that the CB is 
not necessary for initiating respiratory LTF, rather that spinal protein synthesis 
maintains respiratory LTF as opposed to any continued input from the CB. 
Additionally, inhibition of 5HT2 receptors prior to acute IH exposure but not 
immediately following acute IH abolished phrenic LTF (Fuller et al., 2001). 
Although this serotonin-dependant mechanism for acute IH-induced respiratory 
LTF has been well described in animal studies (Mahamed and Mitchell, 2007, 
MacFarlane et al., 2008), acute CH does not elicit the same pattern of respiratory 
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LTF (Baker and Mitchell, 2000, Mitchell et al., 2001b, Turner and Mitchell, 1997, 
Dwinell et al., 1997, McKay et al., 2004) and only intermittent but not continuous 
application of serotonin or 5-HT2 receptor agonists evokes phrenic LTF (Lovett-
Barr et al., 2006, MacFarlane and Mitchell, 2009) and hypoglossal LTF (Bocchiaro 
and Feldman, 2004). Therefore, animal studies can only provide us with limited 
clues as to the possible mechanism(s) for ventilatory LTF following acute CH in 
awake humans as shown in our study. However, a recent study reported an 
equivalent magnitude and pattern of phrenic LTF following acute CH to that of 
acute IH, when serine/threonine protein phosphatase in the spinal cord of rats 
exposed to acute CH was inhibited with okadaic acid (Wilkerson et al., 2008). 
Furthermore, in the same study intravenous infusion of the broad spectrum 
serotonin inhibitor, methysergide, blocked phrenic LTF in rats exposed to acute IH 
or acute CH with okadaic acid. Okadaic acid administration alone did not evoke 
phrenic LTF and these results thus suggest the equivalent phrenic LTF following 
acute IH and acute CH with okadaic acid were mediated by the same serotonin-
dependant mechanism. Reactive oxygen species (ROS) are known to inhibit many 
protein phosphatases and observations from various studies would suggest that 
acute IH-induced ROS may inhibit these okadaic acid-sensitive serine/threonine 
phosphatases and thus remove their inhibitory restraint on phrenic LTF which does 
not occur during acute CH a stimulus not known to induce ROS generation 
(Wilkerson et al., 2007). Indeed, MacFarlane and Mitchell (2009) showed 
intermittent serotonin application to the spinal cord induces phrenic LTF but was 
abolished with NADPH oxidase inhibition (MacFarlane and Mitchell, 
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2009)(MacFarlane and Mitchell, 2009).  An attractive explanation for the 
appearance of ventilatory LTF following acute CH in our study is that the existence 
or regulation of these specific okadaic acid-sensitive serine/threonine 
phosphatases during hypoxic exposure is different in rats and thus the serotonin-
dependant mechanism for respiratory LTF during acute CH is not constrained in 
humans. 
 
Although serotonin-induced phrenic LTF (Lovett-Barr et al., 2006, MacFarlane and 
Mitchell, 2009) and hypoglossal LTF (Bocchiaro and Feldman, 2004) require 
intermittent activation of serotonin receptors, different respiratory pools may not 
require an intermittent pattern. Indeed, continuous spinal serotonin application is 
sufficient to induce LTF in thoracic (intercostals) inspiratory motor output in the 
neonatal rat brainstem/spinal cord preparation (Lovett-Barr et al., 2006). As 
ventilation is a product of combined respiratory output from various respiratory 
motor pools it is plausible that significant thoracic LTF following acute CH could in 
part mediate the ventilatory LTF demonstrated in our study. Furthermore, humans 
may demonstrate a variation from the situation in the rat in which respiratory motor 
pools express serotonin-induced LTF to continuous activation of serotonin 
receptors and thus phrenic LTF or hypoglossal LTF may be evoked by acute CH. 
 
If hypoxic-induced CB activity was the only mechanism capable of initiating 
respiratory LTF then CB denervation should completely abolish respiratory LTF 
when in fact it has been shown in rats to only attenuate acute IH-induced phrenic 
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LTF (Sibigtroth and Mitchell, 2011, Bavis and Mitchell, 2003). Therefore, although 
phrenic LTF following acute IH and episodic stimulation of the carotid sinus nerve 
is completely abolished with methysergide (Bach and Mitchell, 1996, Millhorn et al., 
1980b) suggesting a serotonin-dependant mechanism is capable of mediating the 
full expression of phrenic LTF in rats with intact CBs, it would appear that it is a 
redundant system as an additional central mechanism(s) must exist for phrenic 
LTF to develop in CB denervated rats. The exact central mechanism(s) remains 
unknown but in the absence of chemoreceptor feedback from the CB during 
hypoxia the initiating stimulus must be central hypoxia. It is therefore possible that 
central hypoxia may have been responsible for part or all of the ventilatory LTF 
following acute IH and more likely following acute CH where the 32 minutes of 
sustained hypoxia may have allowed greater development of central hypoxia than 
during the four-minute episodes in acute IH. 
 
A further intriguing possibility is that the ventilatory LTF following acute IH and 
acute CH in our study represents two different forms of respiratory LTF. The 
majority of animal studies investigating respiratory LTF use anaesthetised rats and 
demonstrate a progressive increase in phrenic LTF or ventilatory LTF following 
acute IH that does not peak until > 30 minutes and is sustained for > 1hr (Mitchell 
et al., 2001a). Ventilatory LTF following acute IH in awake unrestrained rats follows 
an equivalent pattern to anesthetised rats (Olson et al., 2001). However, under 
these awake and unrestrained conditions that most closely mimic the experimental 
conditions of our study, acute CH evoked a significant sustained elevation in 
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ventilation that peaked immediately following acute CH and then declined back to 
baseline levels within 40 minutes. It was suggested that the differences in the 
pattern of the elevated ventilation following acute IH and acute CH might arise as 
they represent different forms of LTF (Olson et al., 2001). In contrast, there did not 
appear to be noticeable differences in the pattern of the elevated ventilation 
following acute IH and acute CH in our study. It is possible that differences would 
have been displayed if our relatively short recovery period was extended. 
 
Summary 
We have demonstrated that, in awake humans, acute CH evokes an equivalent 
magnitude and pattern of sustained elevation in ventilation as that of acute IH and 
that part of this apparent ventilatory LTF is due to a gradual ventilatory ‘drift’ 
induced by the concomitant hypercapnia. Furthermore, by demonstrating that CB 
inhibition with hyperoxic exposure does not attenuate ventilatory LTF we provide 
further corroborative evidence against a role for the CB in actively maintaining 
ventilatory LTF. 
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6 CHAPTER 6 - USE OF AN ANIMAL AIRWAY OCCLUSION 
MODEL OF OSA TO INVESTIGATE WHETHER SIMULTANEOUS 
HYPERGLYCAEMIA AUGMENTS IH-INDUCED OXIDATIVE 
STRESS 
 
 
6.1 Introduction 
 
Elevations in biomarkers of oxidative stress have been reported in the plasma 
(Christou et al., 2009) and urine (Yamauchi et al., 2005) of OSA patients and are 
correlated to hypoxic indices such as, the average nadir in SaO2 and the frequency 
of O2 de-saturation events. Furthermore, exposure to acute IH evokes increased 
oxidative stress in OSA patients (Lee et al., 2009) and healthy humans (Pialoux et 
al., 2009). In addition, animals exposed to chronic IH demonstrate elevated levels 
of oxidative stress and develop cardiovascular disease which are both attenuated 
by antioxidant treatment suggesting oxidative stress as causal in the development 
of cardiovascular disease (Burckhardt et al., 2008, Troncoso Brindeiro et al., 2007, 
Peng et al., 2006). Another disease where oxidative stress is heavily implicated in 
the mediation of health complications is T2DM. Chronic hyperglycaemia-induced 
ROS generation in T2DM patients is believed to play a major role in the mediation 
of many of the associated health complications of T2DM (e.g. blindness, renal 
failure, nerve damage and atherosclerosis) (Brownlee, 2001). Furthermore, 
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experimentally induced chronic hyperglycaemia even without coexisting 
comorbidities (e.g. obesity) has been shown to elevate levels of oxidative stress in 
animal studies (Kayali et al., 2003, Cakatay and Kayali, 2006). In contrast, acute 
exposure to hyperglycaemia in insulin sensitive humans and rodents does not 
appear to cause an elevation in oxidative stress (Fisher-Wellman and Bloomer, 
2010, Kayali et al., 2003, Cakatay and Kayali, 2006). However, although acute 
exposure to hyperglycaemia may not independently increase oxidative stress there 
is a line of evidence that has lead us to hypothesise that acute hyperglycaemia 
may greatly augment the degree of oxidative stress occurring during exposure to 
IH. As previously discussed in detail (General introduction: Mechanisms for IH-
induced oxidative stress) the mechanistic pathways responsible for the generation 
of ROS during IH and IRI may be similar because of the comparable pattern of 
hypoxia and re-oxygenation (Lavie, 2003, Pack and Gislason, 2009). Recent 
evidence from experimental animal studies has shown that acute hyperglycaemia 
augments the generation of ROS and oxidative stress during exposure to IRI 
(Hirose et al., 2008, Bemeur et al., 2007, Tsuruta et al., 2010). Indeed, in two of 
these studies acute hyperglycaemia per se had no effect on ROS generation or 
oxidative stress but greatly augmented the response during both ischaemia and 
early reperfusion (Hirose et al., 2008, Tsuruta et al., 2010). We believe research is 
required to investigate whether these findings in IRI are also true for IH because 
over half of T2DM patients suffer from OSA (Einhorn et al., 2007) and thus millions 
of patients worldwide will experience hyperglycaemia and IH simultaneously during 
sleep.  
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Previously (chapter 3 and 4) we have used a newly designed airway occlusion 
model of OSA in healthy awake humans to investigate the effects of IH that occurs 
in OSA. Although we felt this model was successful in closely mimicking the 
generation of IH that occurs during obstructive apnoeas in OSA, participants found 
performing the airway occlusions for long periods uncomfortable. Therefore, this 
model is not suitable for exposing individuals to airway occlusions for a similar 
duration to that experienced by OSA patients during sleep (i.e. 6-8 hours). An 
alternative approach is to use an animal airway occlusion model of OSA whereby 
longer exposures are feasible. Indeed, it is possible to frequently occlude an airway 
cannula in anaesthetised rodents
 
evoking transient but significant drops in PaO2 
that mimic those occurring in OSA (Simpson et al., 2008, Othman et al., 2010, 
Tadjalli et al., 2010). We therefore feel this is a suitable model to use in order to 
investigate our hypothesis that simultaneous hyperglycaemia will increase the 
magnitude of oxidative stress elicited by IH. 
 
In addition to investigating this primary hypothesis using an animal model of airway 
occlusions we are also able to gain an insight into the possible development of 
ventilatory LTF and progressive augmentation of the HVR in OSA. Although airway 
occlusions in OSA evoke a significant magnitude of IH that would be expected to 
evoke ventilatory LTF and progressive augmentation of the HVR, to date there 
exists no conclusive evidence confirming or refuting the existence of these 
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phenomena in OSA. The absence of any evidence is because of the difficulty in 
accurately measuring a change in ventilatory control in OSA patients for two main 
reasons. Firstly, in most OSA patients there is an absence of suitable durations of 
unrestricted breathing to assess ventilation during room air breathing or hypoxic 
exposures and secondly changes in sleep stage elicit rapid changes in ventilation 
which may confound results. 
 
In chapter 4 we exposed healthy individuals to hypoxic airway occlusions aimed to 
mimic OSA and were able to demonstrate the expression of ventilatory LTF and 
progressive augmentation of the HVR but only when PETCO2 was elevated by ~1 
mmHg above normal levels. It has previously been hypothesised that the 
demonstration of respiratory LTF and progressive augmentation of the HVR in 
awake humans when PETCO2 is raised above normal levels is because ventilation 
is then controlled by the central and peripheral chemoreflex, rather than arousal 
and/or behavioural stimuli (Harris et al., 2006). As ventilation in anaesthetised 
animals cannot be maintained by arousal and/or behavioural stimuli it would seem 
likely that airway occlusions that elicit a significant magnitude of IH would evoke 
ventilatory LTF and progressive augmentation of the HVR. Although a number of 
studies with anaesthetised or sleeping animals have been undertaken previously to 
investigate the effects of repetitive airway occlusions (Simpson et al., 2008, 
Othman et al., 2010, Tadjalli et al., 2010, Schoorlemmer et al., 2011) only one 
investigated whether ventilatory LTF manifest (Tadjalli et al., 2010). In this study 
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rats who were exposed to a ten minute protocol of 15 second airway occlusions 
once every minute did not demonstrate LTF of diaphragm activity. However, we 
considered it possible that the small number of airway occlusions used in this study 
may have been insufficient to elicit ventilatory LTF. 
 
Study aims 
The primary aim of this study was to assess whether simultaneous exposure to 
hyperglycaemia augments the level of oxidative stress in animals exposed to 
repetitive airway occlusions that replicate IH occurring in OSA. A secondary aim of 
the study was to investigate whether ventilatory LTF and progressive augmentation 
of the HVR manifest in animals exposed to airway occlusions under poikilocapnic 
conditions for a similar duration to that experienced by OSA patients.  
 
6.2 Methods 
 
Experiments were performed on 24 male Wistar rats (weight 279 ± 57g; Charles 
River, Kent, UK) (mean ± standard deviation). All rats were housed in cages in the 
Biomedical Services Unit (BMSU) at the University of Birmingham and kept on a 
controlled 12 hour light-dark cycle and fed standard rat chow and water ad libitum. 
Food was withdrawn from rats at 4pm the afternoon before experiments and 
replaced with a food ration of 10g standard rat chow so all rats were considered 
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fasted at the start of each experiment. All procedures compiled with the Animals 
(Scientific Procedures) Act 1986.  
 
Anaesthesia 
Anaesthesia was induced in a small volume chamber via inhalation of isoflurane 
(3-4 %) in 3-4 l/min O2. Animals were deemed sufficiently anaesthetised upon a 
lack of righting ability and loss of the pedal withdrawal reflex at which time they 
were immediately placed on an operating table in the supine position and 
anaesthesia maintained via a face mask with 3-4 % isoflurane in 3-4 l/min O2. A 
vinyl cannula (Portex OD = 1.40 mm, ID = 0.63 mm) was then inserted into the 
jugular vein so that anaesthesia could be maintained with the steroid anaesthetic 
alfaxan (alfaxalone 10 mg/ml dissolved in cyclodextrin) diluted 1:1 with 0.9% 
saline. The flow of isoflurane was stopped and the face mask removed. 
Anaesthesia was then maintained throughout the experiment by a continuous 
infusion of alfaxan (~1.2 ml/h; dose of ~21.5 mg/kg/h) via an infusion pump (Braun 
Perfusor Secura FT, Braun, Germany). Somatic reflexes were frequently tested 
throughout the experiment in order to determine the depth of anaesthesia and 
additional bolus doses of 0.05 ml alfaxan were administered if deemed necessary. 
 
Surgical Preparation 
Following initiation of the continuous infusion of alfaxan the trachea was isolated 
and cannulated with a stainless steel T-shaped cannula. The T-shaped cannula 
maintained patency of the airway and allowed control of inspired gases using a 
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rotameter (e.g. hypoxia or room air) and allowed the airway to be transiently 
occluded as described below. A fluid filled cannula connected to a pressure 
transducer was introduced into the steel cannula and was sealed to allow airway 
pressure to be continuously measured. A short length of Nalgene tubing was 
attached to the remaining external end of the stainless steel T-shaped cannula 
which could be rapidly collapsed by a solenoid valve (2-way no pinch valve Kinesis 
Ltd, Cambridge, UK) to induce upper airway occlusions (see: experimental 
protocols). Immediately beyond the solenoid a spirometer was attached to 
measure airflow. Hypoxia could be induced by flowing 10% O2 balance nitrogen 
past the spirometer from a rotameter.   
 
The right brachial artery was cannulated with polythene tubing (Portex, OD = 0.8 
mm, ID = 0.4 mm) and was used to draw arterial blood samples for the assessment 
of blood glucose concentrations and blood gases. 
 
The right femoral artery was cannulated with polythene tubing (Portex, OD = 0.96 
mm, ID = 0.58 mm) and BP was continuously measured with a pressure 
transducer. Prior to each experiment the pressure transducer was calibrated with a 
mercury sphygmomanometer. 
 
The femoral vein was isolated and cannulated with vinyl cannula (Portex OD = 
1.40 mm, ID = 0.63 mm) and used for the infusion of glucose or saline. 
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The animal was maintained at 37˚C throughout the experiment using a 
thermostatic blanket that automatically corrected the temperature based on a 
thermocouple that measured rectal temperature. 
 
A MacLab/8s (AD Instruments Ltd, Oxford, UK) data acquisition system sampling 
at 100 Hz was used to collect cardiovascular and respiratory variables onto a 
Power Mac G4 computer with Chart software (AD Instruments Ltd.). Mean arterial 
pressure (MAP) was calculated on-line from the BP trace and TV and breathing 
frequency were derived on-line using the continuous air flow trace. V˙E was 
calculated off line by multiplying the two respiratory components. To determine the 
SaO2 during airway occlusions a pulse oximeter was attached to a paw of three rats 
in the NGAO group and SaO2 immediately prior to airway occlusions and the nadir 
following airway occlusions was manually recorded. 
 
Following surgery and setting up all recording equipment 20-30 minutes of 
equilibration was given before a baseline blood glucose measurement was taken 
once all measurements were deemed stable. Blood glucose was measured from a 
small drop (~0.6 µl) of arterial blood using an AccuChek Aviva Glucose Meter 
(Roche Diagnostics GmbH, Mannheim, Germany). In addition, in four animals 
arterial blood samples (150 $l) were removed anaerobically and PaCO2, PaO2 and 
pH
 
was assed using a blood gas analyser (Instrumentation Laboratory, MA, USA). 
This was repeated again during baseline hypoxia and room air recovery. 
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At the end of each experimental protocol blood was drawn from the femoral artery 
and transferred into a 5 ml K3-EDTA vacutainer (Becton Dickinson) previously kept 
on ice. Blood was then immediately centrifuged at 2,000g at 4°C for 12 minutes. 
Plasma was then aspirated into several aliquots that were precooled on ice and 
immediately frozen in liquid nitrogen before being moved to storage at −80°C. At 
the end of each experiment the animal was killed by exsanguination.  
 
Experimental protocol 
Male, Wistar rats were investigated in this study in four different groups. 
 
Group 1 (time control): Normal glucose airway unrestricted - (NGAU)  
Baseline measurements were recorded for 10 minutes during room air ventilation. 
Following this, animals were exposed to three minutes of poikilocapnic hypoxia 
(10% inspired O2). A further 5-10 minutes of room air ventilation was given to 
ensure blood gases had returned to normal and all measurements had stabilised 
before a saline bolus (10 ml/kg) was administered. Immediately following the saline 
bolus a constant infusion of saline was started at an infusion rate of 0.6-0.8 ml/h 
(chosen to approximately match the volume infused in rats in the two 
hyperglycaemic groups). Blood samples were drawn and assessed for blood 
glucose levels every half hour for six hours. After six hours, recovery 
measurements were performed which were identical to those performed at 
baseline (i.e. ten minutes of room air breathing followed by three minutes of 
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poikilocapnic hypoxia). Upon completion of recovery measurements, saline 
infusion was stopped and > 5 ml of blood was drawn for later assessment of 
oxidative stress and antioxidant capacity. 
 
Group 2: High glucose airway unrestricted - (HGAU)  
Animals in group 2 were exposed to a similar experimental exposure as those in 
group 1 except they were additionally exposed to sustained hyperglycaemia. The 
saline bolus was replaced with a glucose bolus (50 % w/v in saline; Sigma Aldrich, 
Poole, UK) of (10 ml/kg) and glucose was then infused at a rate selected with the 
aim of maintaining blood glucose levels between 11-12 mM/l for the remainder of 
the experiment (see: figure 6.1 for average infusion rates). Blood samples were 
drawn and assessed for blood glucose levels every half hour for six hours. If 
required glucose infusion rate was adjusted following each assessment of blood 
glucose levels. Baseline and recovery measurements were identical to those 
performed in group 1. 
 
Group 3: Normal glucose airway occlusion - (NGAO)  
Animals in group 3 were exposed to the same saline bolus and saline infusion as 
described in group 1 but were also exposed to six hours of airway occlusions. 
Upon initiating the saline infusion animals were simultaneously exposed to airway 
occlusions aimed to mimic a pattern of IH that occurs in OSA. Using an automated 
system (Master-8 stimulator) to control the solenoid valve, the airway cannula was 
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occluded for fifteen seconds every minute for six hours. Baseline and recovery 
measurements were identical to those performed in group 1. 
 
Group 4: High glucose airway occlusion - (HGAO)  
Animals in group 4 were exposed to hyperglycaemia as described in group 2 
simultaneously to airway occlusions as described in group 3 (i.e. six hour exposure 
to airway occlusions beginning immediately following the glucose bolus). Baseline 
and recovery measurements were identical to those performed in group 1. 
 
Analytical procedures 
 
MDA: A commercially available ELISA kit was used for the assessment of 
malondialdehyde-protein adducts (MDA) in plasma (OxiSelect MDA Adduct; Cell 
Biolabs, San Diego, CA).  
 
MDA assay principle: In brief, MDA-protein adducts were expressed relative to 
protein concentration thus the total plasma protein concentration was first 
determined using the bicinchoninic acid method (BCA) as previously described by 
Smith et al. (1985). Six protein standards were prepared by diluting a stock solution 
of Bovine Serum Albumin (BSA) (1 mg/ml) in dH2O.  Standards (10 $l) and 
samples (10 $l, diluted 1:200 in dH2O) were added to a 96 well plate in triplicate 
and 200 $l of BCA working solution (250 $l of copper sulphate solution (4% w/v) to 
12.5 ml BCA solution (Sigma, UK)) added to each well. Plates were incubated at 
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37 ºC for 30 minutes whilst protected from light. Plates were read at 490 nm 
(Multiscan MS, Labsystems, Finland) and total plasma protein concentration 
expressed as mg/ml. 
 
Based on the BCA data plasma samples were diluted to 10 µg/ml in PBS and then 
diluted protein samples and standards were added to a 96 well protein binding 
plate. Rabbit antibody specific to MDA-protein adducts was added to the plate 
followed by a horseradish peroxidase (HRP) secondary antibody. Plates were read 
at 450 nm (Multiscan MS, Labsystems, Finland) and the concentration of MDA-
protein adducts in the samples were determined by comparison with the standard 
curve and expressed as pmol/mg of protein. 
 
Nitrotyrosine: A commercially available ELISA kit was used for the assessment of 
nitrotyrosine in plasma (Hbt nitrotyrosine; HyCult Biotechnology, Uden, 
Netherlands).  
 
Nitrotyrosine assay principle: In brief, samples and standards were added to a 96 
well plate coated in an antibody specific to nitrotyrosine. A biotinylated tracer 
antibody was then added which binds to the captured nitrotyrosine. Streptavidin-
peroxidase conjugate was then added and binds to the biotinylated tracer antibody. 
Finally, tetramethylbenzidine was added which reacts with the enzyme 
streptavidin-peroxidase conjugate emitting a colour change. Plates were read at 
450 nm (Multiscan MS, Labsystems, Finland) and the concentration of nitrotyrosine 
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in the samples were determined by comparison with the standard curve and 
expressed as nM. 
 
FRAP: Total antioxidant capacity was assessed in plasma using a modification of 
the Ferric Reducing Ability of Plasma (FRAP) assay described previously by 
(Benzie and Strain, 1999). 10 $l of samples and 10 $l of standards (0-1000 $M 
ascorbic acid) were added in triplicate to a 96 well plate. 300 $l of freshly prepared 
FRAP reagent (300 mM acetate buffer (pH 3.6), 20 mM ferric chloride, 10 mM 2, 4, 
6- tripyridyltriazine) was added and incubated for eight minutes at room 
temperature. Absorbance values were read at 650 nm (Multiscan MS, Labsystems, 
Finland) and expressed as $M of antioxidant power relative to ascorbic acid as 
determined from a seven-point linear standard curve. 
 
Statistical analysis 
One-way ANOVA in conjunction with a post hoc LSD test was used to determine 
whether there was a significant difference in oxidative stress (MDA, nitrotyrosine) 
and antioxidant capacity (FRAP) between the four groups of animals. A two-way 
mixed-design ANOVA in conjunction with a post hoc LSD test was used to 
determine whether there was a significant group-by-time interaction in V˙E. Analysis 
was performed separately for room air conditions (i.e. baseline room air vs. 
recovery room air) and for hypoxic exposures (i.e. baseline hypoxia and recovery 
hypoxia). A one-way ANOVA with repeated measures was used to more closely 
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determine whether there was a change over time in V˙E in each group. All data are 
expressed as mean ± SEM. Differences were considered significant if P # 0.05. 
 
6.3 Results 
 
Airway occlusion induced reductions in SaO2 
Fifteen second airway occlusions caused significant hypoxia as demonstrated by 
an average decrease in SaO2 from 92.4 ± 0.38 % pre airway occlusion to 67.9 ± 2.3 
% post airway occlusion in three rats in the LGAO group. 
 
Blood gases 
Arterial blood gas samples were assessed during baseline euoxia, baseline 
hypoxia and recovery euoxia in three rats in the NGAO group and one rat in the 
HGAO group. PaCO2 fell from 45.5 ± 1.5 mmHg during room air baseline to 42.8 ± 
2.1 mmHg during room air recovery. This was accompanied by a change in pH 
which increased from 7.42 ± 0.03 during room air baseline to 7.45 ± 0.01 during 
room air recovery. PaO2 increased from 74.3 ± 3.2 mmHg during room air baseline 
to 81.5 ± 1.8 mmHg during room air recovery. Furthermore, exposure to 10% 
inspired O2 induced a notable degree of hypoxia as PaO2 averaged 38.8 ± 2.7 
mmHg. Subsequent hyperpnoea caused hypocapnia as PaCO2 averaged 31.5 ± 
1.85 mmHg which was accompanied by an increase in pH which averaged 7.51 ± 
0.01. 
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Blood glucose 
Figure 6.1 shows blood glucose values at baseline and every 30 minutes for six 
hours following glucose (HGAO and HGAU) or saline infusions (NGAO and NGAU) 
and also shows the glucose infusion rates (HGAO and HGAU). Blood glucose 
levels remained relatively stable throughout the experimental protocol in the NGAU 
and NGAO groups. In contrast, by design, blood glucose was elevated above 
baseline levels during glucose infusions in animals in the HGAU and HGAO 
groups. After an initial over shoot in the desired blood glucose levels in the first 30 
minutes in both groups, blood glucose was reduced and stabilised at the desired 
value, averaging 11.6 ± 0.12 and 11.52 ± 0.14 mM for the remainder of the 
experiment for HGAU and HGAO groups respectively. 
 
Oxidative stress and antioxidant capacity 
Figure 6.2 shows plasma MDA levels for the four different groups of animals, 
where none of the groups demonstrated a significant difference from another. 
Figure 6.3 shows plasma nitrotyrosine for all four groups of animals. For the 
majority of animals plasma levels of nitrotyrosine was low and only slightly above 
the detection limit of the assay. However, there were also animals that exhibited 
more notable levels of plasma nitrotyrosine but as these animals were spread 
between all four groups there was no significant difference between groups. Figure 
6.4 shows plasma antioxidant capacity as assessed by the FRAP assay.  As with 
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the biological markers of oxidative stress there was no notable difference in 
antioxidant capacity between the four groups of animals. 
 
Ventilation  
Figure 6.5 shows averaged V˙E during the final three minutes of baseline and 
recovery room air breathing in all groups. V˙E significantly increased from baseline 
to recovery in the HGAU trial (P = 0.016) without a significant change in any of the 
other groups. However the change in V˙E over time in the HGAU group was not 
significantly different to the other groups. Figure 6.6 shows averaged V˙E for the first 
20 seconds of the hypoxic exposure at baseline and recovery in all groups. V˙E did 
not change between baseline and recovery in any of the groups. 
 
Mean arterial pressure 
Figure 6.7 shows averaged MAP during baseline and recovery room air breathing 
in all four groups. None of the groups demonstrated a notable change over time. 
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Figure 6.1: Solid lines indicate average blood glucose levels for all four groups taken at baseline (0 min) and every half
hour for the next six hours (HGAO - red, HGAU - green, NGAO - purple, NGAU - blue). Dashed lines indicate glucose
infusion rates (GIR) (HGAO - Red, HGAU - Green) with each point indicating the GIR set for the following half hour.
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Figure 6.2: Averaged plasma levels of malondialdehyde-protein adducts
(MDA) in all four groups of animals.
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Figure 6.4: Averaged antioxidant capacity of plasma (FRAP) in all four
groups of animals. (antioxidant power relative to ascorbic acid).
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Figure 6.5: Averaged minute ventilation during baseline and recovery room
air in all four groups of animals. * significantly greater than baseline P < 0.05.
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Figure 6.6: Averaged minute ventilation during the first twenty seconds of
hypoxic exposure at baseline and recovery in all four groups of animals.
Baseline Recovery
Ve
n
til
at
io
n
 
(m
l/m
in
)
0
100
150
200
250
300 NGAU 
HGAU
NGAO 
HGAO 
198
Figure 6.7: Averaged mean arterial pressure (MAP) during baseline and
recovery room air breathing in all four groups of animals.
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6.4 Discussion 
 
The primary aim of this study was to determine whether exposure to simultaneous 
hyperglycaemia augmented the level of oxidative stress during exposure to 
repetitive airway occlusions that replicated the generation of IH occurring in OSA. 
Analysis of plasma levels of oxidative stress (MDA and nitrotyrosine) was unable to 
support our hypothesis as there was no notable elevation in oxidative stress in 
animals exposed to simultaneous (HAGO) rather than independent exposure to 
hyperglycaemia (HGAU) or repetitive airway occlusions (NGAO). Furthermore, the 
level of oxidative stress in these three groups of animals did not appear to be 
greater than in control animals (i.e. freely breathing, saline infused animals). Thus, 
suggesting that neither stimulus alone or simultaneously was capable of inducing 
oxidative stress in the healthy rats used in this study.  
 
The secondary aim of this study was to investigate whether ventilatory LTF and/or 
progressive augmentation of the HVR manifest in rats exposed to six hours 
repetitive airway occlusions aimed to mimic a night of OSA. Ventilation during 
recovery room air breathing following six hours airway occlusions with or without 
simultaneous hyperglycaemia was not greater than during baseline room air 
breathing. In addition, there was no difference in the level of ventilation during 
baseline hypoxia and recovery hypoxia. In contrast, ventilation during recovery 
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room air breathing was significantly greater than baseline room air breathing in rats 
exposed to sustained hyperglycaemia without airway occlusions (HGAU).  
 
Oxidative stress 
Lipid peroxidation (LPO) represents oxidative damage of lipids most commonly 
associated with polyunsaturated fatty acids and elevated levels of LPO have been 
reported in plasma and tissues from patients with cardiovascular disease (Niki, 
2009, Rumley et al., 2004). Peroxidation of polyunsaturated fatty acids generates a 
number of secondary products of which MDA is the major product. MDA expresses 
a high level of toxicity, and is able to alter DNA and various proteins and is 
considered to have atherogenic and mutagenic properties (Del Rio et al., 2005). 
Eight weeks of nightly IH exposure has been shown to cause a twofold increase in 
plasma MDA levels in rats (Savransky et al., 2007). Furthermore, simultaneous 
exposure to acute hyperglycaemia increased the generation of MDA in the plasma 
and brain of rodents exposed to cerebral IRI (Tsuruta et al., 2010). Therefore, we 
felt plasma MDA was an appropriate marker of oxidative stress to use in order to 
investigate whether simultaneous hyperglycaemia increased oxidative stress 
during repetitive airway occlusions aimed to replicate IH occurring in OSA. 
However, we were unable to demonstrate an appreciable difference in plasma 
MDA levels between any of the groups and control animals. 
 
Oxidative stress is a product of ROS and reactive nitrogen species (RNS) of which 
peroxynitrite is one of the most potent RNS generated when superoxide anions 
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react with nitric oxide. Peroxynitrite can react with tyrosine residues in proteins 
forming a 3-nitrotyrosine adduct (Souza et al., 2008) and thus 3-nitrotyrosine is 
commonly used as a marker for peroxynitrite (Beckman and Koppenol, 1996, 
Oldreive and Rice-Evans, 2001). Nitrotyrosine has been shown to be associated 
with endothelial dysfunction (Kohler et al., 2010) likely as a result of increased 
levels of peroxynitrite reducing the bio-availability of nitric oxide. It has previously 
been demonstrated that OSA patients have elevated levels of nitrotyrosine in 
endothelial cells and impaired endothelial function as assessed by flow mediated 
dilation (FMD) (Jelic et al., 2010, Jelic et al., 2008). Furthermore randomized trials 
with CPAP have demonstrated improvements in circulating levels of nitrate and 
nitrite (Cross et al., 2008). Interestingly, it has also been shown in rodents that 
hyperglycaemia simultaneous to IRI increases nitrotyrosine in hepatic (Behrends et 
al., 2010), kidney (Hirose et al., 2008) and cerebral tissue (Ste-Marie et al., 2001). 
Therefore, we felt assessing the level of plasma nitrotyrosine would be an 
appropriate measurement to investigate whether simultaneous hyperglycaemia 
increased oxidative stress during airway occlusions. However, as with the 
assessment of plasma MDA levels we were unable to demonstrate a noticeable 
elevation in nitrotyrosine in any of the groups compared to control animals. 
 
With the important role that antioxidants play in attenuating oxidative stress and 
evidence demonstrating impaired antioxidant capacity in disease states (Barcelo et 
al., 2006, Baynes, 1991) we sought to assess antioxidant capacity in addition to 
measures of oxidative stress. We used a FRAP assay to assess total antioxidant 
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capacity of the plasma which includes the sum of all antioxidants (i.e. endogenous 
and exogenous) (Bartosz, 2010). Having demonstrated both separate and 
simultaneous exposure to hyperglycaemia and airway occlusions did not increase 
the level of oxidative stress in animals it is maybe not surprising that there was no 
difference in the antioxidant capacity of the plasma between groups.  
 
We did not expect oxidative stress to be elevated in animals exposed to acute 
hyperglycaemia alone as previous literature has shown that acute exposure to 
hyperglycaemia does not increase oxidative stress in insulin sensitive rodents 
(Cakatay and Kayali, 2006, Kayali et al., 2003) or healthy humans (Fisher-Wellman 
and Bloomer, 2010). However, we did expect to see an increase in oxidative stress 
following six hours of airway occlusions that evoked a significant degree of IH, 
because of existing human research that demonstrates acute exposure to 
experimentally-induced IH causes oxidative stress (Pialoux et al., 2009, Lee et al., 
2009). Furthermore, we hypothesised that simultaneous hyperglycaemia would 
enhance IH-induced oxidative stress as it has been shown to do during IRI in 
various animal studies (Hirose et al., 2008, Bemeur et al., 2007, Tsuruta et al., 
2010). Although elevated levels of plasma MDA have been shown in animals 
exposed to chronic IH (Savransky et al., 2007), the study does not report a time 
course of changes in plasma MDA levels and thus it is unknown whether an 
elevation is seen after as little as one day of exposure which did not occur in our 
study. Interestingly, a recent study that also used airway occlusions in 
anaesthetised rats to replicate an acute exposure to IH as occurs in OSA reported 
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an increase in plasma protein oxidation but did not demonstrate a noticeable 
change in plasma MDA levels (Celec 2012). Furthermore, IH may not be a stimulus 
capable of increasing levels of nitrotyrosine as two studies exposing rats to chronic 
IH were unable to show an effect (Philippi et al., 2010, Jun et al., 2008). It is 
therefore possible that in our study an alternative choice of biomarkers of oxidative 
stress from that of nitrotyrosine and MDA may have demonstrated an elevation in 
oxidative stress.  
 
Respiratory plasticity 
In contrast to our hypothesis that airway occlusions would elicit ventilatory LTF, 
ventilation during recovery room air breathing following six hours of airway 
occlusions with or without hyperglycaemia was not greater than during baseline 
room air breathing. Although the pattern of breathing in recovery from airway 
occlusions was stable, without any notable pauses that might indicate PaCO2 had 
fallen below the apnoeic threshold, it is possible that a sizeable reduction in PaCO2 
as a result of post airway occlusion hyperventilation may still have inhibited the 
expression of respiratory LTF. Previous studies investigating respiratory LTF in 
anaesthetised animals following exposure to intermittent reductions in PIO2 have 
considered that reduced chemoreceptor feedback as a result of hyperventilation-
induced hypocapnia could restrain the expression of respiratory LTF. Therefore, 
these studies have often used supplemental CO2 to ensure PaCO2 does not fall 
below baseline levels during exposures to IH (Bach and Mitchell, 1996, Kinkead 
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and Mitchell, 1999, Baker and Mitchell, 2000). Indeed,  in awake rats an increase 
in ventilation of only 20% was evident 60 minutes post acute IH but increased to 
57% when supplemental CO2 was subsequently given to return PaCO2 to baseline 
levels (Olson et al., 2001). A major limitation of our study is that blood gases were 
only measured in four rats, none of which were exposed to airway occlusions. We 
can only speculate that the substantial hyperventilation following each airway 
occlusion may have lowered PaCO2 below baseline levels. It is important to note 
that the average baseline PaO2 of 74.3 ± 3.2  in the four rats assessed for blood 
gases is mildly hypoxic which could have been due to rats lying on their back partly 
restricting inspiration or as a consequence of anaesthesia. Therefore, the relatively 
high baseline PaCO2 of 45.5 ± 1.5 may also have been elevated above normal 
normal levels. If animals in the airway occlusion group demonstrated similar 
baseline PaCO2 and PaO2 as would be expected then it is possible that airway 
occlusion induced hyperventilation could have caused a considerable lowering in 
PaCO2 restraining the expression of ventilatory LTF without PaCO2  falling below the 
apnoeic threshold.  
 
Ventilation during exposure to 10% inspired O2 during recovery from six hours of 
airway occlusions was not greater than during hypoxic exposure at baseline. This 
indicates the absence of any progressive augmentation of the HVR but similar to 
ventilatory LTF, it may have been restrained by lower PaCO2 values. It is possible 
to assess PaCO2 regularly during recovery to allow supplemental CO2 to be used in 
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order to maintain PaCO2 at baseline levels. However, this artificial control of PaCO2 
does not occur in OSA during sleep and thus by allowing PaCO2 to change as it 
would naturally occur we have presented evidence to suggest ventilatory LTF and 
progressive augmentation of the HVR are unlikely to be expressed in OSA 
patients. However, as previously suggested by (Tadjalli et al., 2010) who was also 
unable to demonstrate ventilatory LTF following airway occlusions in anaesthetised 
rodents, it is possible that ventilatory LTF and progressive augmentation of the 
HVR are suppressed by different types and levels of anaesthesia.  
 
An unexpected finding in this study was that in the HGAU group, ventilation in 
room air recovery was greater than room air baseline. As MAP pressure was not 
elevated above baseline levels it would seem unlikely that the greater ventilation 
was a result of a decreased level of anaesthesia. It is important to note that 
baseline measurements were made in fasted rats prior to the glucose infusion, 
whereas recovery measurements were made during continued glucose infusions. It 
is therefore possible an increased metabolic rate during recovery in response to 
the sustained hyperglycaemia could have increased PaCO2 from baseline levels 
and thus mediated the elevation in ventilation. It is interesting to note that PaCO2 in 
the three animals assessed for blood gases in the LGAU group demonstrated an 
average decrease in PaCO2 of 4 ± 0.58 mmHg from baseline to recovery where the 
one rat in the HGAU group increased by 1 mmHg despite an increase in PaO2 of 8 
mmHg. Future research with blood gas measurements made in considerably more 
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animals is required before the responsible mechanisms of ventilatory LTF in the 
HGAU group and absence in the two airway occlusions groups can be established.  
 
Summary 
In contrast to our hypothesis, levels of plasma MDA and nitrotyrosine were not 
greater in animals exposed to simultaneous hyperglycaemia and repetitive airway 
occlusions. Indeed, neither simultaneous nor independent exposure to these 
stimuli over six hours was capable of increasing oxidative stress in healthy rats. 
Future studies aimed to investigate our hypothesis should use exposures lasting 
several weeks which have previously been shown to augment oxidative stress in 
animals and better resembles the chronic conditions of T2DM and OSA. Finally, in 
contrast to our hypothesis, six hours of repetitive airway occlusions with or without 
simultaneous hyperglycaemia did not evoke ventilatory LTF or progressive 
augmentation of the HVR.  
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7 CHAPTER 7 - SIMULTANEOUS EXPOSURE TO ACUTE 
INTERMITTENT HYPOXIA AND COMBINED POSTPRANDIAL 
HYPERGLYCAEMIA AND HYPERLIPIDAEMIA IN HEALTHY 
HUMANS 
 
7.1 Introduction 
 
IH is known to be a stimulus capable of inducing oxidative stress in humans and it 
is considered to be one of the primary candidates for mediating the development 
and progression of cardiovascular disease in OSA patients (Lavie and Lavie, 2009, 
Pack and Gislason, 2009, Garvey et al., 2009). Indeed, OSA patients demonstrate 
elevated levels of oxidative stress that are correlated to indices of hypoxic 
exposure such as the average nadir in SaO2 and the frequency of O2 de-saturation 
events (Christou et al., 2009, Yamauchi et al., 2005). Furthermore, animals 
exposed to chronic IH express elevated levels of oxidative stress and develop 
cardiovascular disease, both of which are attenuated by antioxidant treatment 
(Burckhardt et al., 2008, Troncoso Brindeiro et al., 2007, Peng et al., 2006). In 
humans, exposure to acute IH also evokes increased oxidative stress (Pialoux et 
al., 2009, Lee et al., 2009).  
 
Postprandial hyperlipidaemia (Ceriello et al., 2002) and postprandial 
hyperglycaemia (Ceriello et al., 2004) are also stimuli capable of inducing oxidative 
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stress in humans. It is likely that OSA patients who consume meals late in the 
evening will experience IH simultaneously with postprandial hyperglycaemia and 
hyperlipidaemia. This is even more likely in the 50 percent of T2DM patients who 
have coexisting OSA (Einhorn et al., 2007) because exaggerated and prolonged 
postprandial hyperglycaemia and hyperlipidaemia are hallmarks of T2DM. Based 
on a substantial body of evidence showing that simultaneous hyperglycaemia 
augments oxidative stress following IRI we hypothesised previously (chapter six) 
that simultaneous hyperglycaemia would elevate oxidative stress during IH. This 
was hypothesised because the mechanistic pathways responsible for the 
generation of ROS during IH and IRI may be similar because of the comparable 
pattern of hypoxia and re-oxygenation (Lavie, 2003, Pack and Gislason, 2009). In 
contrast to our hypothesis, we were unable to demonstrate a significant increase in 
oxidative stress in hyperglycaemic rats exposed to six hours of airway occlusions 
that induced IH mimicking what occurs in OSA. However, until now no study has 
investigated the effects of simultaneous exposure to IH and combined postprandial 
hyperglycaemia and hyperlipidaemia on oxidative stress in humans.  
 
The high prevalence of T2DM in the OSA population is primarily due to the shared 
risk factor of excess weight (Einhorn et al., 2007) but recent evidence also 
suggests there is an independent association (Punjabi et al., 2004, Sulit et al., 
2006, Reichmuth et al., 2005). It is well known that the diabetes health 
complication, diabetes autonomic neuropathy, can cause OSA as ventilatory 
control is impaired (Bottini et al., 2003, Bottini et al., 2000) but evidence is 
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emerging to suggest that OSA-induced IH may also cause the development and/or 
progression of T2DM. Indeed, rats and humans exposed to acute IH demonstrate a 
marked reduction in insulin sensitivity (Iiyori et al., 2007, Louis and Punjabi, 2009). 
Although (Louis and Punjabi, 2009) presented strong evidence showing IH caused 
a significant impairment in glucose removal during glucose infusion, no study until 
now has investigated the effects of IH on postprandial hyperglycaemia as would be 
experienced in OSA patients with T2DM.  
 
In addition to investigating the effects of acute IH exposure on oxidative stress 
levels and a possible augmentation in postprandial hyperglycaemia a further 
opportunity is presented to investigate IH-induced respiratory plasticity. Previously, 
in chapters 4 and 5 we demonstrated the manifestation of ventilatory LTF in awake 
humans following an acute bout of hypoxic airway occlusions or acute exposure to 
intermittent reductions in PIO2, respectively. In these studies ventilatory LTF was 
only expressed when PETCO2 was elevated above normal levels as previously 
shown by (Harris et al., 2006). However, all published studies specifically 
undertaken to investigate ventilatory LTF in humans and those performed in 
chapter 4 and 5 of this thesis have exposed participants to a relatively brief period 
of IH (< 90 minutes) (Harris et al., 2006, Wadhwa et al., 2008, Lee et al., 2009, 
Gerst et al., 2011). We considered it possible that an extended duration of IH 
exposure (i.e. six hours) could result in a greater activation of the responsible 
mechanisms for the development of ventilatory LTF and thus ventilatory LTF may 
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be expressed without supplemental CO2. Furthermore, progressive augmentation 
of the HVR, like ventilatory LTF, has only been reported in humans if PETCO2 is 
elevated above normal levels (Harris et al., 2006). However, as is the case for 
ventilatory LTF, no study has investigated whether exposure to acute IH for a 
period longer than ninety minutes is capable of inducing progressive augmentation 
of the HVR.   
 
Study aims 
The primary aim of this study was to investigate the effects of simultaneous 
exposure to six hours of IH and combined postprandial hyperglycaemia and 
hyperlipidaemia on oxidative stress in awake humans. We hypothesised that 
oxidative stress would be greater following simultaneous exposure to IH and 
combined postprandial hyperglycaemia and hyperlipidaemia than following either 
stressor alone. Furthermore, we aimed to investigate the interaction between IH 
and postprandial hyperglycaemia and hypothesised that IH would augment 
postprandial hyperglycaemia. The secondary aim of this study was to investigate 
whether ventilatory LTF and progressive augmentation of the HVR would be 
expressed under poikilocapnic conditions following a longer six-hour exposure to 
acute IH.  
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7.2 Methods 
 
Ethical approval 
After receiving detailed information on the procedures and risks all participants 
gave written consent to take part. The study was performed according to the latest 
revision of the Declaration of Helsinki and was approved by the local ethics 
committee (University of Birmingham ethical review committee). 
 
Participants 
We attempted to recruit overweight, middle aged, sedentary (< one hour per week 
of structured exercise) but otherwise healthy males. This population was chosen in 
order to resemble as closely as possible the characteristics of OSA patients with 
coexisting T2DM. In total, eleven healthy male individuals participated in the study. 
All participants were non-smokers, had no history of cardiovascular, respiratory 
and metabolic disease and were not taking any medication.  
 
Protocol 
All participants visited the laboratory for three experimental trials in a randomized 
order separated by at least 48 hours: Trial 1 - IH following a high glucose/high lipid 
meal (IH + HG/HL), Trial 2 - room air breathing following a high glucose/lipid meal 
(RA + HG/HL); and Trial 3 - IH following a low glucose/low lipid meal (IH + LG/LL). 
Prior to experimental visits participants also undertook a preliminary visit to 
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become familiarised with the instrumentation and exposure to IH. For all 
experimental trials participants were asked to refrain from alcohol consumption and 
moderate to vigorous exercise for 24 hours and caffeine intake for 12 hours prior to 
arriving at the laboratory. All participants were supplied with three sets of identical 
mixed meals and they were instructed to consume the meal by 8 pm the evening 
before each experimental visit. Following consumption of the supplied evening 
meal participants were instructed to refrain from consuming additional food and to 
only drink water before visiting the laboratory the next morning at 7 am. 
 
Preliminary visit 
Participants were instrumented as previously described in chapter 5 (see: 
Preliminary visit). After breathing room air for approximately ten minutes they were 
exposed to a further ten minutes of IH in an identical way to what they would 
experience in the experimental visits as described in the next section. 
 
IH protocol 
We previously described a new model of airway occlusions that more realistically 
evokes IH as occurs in OSA than exposing individuals to intermittent reductions in 
PIO2 (chapter 2). However, during the development of this model participants 
reported that it was too uncomfortable and tiresome to perform airway occlusions 
for longer than one hour. Therefore, in order to expose participants to IH of a 
similar duration to that experienced nightly by OSA patients (six hours) we chose 
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not to use that model. Therefore, participants were exposed to a continuous cycle 
of two minutes of hypoxia (PETO2 = 50 mmHg) followed by two minutes of euoxia 
(PETO2 = 100 mmHg) previously shown to elicit an elevation in oxidative stress in 
healthy humans (Pilaoux 2008). During hypoxia PETO2 was rapidly reduced to 50 
mmHg and then it was tightly controlled at this value. During euoxia PETO2 was 
quickly brought back to 100 mmHg by inspiration of a single breath of 100 % O2 
and then maintained at this value. Supplemental CO2 was not given and thus the 
IH exposure was poikilocapnic. 
 
Experimental trials 
In all experimental trials participants arrived at the laboratory at 7 am and had a 
cannula inserted into a vein in the antecubital or forearm region (Venflon, Becton 
Dickinson). They then positioned themselves comfortably on a couch in the supine 
position and were instrumented the same way as they were for the preliminary 
visit. Participants then breathed room air for fifteen minutes to allow measurements 
of resting ventilation to be assessed. Upon completion of baseline ventilatory 
measurements a fasting blood sample was drawn.  
 
Participants then consumed a meal that was specific to the experimental trial being 
undertaken. In Trial 1 (IH + HG/HL) and Trial 2 (RA + HG/HL) participants 
consumed a croissant (45 g) with butter (15 g) and a dairy milkshake (skimmed 
milk 250 ml, double cream 100 ml and glucose 60 g). This meal provided 1110 
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kcal, 15 g protein, 75 g of lipid and 93 g carbohydrate of which 77 g were sugars. A 
dairy milkshake was chosen as it enabled ingestion of a large glucose load with the 
aim of eliciting a substantial hyperglycaemic spike. The buttered croissant was 
chosen to increase the total ingestion of lipid aimed at evoking hyperlipidaemia and 
thus enabled the required volume of cream in the milkshake to be limited ensuring 
it was palatable. In Trial 3 (IH + LG/LL) participants consumed a bowl of high fibre 
cereal (37.5 g) with skimmed milk (100 ml). This meal provided 171 kcal, 8 g 
protein, 1 g of lipid and 31 g carbohydrate of which only 7 g were sugars and thus 
was chosen with the aim of not eliciting postprandial hyperglycaemia or 
hyperlipidaemia but preventing excess hunger in the fasted participants.  
 
Participants were asked to consume their meal within five minutes. They were then 
asked to re-position themselves comfortably on the couch. Participants were then 
exposed to six hours of IH in Trial 1 (IH + HG/HL) and Trial 3 (IH + LG/LL) as 
described above (IH protocol). In contrast, participants breathed room air for six 
hours in Trial 2 (RA + HG/HL). During Trial 1 (IH + HG/HL) and Trial 2 (RA+HG/HL) 
in an attempt to prolong postprandial hyperglycaemia to better mimic what occurs 
in T2DM patients, participants briefly removed their facemask and drank a high 
glucose drink (60 g glucose and 350 ml water) one hour after consumption of the 
meal. In Trial 3 (IH+LG/LL) participants drank an equal volume of water (350 ml). 
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In all experimental trials in addition to a fasting blood sample, blood was drawn at 
0.5, 1, 1.5, 2, 3 and 6 hours. Figure 7.1 is an illustration showing the different 
experimental protocols in the three trials. 
 
Blood processing 
Blood drawn at each collection time point was transferred from a 10 ml syringe into 
a 10 ml K3-EDTA vacutainer (Becton Dickinson) previously kept on ice. Blood was 
immediately centrifuged at 2000g at 4°C for 15 minutes. Plasma was then 
aspirated into several aliquots that were pre-cooled on ice and then immediately 
moved to storage at −80 °C. 
 
Analytical procedures 
Plasma samples were analysed for two different biological markers of oxidative 
stress (protein carbonylation and lipid peroxidation - LPO) and antioxidant capacity 
using three separate assays. 
 
Protein carbonylation: The level of protein carbonylation was expressed relative 
to protein concentration and thus total plasma protein concentration was first 
determined using the bicinchoninic acid method (BCA) as previously described in 
chapter 6. The level of plasma protein carbonylation was assessed by an ELISA 
previously described by (Buss et al., 1997). Based on the BCA data plasma 
samples were diluted to 0.05 mg/ml in a coating buffer (50 mM Sodium Carbonate 
pH = 7.4). (1) Samples and standards (50 $l) were then added to a 96 well multi-
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sorb plate (Nunc, Fisher Thermo Scientific, UK) and allowed to bind for one hour at 
37 ºC. (2) 50 $l of 2, 4-dinitrophenylhydrazine (1 mM) in 2 M hydrochloric acid was 
added to each well and incubated for one hour at room temperature. (3) Plates 
were blocked with 200 $l tris-buffered saline (TBS - Tween 20, 0.1 %) overnight at 
4 °C. (4) 50 $l diluted (1:1000) mouse anti-DNP antibody was added to each well 
and incubated for two hours at 37 °C. (5) 50 $l diluted (1:5000) peroxidise labelled 
rat anti-mouse antibody was added to each well and incubated for one hour at 37 
ºC. (6) 50 $l citrate-phosphate based substrate (0.15 M, pH 5) was added to each 
well and incubated in the dark for 15/30 minutes. (7) The reaction was stopped with 
2 M sulphuric acid and plates were read at 490 nm (Multiscan MS, Labsystems, 
Finland). Protein carbonylation values were expressed as nmol/mg of protein. 
Plates were washed four times between each step (1-7) with TBS (Tween 20, 0.5 
%). 
 
Lipid peroxidation: To determine the level of LPO in the plasma a 
spectrophotometric assay was used (Turner et al., 2011). 10 $l of samples, positive 
control (1:1000 hydrogen peroxide) and blank standard (distilled water) were 
added to 96 well plates in triplicate. 100 $l of reagent mix (0.2 M potassium 
phosphate (pH 6.2), 0.12 M potassium iodide, 0.15 mM sodium azide, 2 g/l Triton 
X, 0.1 g/l alkylbenzyldimethylammonium chloride, 10 $M ammonium molybdate) 
was added to each well and incubated for 30 minutes at room temperature in the 
dark. Plates were read at 340 nm (Multiscan MS, Labsystems, Finland) and LPO 
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was determined using the Beer-Lambert Law (extinction coefficient of 24600). 
Plasma LPO values were expressed as nmol/ml plasma. 
 
Antioxidant capacity: The antioxidant capacity of plasma was assessed using the 
FRAP assay as previously described in chapter 6 and expressed as $M of 
antioxidant power relative to ascorbic acid.  
 
Assessment of plasma glucose and TAG 
Plasma glucose and triglyceride (TAG) concentration was analysed using an ILAB 
automated analyser (Instrumentation Laboratory, Cheshire, UK).  
 
Ventilatory analysis 
In all experimental trials, V˙E, PETCO2, PETO2 and SaO2 were recorded continuously. 
Ventilatory measurements were averaged during the last five minutes of room air 
breathing during the baseline and recovery periods. Furthermore, ventilatory 
measurements during the final minute of the first ten hypoxic episodes were 
averaged and compared to the average of the last ten hypoxic episodes in Trial 1 
(IH + HG/HL) and Trial 3 (IH+LG/LL). 
 
Statistical analysis 
A two-way ANOVA with repeated measures in conjunction with a post hoc LSD test 
was used to determine whether there was a significant trial-by-time interaction for 
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each marker of oxidative stress (protein carbonylation, LPO), antioxidant capacity 
and ventilatory measurements (V˙E, PETCO2, PETO2 and SaO2) and blood glucose 
and TAG. A one-way ANOVA with repeated measures was used to more closely 
determine whether there was a significant change over time in any of the above 
variables for each trial. Plasma glucose and TAG levels were also assessed by 
calculating the incremental area under the curve (iAUC) using the trapezoidal rule. 
iAUC responses represent the AUC with baseline reset to the fasting value and 
thus describe the change in concentration of plasma glucose and TAG from 
baseline (i.e. after meal consumption). A one-way ANOVA with repeated measures 
in conjunction with a post hoc LSD test was used to determine whether there was a 
difference in iAUC for plasma glucose and TAG between trials. The relationship 
between the percentage change from baseline in FRAP and LPO in each trial was 
examined using Pearson’s product moment correlation coefficient. Values are 
expressed as mean ± standard error and differences were considered significant if 
P # 0.05. 
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Figure 7.1: Schematic illustrating the protocol used for experimental trials. Blue square indicates six hour exposure to IH
(Trial 1 and 2) or room air breathing (Trial 3)
Consumption
of  evening meal
Cannulate High glucose drink 
(Trial 1 & 2) 
or water (Trial 3)
Baseline 
ventilation
Recovery 
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7.3 Results 
 
Participants 
We found recruiting volunteers who closely fitted the inclusion criteria challenging 
due to the long laboratory visits required. Seven participants completed the entire 
study but four participants stopped short of completing one or more trials. 
Therefore, we were only able to make oxidative stress and ventilatory 
measurements for the seven participants who completed the full duration of each 
experimental trial. However, as a three-hour blood withdrawal was taken in all 
participants, baseline and postprandial blood glucose and TAG data is presented 
for eleven participants.  
 
The seven healthy male participants who completed all three full experimental 
protocols and thus provided oxidative stress data had an average age of 44.9 ± 8.3 
years, weight of 84.0 ± 14.6 kg, height of 174.8 ± 4.7 cm and a BMI of 27.4 ± 4.11 
and where all sedentary. With the addition of the four participants who did not 
complete one or more experimental trials beyond the three hour blood sample the 
11 participants had an average age of 44.5 ± 12.38 years, weight of 90.2 ± 20.1 kg, 
height of 175.6 ± 7.9 cm and a BMI of 29.0 ± 4.3 and where all sedentary. All 
values are mean ± standard deviation. 
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Oxidative stress 
 
Plasma LPO: Figure 7.2 shows plasma LPO levels at baseline and recovery in 
each of the different experimental trials. In Trial 1 (IH + HG/HL) six of the seven 
participants demonstrated an increase in LPO levels and one did not change from 
baseline to recovery following simultaneous exposure to IH and combined 
postprandial hyperglycaemia and hyperlipidaemia. Analysis showed a significant 
increase over time (6.78 ± 0.66 vs. 8.34 ± 0.64 nmol/ml, P = 0.006). Furthermore, 
the change in LPO levels over time was significantly different (P = 0.007) fromTrial 
2 (RA + HG/HL) and Trial 3 (IH + LG/LL) where exposure to combined postprandial 
hyperglycaemia and hyperlipidaemia or IH independently did not cause an 
increase in LPO levels. 
 
Plasma protein carbonylation: Figure 7.3 shows the level of plasma protein 
carbonylation at baseline and recovery in each of the different experimental trials. 
The level of protein carbonylation was not different between baseline and recovery 
in any of the experimental trials. 
 
Antioxidant capacity: Figure 7.4 shows the antioxidant capacity of plasma at 
baseline and recovery in each of the different experimental trials.  In Trial 1 (IH + 
HG/HL) all seven participants demonstrated an increase in antioxidant capacity 
from baseline to recovery following simultaneous exposure to IH and combined 
postprandial hyperglycaemia and hyperlipidaemia. Analysis showed a significant 
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increase over time (835 ± 47.7 vs. 954 ± 46.3 µM, P = 0.014). In contrast, the 
change over time in Trial 2 (RA + HG/HL) and Trial 3 (IH + LG/LL) was variable 
and did not reach significance in either trial (Trial 2: 843 ± 44.3 vs. 873 ± 53.0 µM, 
P = 0.490; Trial 3: 831 ± 39.5 vs. 858 ± 44.1 µM, P = 0.170). The change in 
antioxidant capacity over time was however not significantly different between trials 
(P = 0.148). 
 
Correlation between the change in antioxidant capacity and LPO levels 
Figure 7.5 shows the correlation between the percentage change in antioxidant 
capacity of the plasma and LPO levels in all three experimental trials. A significant 
(P = 0.004) correlation of r = 0.888 was calculated for Trial 1 (IH + HG/HL), a non 
significant (P = 0.094) correlation of r = 0.56 for Trial 2 (RA + HG/HL) and a 
significant (P = 0.030) correlation of r= 0.703 for Trial 3 (IH + LG/LL). 
 
 
 
 
 
 
 
 
 
 
Figure 7.2: Levels of plasma lipid peroxidation (LPO) at baseline and
recovery in all trials. LPO increased significantly over time in Trial 1 (IH +
HG/HL) (P = 0.006) but did not change in Trial 2 (RA + HG/HL) or Trial 3 (IH
+ LG/LL). * significantly different from baseline.
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Figure 7.3: Levels of plasma protein carbonylation at baseline and recovery in
all trials. There was no change from baseline to recovery in any of the trials.
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Figure 7.4: Plasma antioxidant capacity at baseline and recovery in all trials.
Antioxidant capacity increased significantly over time in Trial 1 (IH + HG/HL)
(P = 0.014) but did not change in Trial 2 (RA + HG/HL) or Trial 3 (IH +
LG/LL). * significantly different from baseline.
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Figure 7.5: Graph showing the correlation between the percentage change
from baseline of plasma lipid peroxidation (LPO) and antioxidant capacity in all
trials. Pearson’s correlation coefficient r = 0.89 for Trial 1 (IH + HG/HL), P =
0.004, r = 0.56 for Trial 2 (RA + HG/HL), P = 0.094, and r = 0.73 for Trial 3 (IH
+ LG/LL), P = 0.030.
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Respiratory Plasticity 
 
Room air breathing: Table 7.1 shows average values for V˙E, PETCO2, PETO2 and 
SaO2 during room air breathing at baseline and recovery in all experimental trials. 
Ventilatory LTF did not manifest in any of the experimental trials as V˙E was not 
different between baseline and recovery. There were no significant changes over 
time for any of the other variables (PETCO2, PETO2 and SaO2) in any of the 
experimental trials.  
 
Hypoxic exposures: Table 7.2 shows average values for  V˙E, PETCO2, PETO2 and 
SaO2 for the first ten hypoxic episodes and the last ten hypoxic episodes in Trial 1 
(IH + HG/HL) and Trial 3 (IH + LG/LL). Progressive augmentation of the HVR was 
not evident during six hours of IH in Trial 1 (IH + HG/HL) or Trial 3 (IH + LG/LL) as 
V˙E during the last ten hypoxic episodes was not significantly different to the first ten 
in either trial. In Trial 3 (IH + LG/LL) PETCO2 significantly decreased from baseline 
to recovery (35.9 ± 0.89 vs. 33.7 ± 1.27 mmHg, P = 0.023) but this change was not 
statistically different from Trial 1 (IH + HG/HL). There were no significant changes 
between the first ten hypoxic episodes and the last ten hypoxic episodes for PETO2 
or SaO2 in either of the experimental trials.  
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Postprandial hyperglycaemia 
Figure 7.6 shows the change in plasma glucose levels over time in each of the 
different experimental trials. As was expected, plasma glucose levels in Trial 3 (IH 
+ LG/LL) demonstrated a small increase following the low glucose meal, peaking at 
30 minutes and then gradually declining thereafter, falling slightly below baseline at 
three hours (P = 0.001). Plasma glucose levels also changed over time following 
the high glucose meal and drink in Trial 1 (IH + HG/HL) (P = 0.001) and Trial 2 (RA 
+ HG/HL) (P = 0.050) but despite identical glucose loads the change over time in 
these studies was significantly different (P = 0.020). Plasma glucose levels were 
similar in Trial 1 (IH + HG/HL) and Trial 2 (RA + HG/HL) at 30 minutes when they 
peaked in both experimental trials in response to the high glucose meal. However, 
plasma glucose levels then remained above baseline levels at sixty minutes in Trial 
1 (IH + HG/HL) whereas they decreased close to baseline levels in Trial 2 (RA + 
HG/HL). Furthermore, consumption of the high glucose drink one hour after 
consuming the meal caused a secondary spike in glucose levels at 90 minutes in 
both trials but this was significantly greater in Trial 1 (IH + HG/HL) than Trial 2 (RA 
+ HG/HL). 
 
Figure 7.7 shows plasma glucose iAUC for all trials. Analysis showed plasma 
glucose levels were significantly different between trials (P = 0.002). Post hoc 
analysis showed plasma glucose iAUC was significantly greater in Trial 1 (IH + 
HG/HL) than both Trial 2 (RA + HG/HL) and Trial 3 (IH + LG/LL) but that the 
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difference between Trial 2 (RA + HG/HL) and Trial 3 (IH + LG/LL) was not 
statistically significant. 
 
Postprandial hyperlipidaemia 
Figure 7.8 shows how plasma TAG levels changed over time in each of the 
different experimental trials. Plasma TAG gradually increased over time in Trial 1 
(IH + HG/HL) (P = 0.004) and Trial 2 (RA + HG/HL) (P = 0.000) following 
consumption of a high lipid meal and did not change following consumption of the 
low lipid meal in Trial 3 (IH + LG/LL). Figure 7.9 shows plasma TAG iAUC for all 
trials. Analysis showed plasma TAG levels were significantly different between 
trials (P = 0.001). Post hoc analysis showed plasma TAG iAUC was significantly 
greater in Trial 1 (IH + HG/HL) and Trial 2 (RA + HG/HL) from Trial 3 (IH + LG/LL) 
as was expected with the different lipid loads. 
 
 
 
 
 
 
 
 
 
 
Table 7.1: Averaged ventilatory measurements during baseline and
recovery room air breathing in all trials.
Time Baseline Recovery Baseline Recovery Baseline Recovery
VE (l/min) 8.9 ± 0.4 9.4 ± 0.4 9.0 ± 0.4 9.1 ± 0.3 9.2 ± 0.5 8.6 ± 0.3
PETCO2 (mmHg) 39.5 ± 1.3 36.8 ± 0.7 37.9 ± 1.0 38.5 ± 0.5 38.0 ± 1.0 37.1 ± 1.1
PETO2 (mmHg) 100 ± 2.7 99 ± 1.2 103 ± 2.4 101 ± 0.9 103 ± 2.0 99 ± 1.1
SaO2 (%) 96.7 ± 0.3 96.7 ± 0.2 96.8 ± 0.4 97.3 ± 0.2 96.6 ± 0.4 96.5 ± 0.2
Trial 1 - (IH+HG/HL) Trial 2 - (RA+HG/HL) Trial 3 - (IH+LG/LL)
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Table 7.2: Averaged ventilatory measurements for the first ten hypoxic
episodes (early hypoxia) and the last ten hypoxic episodes (late hypoxia)
of a six-hour exposure to IH, in Trial 1 (IH + HG/HL) and Trial 3 (IH +
LG/LL). * significantly different from early hypoxia of the same trial.
Time Early Hypoxia Late Hypoxia Early Hypoxia Late Hypoxia
VE (l/min) 12.7 ± 0.6 13.7 ± 0.7 12.4 ± 0.9 12.6 ± 0.8
PETCO2 (mmHg) 35.6 ± 1.0 34.0 ± 0.7 35.9 ± 0.9 33.7 ± 1.3 !
PETO2 (mmHg) 49.5 ± 0.6 48.9 ± 1.0 50.4 ± 1.4 49.0 ± 0.8
SaO2 (%) 85.9 ± 0.6 86.1 ± 0.7 87.2 ± 0.6 86.6 ± 0.5
Trial 1 - (IH+HG/HL) Trial 3 - (IH+LG/LL)
Figure 7.6: Plasma glucose levels in Trial 1 (IH + HG/HL), Trial 2 (RA +
HG/HL) and Trial 3 (IH + LG/LL) at baseline, and following a high (Trial 1 and
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Figure 7.7: Plasma glucose three-hour incremental area under the curve
(iAUC) for Trial 1 (IH + HG/HL), Trial 2 (RA + HG/HL) and Trial 3 (IH + LG/LL).
* significantly different from Trial 2 (RA + HG/HL) and Trial 3 (IH + LG/LL).
Trial 2) or low (Trial 3) glucose meal with additional high (Trial 1 and Trial 2) or
low glucose drink (Trial 3) one hour later. † significantly different from Trial 3 (IH
+ LG/LL). ‡ significantly different Trial 2 (RA + HG/HL).
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Figure 7.8: Plasma triglyceride (TAG) levels in Trial 1 (IH + HG/HL), Trial 2 (RA
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Figure 7.9: Plasma triglyceride (TAG) three-hour incremental area under the
curve (iAUC) for Trial 1 (IH + HG/HL), Trial 2 (RA + HG/HL) and Trial 3 (IH +
LG/LL). * significantly different from Trial 3 (IH + LG/LL).
+ HG/HL) and Trial 3 (IH + LG/LL) at baseline, and following a high (Trial 1 and
Trial 2) or low (Trial 3) lipid meal.
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7.4 Discussion 
 
Primary findings 
The primary findings of this study are four fold: 1) exposure to six hours of IH 
simultaneously with combined postprandial hyperglycaemia and hyperlipidaemia 
significantly increased oxidative stress (LPO), whereas independent exposures 
that did not; 2) the elevation in oxidative stress is closely correlated to an elevation 
in plasma antioxidant capacity; 3) exposure to IH augments postprandial 
hyperglycaemia and finally, 4) six hours exposure to IH with or without 
simultaneous combined postprandial hyperglycaemia and hyperlipidaemia does 
not elicit ventilatory LTF or progressive augmentation of the HVR. 
 
Oxidative stress 
LPO represents oxidative damage of lipids most commonly associated with 
polyunsaturated fatty acids that make up the major component of cell membranes 
(Niki, 2009). We used an assay previously shown to be sensitive to changes in 
plasma LPO levels in healthy humans (Turner et al., 2011) and were able to 
demonstrate a significant elevation in LPO following six hours of IH if participants 
also consumed a high glucose/lipid meal (Trial 1). In contrast to a previous report 
(Pialoux et al., 2009) six hours exposure to IH without consumption of a high 
glucose and lipid meal in our study did not increase LPO levels (Trial 3) and nor did 
consumption of the high glucose and lipid meal independently (Trial 2). It has been 
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demonstrated that LPO can alter cell membrane structure and lead to a loss of 
cellular function in addition to promoting a pro-atherogenic form of low-density 
lipoprotein (i.e. oxidised-LDL) (Niki, 2009, Yoshida and Kisugi, 2010). Indeed, 
numerous studies have shown elevated levels of LPO in plasma and tissues in 
patients with cardiovascular disease (Niki, 2009, Rumley et al., 2004). Therefore, 
our results may have implications for the development and/or progression of 
cardiovascular disease in OSA patients with T2DM consuming high glucose and 
lipid evening meals. 
 
Numerous human diseases are associated with elevated levels of protein 
carbonylation such as diabetes, Alzheimer's disease and chronic lung and kidney 
disease (Dalle-Donne et al., 2003). Therefore, we thought this was an appropriate 
biological marker of oxidative stress to assess in this study. However, in contrast 
with LPO levels there was no elevation in plasma protein carbonylation in recovery 
in any of the three experimental trials. Proteins are susceptible to oxidation 
particularly from end products of LPO (e.g. hydroxynonenal (4-HNE) and 
malonaldehyde (MDA)) that react with proteins causing carbonyl groups to be 
added (Berlett and Stadtman, 1997). Although speculative it is possible that in this 
study the increase in LPO in healthy albeit overweight humans following acute 
exposure to IH and postprandial hyperglycaemia and hyperlipidaemia is insufficient 
in magnitude or not sustained for a required duration to cause a noticeable 
increase in plasma MDA levels. If this is correct it may explain the absence of any 
increase in plasma protein carbonylation. In chapter 6 we showed that in rats 
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exposure to sustained hyperglycaemia and IH, MDA levels were not increased but 
having not measured plasma LPO levels it is not possible to make further judgment 
on this. 
 
Possible mechanisms for increased oxidative stress 
To the best of our knowledge this is the first study performed in humans to 
investigate the effects of simultaneous exposure to IH and combined postprandial 
hyperglycaemia and hyperlipidaemia on oxidative stress. The study was not 
designed to specifically investigate potential mechanisms of how hyperglycaemia 
and/or hyperlipidaemia could augment oxidative stress during IH exposure. Rather, 
we aimed to describe whether there was an effect under conditions aimed to mimic 
a real life situation (i.e. a mixed meal with six hours IH to mimic that occurring 
during a night of OSA). Although future studies are required to investigate the 
possible mechanisms that are involved we have identified some possibilities. 
 
Firstly, during acute periods of ROS overproduction the level of subsequent 
oxidative stress is greatly limited by the body’s antioxidant defence system. It is 
possible that greater levels of ROS production during simultaneous exposure to IH 
and combined postprandial hyperglycaemia and hyperlipidaemia could lead to 
substantially greater levels of oxidative stress than during individual stressors due 
to the greater level of ROS overwhelming antioxidant defences.  
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Secondly, in healthy insulin-sensitive individuals, postprandial hyperglycaemia 
does not produce an elevation in plasma lipid oxidation even after ingestion of as 
much as 150 g of glucose (Fisher-Wellman and Bloomer, 2010). However, in 
T2DM patients who experience exaggerated postprandial hyperglycaemia there is 
significant elevation in lipid oxidation after much smaller glucose loads (Ceriello et 
al., 2004). It is possible that the increase in LPO in Trial 1 (IH + HG/HL) is partly 
due to the IH-induced augmentation in postprandial hyperglycaemia. 
 
Thirdly, hyperglycaemia may not have independently increased ROS production in 
the healthy albeit overweight participants in this study but could have augmented 
IH-induced generation of ROS. Studies have shown acute exposure to 
hyperglycaemia does not cause an elevation in oxidative stress in insulin sensitive 
humans and rodents (Fisher-Wellman and Bloomer, 2010, Kayali et al., 2003, 
Cakatay and Kayali, 2006). However, recent evidence from experimental animal 
studies has shown that acute hyperglycaemia augments the generation of ROS 
and oxidative stress during exposure to IRI (Hirose et al., 2008, Bemeur et al., 
2007, Tsuruta et al., 2010). Indeed, in two of these studies acute hyperglycaemia 
per se had no effect on ROS generation or oxidative stress but greatly augmented 
the response during both ischaemia and early reperfusion (Hirose et al., 2008, 
Tsuruta et al., 2010). As previously discussed in detail (General introduction: 
Mechanisms for IH-induced oxidative stress) the mechanistic pathways responsible 
for the generation of ROS during IH and ischaemia-reperfusion injury may be 
similar because of the comparable pattern of hypoxia and re-oxygenation (Lavie, 
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2003, Pack and Gislason, 2009). Therefore it is tempting to speculate that 
simultaneous hyperglycaemia could also augment IH-induced ROS generation as it 
does for IRI.  
 
Although speculative and requiring complex studies to confirm its existence we 
have developed a working model for how hyperglycaemia could increase ROS 
generation during IRI and IH exposure that involves the enzyme xanthine oxidase. 
A detailed description of the possible role that xanthine oxidase plays in mediating 
the elevation in ROS during IRI is given previously (General introduction: 
Mechanisms for IH-induced oxidative stress). In brief, xanthine oxidase catalyses 
the oxidation of hypoxanthine to xanthine and subsequently to uric acid with O2 
and produces superoxide. During ischaemia the non-ROS producing enzyme 
xanthine dehydrogenase is converted to xanthine oxidase (McKelvey et al., 1988, 
Engerson et al., 1987) and a reduction in oxidative phosphorylation results in an 
increase in the availability of hypoxanthine to be catalysed by xanthine oxidase 
(Thompsongorman and Zweier, 1990, Gimpel et al., 1995, Zweier et al., 1994). 
 
Two lines of evidence have recently emerged that suggest that the 
hyperglycaemic-induced increase in ROS production during IRI and presumably IH 
could be mediated by hyperglycaemia up-regulating the activity of xanthine 
oxidase. Firstly, levels of allantonin, a marker of oxidative stress specific to 
xanthine oxidase activity (Serkova et al., 2005) assessed 24 hours after 
simultaneous exposure to hyperglycaemia and renal IRI, were significantly greater 
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than IRI alone or when hyperglycaemia occurred two hours after reperfusion 
(Hirose et al., 2008). Secondly, protein kinase C (PK-C) dependent activation of 
NAD(P)H oxidase during hyperglycaemia may increase ROS production 
(Brownlee, 2001) and it has been demonstrated that ROS production from 
NAD(P)H oxidase regulates xanthine oxidase activity (McNally et al., 2003). 
Therefore, during simultaneous hyperglycaemia and IRI and presumably IH, 
hyperglycaemia-induced activation of NAD(P)H oxidase may increase ROS 
production indirectly by increasing xanthine oxidase activity as illustrated below 
(Figure 7.10). 
 
  
Figure 7.10: Schematic demonstrating how hyperglycaemia may increase xanthine oxidase 
generated ROS during ischaemia-reperfusion injury (IRI) or IH. (A) IRI or IH under euglycaemic 
conditions. (B) IRI or IH under hyperglycaemic conditions. 
 
Most of the uric acid circulating in the blood is in the form urate, which is 
responsible for over half of the total antioxidant capacity of plasma in humans 
(Maxwell et al., 1997). Interestingly, uric acid is produced during activation of 
xanthine oxidase (General introduction: Mechanisms for IH-induced oxidative 
stress) and OSA patients express elevated levels of uric acid that are normalised 
Hyperglycaemia ROS PK-C activation ROS NAD(P)H oxidasexanthine oxidase
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ROS production
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following CPAP treatment (Sahebjami, 1998). Therefore, it might be expected that 
if hyperglycaemia does augment the increase in xanthine oxidase activity during IH 
there would be greater uric acid production leading to greater plasma antioxidant 
capacity. Indeed, endothelial cells that are in contact with the plasma and will be 
most exposed to hyperglycaemia and to fluctuations in arterial oxygen levels are 
known to have high concentrations of xanthine oxidase. We used a FRAP assay to 
assess total antioxidant capacity of the plasma reflected by the sum of all 
antioxidants (i.e. endogenous and exogenous) including uric acid (Bartosz, 2010). 
Interestingly, we demonstrated there was a significant increase in antioxidant 
capacity between baseline and recovery in Trial 1 (IH + HG/HL) following six hours 
of exposure to simultaneous IH and combined postprandial hyperglycaemia and 
hyperlipidaemia. There was not a significant increase over time in either Trial 2 (RA 
+ HG/HL) or Trial 3 (IH + LG/LL) although the change in antioxidant capacity was 
not statistically different between the trials. Furthermore, although correlations on 
such a small number of participants should be analysed with caution it was 
interesting to see such a strong correlation between the change from baseline in 
LPO with that of antioxidant capacity in Trial 1 (IH + HG/HL). 
 
Alternatively, the increase in antioxidant capacity may be a compensatory 
mechanism by the body in response to an increase in ROS generation that does 
not specifically indicate enhanced xanthine oxidase activity. Although chronic 
oxidative stress may result in a depletion of antioxidants as demonstrated in 
patients suffering from a number of diseases (Barcelo et al., 2006, Baynes, 1991) 
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mammals appear to be able to rapidly increase their antioxidant defence capacity 
during acute periods of mild to moderate oxidative stress (Guzel et al., 2000, Ji, 
2008, Rauchova et al., 2005). Indeed, acute hypoxia increased antioxidant enzyme 
activity of catalase and SOD in erythrocytes in rats (Guzel et al., 2000, Rauchova 
et al., 2005). Redox-sensitive signalling has been shown to increase gene 
expression for enzymatic antioxidants within 15 minutes of exercise and thus may 
well occur during six hours IH exposure (Ji, 2008).  
 
Postprandial hyperglycaemia and hyperlipidaemia 
Postprandial hyperlipidaemia following the high lipid meal was not different during 
IH or room air conditions. In contrast, postprandial hyperglycaemia was augmented 
during IH as shown by a significantly greater three-hour iAUC. 
 
Several epidemiological studies have demonstrated that OSA is associated with 
glucose intolerance, insulin resistance and T2DM and that this is independent of 
other comorbidities such as obesity (Punjabi et al., 2004, Sulit et al., 2006, 
Reichmuth et al., 2005). Although sleep fragmentation is likely to play a major role 
in mediating these changes in glucose control (Punjabi and Polotsky, 2005) acute 
IH of durations as little as nine hours induced insulin resistance in lean rodents 
(Iiyori et al., 2007) and just 30 minutes exposure has been shown to decrease 
insulin sensitivity in humans (Oltmanns et al., 2004). Only one study prior to ours 
has investigated the effects of acute IH on glucose metabolism in humans (Louis 
and Punjabi, 2009). (Louis and Punjabi, 2009) exposed participants to eight hours 
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of acute IH that was similar to that used in our study but used the frequently 
sampled intravenous glucose tolerance test (IVGTT) to investigate the effects of 
acute IH on insulin-dependent and insulin-independent mechanisms of blood 
glucose removal. They demonstrated that acute IH decreased insulin sensitivity 
without a compensatory increase in insulin secretion. This is in contrast to the 
normal physiological response to a reduction in insulin sensitivity where increased 
insulin secretion occurs in order to maintain blood glucose homeostasis (Kahn, 
2003). The authors speculate this may have been due to acute IH also inhibiting 
pancreatic ability to compensate (Louis and Punjabi, 2009). Furthermore, they 
demonstrated acute IH caused a significant decrease in insulin-independent 
removal of blood glucose (i.e. glucose mediated disposal).  
 
The authors of that study suggest a number of potential mechanisms that may be 
responsible for the acute IH-induced impairment in glucose metabolism. Firstly, 
acute IH is known to increase sympathetic activity in humans (Xie et al., 2001, Xie 
et al., 2000, Tamisier et al., 2005, Cutler et al., 2004b, Cutler et al., 2004a, 
Leuenberger et al., 2005) and studies have shown that adrenalin inhibits insulin 
secretion (Porte, 1967), augments hepatic glucose output by increased 
gluconeogenesis and glycogenolysis (Exton and Park, 1968, Sherline et al., 1972) 
and decreases hepatic and peripheral tissue insulin sensitivity (Deibert and 
Defronzo, 1980). Secondly, IH may increase circulating levels of cortisol as 
previously shown during sustained hypoxia (Coste et al., 2005, Humpeler et al., 
1980) which has been shown to increase hepatic glucose output, decrease insulin 
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secretion and induce insulin resistance (Andrews and Walker, 1999, Lambillotte et 
al., 1997). Thirdly, an intriguing mechanism responsible for altered glucose 
metabolism during acute IH is that ROS may play a role. It has been shown that 
ROS can activate cellular stress-sensitive pathways impairing cellular signaling 
leading to reduced cellular insulin sensitivity (Bloch-Damti and Bashan, 2005). 
Furthermore, ROS are known to impair pancreatic %-cell function that is a key 
mechanism for reduced insulin secretion (Robertson, 2006, Evans et al., 2003) and 
it was recently shown that exposure of rodents to IH caused increased %-cell death 
mediated by ROS (Xu et al., 2009). In addition to the mechanisms proposed by 
(Louis and Punjabi, 2009) it is possible that IH could have augmented postprandial 
hyperglycaemia by altering gastrointestinal blood flow allowing greater uptake of 
glucose and/or increasing absorption rates of glucose from the gut. Although 
speculative, it is possible that IH may cause a redistribution of blood flow away 
from organs capable of removing glucose from the blood such as skeletal muscle 
and the liver, possibly mediated by elevated sympathetic activity. Interestingly 
(Leuenberger et al., 2005) showed that 30 minutes exposure to IH increased 
forearm vascular resistance in healthy humans. Future studies investigating 
whether exposure to IH attenuates hepatic blood flow could utilise Doppler 
ultrasound to non-invasively determine portal vein blood flow. 
 
As already mentioned the present study was not designed to specifically 
investigate the effects of IH on postprandial hyperglycaemia. There are a number 
of factors in the study design that limit our understanding and drawing mechanistic 
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conclusions should be done cautiously. Firstly, unlike an oral glucose tolerance test 
(OGTT) that is commonly used to assess glucose handling and that involves the 
ingestion of glucose only, our participants consumed a mixed meal that although 
was high in glucose it was also high in lipid and contained complex carbohydrates 
(i.e. starch rather than sugar). Although unlikely, it cannot be ruled out that IH 
alters the breakdown and ingestion of carbohydrate not already in a glucose form 
and it is not known whether the presence of high levels of ingested lipid also 
interacts in some way with IH to alter plasma glucose levels. Secondly, the 
temporal pattern of blood sampling in our study was relatively infrequent (every 30 
minutes) compared to that commonly used in an OGTT (every 15 minutes). The 
inability to gain a clear picture of the postprandial plasma glucose profile because 
of the poor temporal resolution is worsened by the ingestion of the glucose drink at 
one hour that causes a secondary short-lived elevation in plasma blood glucose 
levels. Finally we did not measure plasma insulin levels in our study and thus 
cannot make any conclusions regarding what mediates the augmentation in 
postprandial hyperglycaemia. 
 
Respiratory plasticity 
All previous attempts to elicit respiratory LTF in awake humans under eucapnic or 
poikilocapnic conditions exposed individuals to a relatively brief period of acute IH 
(< 90 minutes) and were unsuccessful (Mateika and Sandhu, 2011). We 
considered it possible that a greater duration of acute IH could lead to a greater 
activation of the responsible mechanisms for respiratory LTF and thus ventilatory 
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LTF could be expressed. However, exposure to six hours of acute IH with or 
without simultaneous exposure to combined postprandial hyperglycaemia and 
hyperlipidaemia did not evoke ventilatory LTF in our participants. These findings 
add support to our previous findings (chapter 4 and 5) and to existing published 
research (Harris et al., 2006, Wadhwa et al., 2008, Lee et al., 2009, Gerst et al., 
2011) that demonstrates the requirement for raising PETCO2 above normal levels 
for ventilatory LTF to be expressed.  
 
In addition to raised PETCO2 being a requirement for the expression of ventilatory 
LTF, previous studies have demonstrated the manifestation of progressive 
augmentation of the HVR is also reliant on elevated PETCO2 (Harris et al., 2006, 
Mateika et al., 2004). We speculated that progressive augmentation of the HVR 
may be evident following acute poikilocapnic IH of a longer duration than 
previously used by studies (< 90 minutes). However we were unable to 
demonstrate any augmentation in ventilation during the final ten hypoxic episodes 
compared with that of the initial ten hypoxic episodes during six hours exposure to 
acute IH with or without combined postprandial hyperglycaemia and 
hyperlipidaemia.  
  
Summary 
In summary, we have demonstrated that simultaneous but not individual exposure 
to six hours of IH and combined postprandial hyperglycaemia and hyperlipidaemia 
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elicited a significant increase in oxidative stress. Furthermore, this increase in 
oxidative stress appears to be associated with an increase in plasma antioxidant 
capacity. These findings could have implications for OSA patients who consume 
high glucose/lipid meals prior to sleep, especially those with coexisting T2DM who 
experience augmented postprandial hyperglycaemia and hyperlipidaemia. 
However, the underlying mechanisms that are responsible for the augmentation in 
oxidative stress during simultaneous exposure to IH and combined postprandial 
hyperglycaemia and hyperlipidaemia remain to be determined. In addition, we have 
supplied evidence to suggest that postprandial hyperglycaemia may be augmented 
during simultaneous exposure to IH. This also has implications for OSA patients 
with coexisting T2DM. Finally, despite a lengthy duration of IH in our study 
compared with previous studies (six hours vs. < 90 minutes) ventilatory LTF and 
progressive augmentation of the HVR were not expressed. This finding provides 
support for the requirement of raising PETCO2 levels in the manifestation of IH-
induced respiratory plasticity in awake humans.  
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8 CHAPTER 8 - GENERAL DISCUSSION 
 
 
8.1 Development of an airway occlusion model of OSA  
 
The first aim of this thesis was to develop an airway occlusion model of OSA that 
would expose humans to as many of the events occurring in OSA with or without 
IH. If successful, such a model would allow a more comprehensive investigation 
into the effects of OSA-related IH. We feel that the newly developed airway 
occlusion model of OSA as described in chapter 2 is superior to other existing 
human models of OSA for a number of reasons. Firstly, generation of negative 
intrathoracic pressures as is experienced by OSA patients was made possible with 
the inclusion of an automated valve in the breathing circuit. Furthermore, we feel 
the model was effective in replicating a number of other physiological events that 
occur during repetitive obstructive apnoeas in OSA (e.g. tachycardia, blood 
pressure rises, hypercapnia etc). Finally, the DEF system was an effective tool in 
isolating the effects of IH. 
 
However, long exposures to airway occlusions were tiring and tedious and the 
value of using this model was severely limited. In retrospect, we do not believe that 
one hour of airway occlusions is sufficient time to induce measurable changes in 
oxidative stress and possibly other physiological consequences that occur in OSA. 
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Therefore, although we used this model in chapter 3 and 4 to investigate a number 
of hypothesis regarding the pulmonary circulation and respiratory plasticity, in later 
chapters we followed different approaches (an animal study and intermittent 
reductions in inspired PIO2 in humans). 
 
8.2 Investigating the effects of acute IH as it occurs in OSA on 
pulmonary arterial pressure 
 
PAP is known to rise during each occluded apnoea in OSA patients but at present 
the responsible mechanism(s) are not fully understood. Because hypoxia is 
present in each apnoea it is widely considered that HPV is responsible for the 
gradual rise in PAP. In support for this hypothesis, inhibition of hypoxia during 
occluded apnoeas in dogs with prior O2 supplementation completely abolished the 
rise in PAP (Schneider et al., 2000, Iwase et al., 1992). However, this has only 
been incompletely investigated in OSA patients (Marrone et al., 1992). Therefore, 
in chapter 3 we attempted to use our newly developed model of OSA to expose 
participants to airway occlusions with and without hypoxia in order to investigate 
whether HPV is responsible for the rise in PAP.  
 
Previous animal and human studies investigating the effect of apnoeas on the 
pulmonary circulation have used Swan-Ganz catheters to measure PAP. Although 
Swan-Ganz catheters are considered to be the gold standard for assessing PAP, 
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the technique is highly invasive so its use in experimental research is limited. 
Therefore, we attempted to use an established Doppler ultrasound technique to 
measure systolic PAP (SPAP). This technique has been extensively used during 
continuous exposures to hypoxia but it has not been used during airway 
occlusions. Disappointingly, we were forced to conclude that Doppler ultrasound is 
not a suitable tool to assess changes in SPAP during airway occlusions because 
the accuracy of measurements were compromised by the brief duration of apnoeas 
and substantial rib cage movements. Consequently, we could not evaluate the 
contribution of HPV to the elevation in PAP during airway occlusions nor could we 
determine whether HPV increased in sensitivity over time. 
 
Although there exists a substantial body of research investigating the time course 
of HPV in animals and humans during continuous exposure to hypoxia little is 
known about the time course to IH in animals and none at all in humans. However, 
evidence from one study in dogs showed that the sensitivity of HPV increases 
during exposure to IH. Although we were unable to use Doppler ultrasound to 
assess SPAP during airway occlusions, this technique has previously been used to 
assess HPV during longer hypoxic exposures (Talbot et al., 2005). Therefore, in 
chapter 4 participants were exposed to either one hour of hypoxic airway 
occlusions or one hour of unrestricted room air breathing followed by a 20-minute 
hypoxic exposure when SPAP was continuously measured. We hypothesised that 
HPV would be augmented following exposure to hypoxic airway occlusions. 
However, in contrast to our hypothesis the magnitude and pattern of HPV during 
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the 20-minute hypoxic exposure following one hour of hypoxic airway occlusions 
was not different to that following unrestricted room air breathing. Future studies 
are required to see if longer exposures to OSA related-IH are capable of 
sensitising HPV. 
 
8.3 IH and oxidative stress 
 
As previously discussed, the mechanistic pathways responsible for the generation 
of ROS during IH may be similar to those during IRI because of the comparable 
pattern of hypoxia and re-oxygenation (Lavie, 2003, Pack and Gislason, 2009). 
Because recent evidence from experimental animal studies has shown that acute 
hyperglycaemia augments the generation of ROS and oxidative stress during 
exposure to ischaemia-reperfusion injury (Hirose et al., 2008, Bemeur et al., 2007, 
Tsuruta et al., 2010) we wanted to investigate whether this was also true during IH. 
We felt this was important as over half of T2DM patients suffer from OSA (Einhorn 
et al., 2007) and thus millions of patients worldwide experience hyperglycaemia 
and IH simultaneously during sleep.  
 
Therefore, in chapter 6 we investigated whether hyperglycaemia augmented the 
level of oxidative stress in rats during exposure to repetitive airway occlusions. In 
contrast to our hypothesis, levels of oxidative stress in the plasma were not greater 
in animals exposed simultaneously to hyperglycaemia and airway occlusions. 
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Indeed, neither simultaneous nor independent exposure to these stimuli over six 
hours was capable of increasing oxidative stress in healthy rats. It is possible that 
in our study a choice of different biomarkers of oxidative stress than that of 
nitrotyrosine and MDA could have demonstrated an elevation in oxidative stress. 
Alternatively, the exposure to IH may have been too brief to evoke a measurable 
change in oxidative stress.  
 
Although we were unable to demonstrate an elevation in oxidative stress in 
animals exposed to hyperglycaemia and IH simultaneously, there may be species 
differences and thus we wished to further investigate this line or research in 
humans. Furthermore, postprandial hyperlipidaemia is capable of inducing 
oxidative stress in humans (Ceriello et al., 2002) and following consumption of an 
evening meal OSA patients especially those with coexisting T2DM are likely to be 
exposed to combined postprandial hyperglycaemia and hyperlipidaemia 
simultaneously with IH. Therefore, in chapter 7 healthy humans were exposed to 
three different conditions; a) IH or b) room air breathing following consumption of a 
high glucose and lipid meal and c) IH following consumption of a low glucose and 
lipid meal.  
 
The primary finding in chapter 7 was that simultaneous but not individual exposure 
to six hours of IH and combined postprandial hyperglycaemia and hyperlipidaemia 
elicited a significant increase in oxidative stress. These findings may therefore 
have implications for OSA patients who consume high glucose/lipid meals prior to 
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sleep, especially those with coexisting T2DM. Although these findings are 
functionally relevant, conclusions regarding the responsible mechanisms for the 
elevation in oxidative stress cannot be made because of limitations in the study 
design. Indeed, because a mixed meal was consumed it was not possible to 
distinguish between postprandial hyperglycaemia or postprandial hyperlipidaemia 
being the responsible stimulus for causing the greater oxidative stress during IH 
exposure or whether a combination of the two was responsible.  
 
In chapter 7, in addition to the interesting results regarding oxidative stress we also 
demonstrated that IH augments postprandial hyperglycaemia. These results may 
go some way to explain why several epidemiological studies have demonstrated 
that OSA is associated with glucose intolerance, insulin resistance and T2DM and 
that this is independent of other co-morbidities such as obesity (Punjabi et al., 
2004, Sulit et al., 2006, Reichmuth et al., 2005). As a result of the absence of 
plasma insulin measurements, the infrequent blood sampling and mixed meal 
consumption, the responsible mechanisms for the augmentation in postprandial 
hyperglycaemia in our study are unknown. 
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8.4 Respiratory plasticity 
 
8.4.1 Respiratory plasticity in OSA and the importance of CO2 
IH-induced respiratory plasticity is most commonly researched because of the well-
established hypothesis that it may promote breathing stability in OSA patients 
(Mateika and Narwani, 2008). However, there is no evidence to conclusively 
confirm or refute that respiratory plasticity manifests during sleep in OSA patients. 
The absence of evidence is primarily due to the lack of suitable durations of 
unrestricted breathing between apnoeas required to assess levels of normal 
ventilation and secondly because changes in sleep stage elicit rapid changes in 
ventilation which may confound results.  
 
In an attempt to overcome these restraints, we used an airway occlusion model of 
OSA in awake humans and anaesthetised rats (chapter 4 and 6 respectively) to 
investigate whether ventilatory LTF and/or progressive augmentation of the HVR 
manifest under these conditions. In chapter 4 we demonstrated that in awake 
humans respiratory plasticity was expressed following hypoxic airway occlusions 
but only when PETCO2 is elevated slightly above normal levels. Additionally, in 
chapter 6, exposure to airway occlusions without supplemental CO2 did not elicit 
respiratory plasticity in anaesthetised rats. Furthermore, we demonstrated the 
expression of ventilatory LTF in awake humans following intermittent reductions in 
PIO2 during mild hypercapnia that was abolished within 1-2 minutes of removing 
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the additional inspired CO2. Finally, in chapter 7 we showed that increasing the 
duration of intermittent reductions in PIO2 to as long as six hours in humans was 
not capable of evoking respiratory plasticity under pokilocapnic conditions.  
 
Therefore, we have presented strong evidence in this thesis to suggest that IH 
occurring during repetitive airway obstructions in OSA is likely to elicit activation of 
mechanisms responsible for the development of respiratory plasticity but its 
expression may be restrained by low PaCO2 levels. However, a recent study 
demonstrated that exposure to intermittent reductions in PIO2 prior to sleep had an 
effect on upper airway stability in OSA patients during sleep (Yokhana et al., 2012). 
This suggests that respiratory plasticity may still be expressed during sleep without 
supplemental CO2 if it is artificially induced. In that study, OSA patients were 
exposed to acute IH each evening for 10 days using an almost identical IH protocol 
to the one we used in chapter 5. Indeed, PETCO2 was elevated above normal levels 
and similar magnitudes of progressive augmentation of the HVR and ventilatory 
LTF were expressed to that shown by us. In contrast to the hypothesis that IH-
induced respiratory plasticity could help stabilise the upper airway, the AHI 
increased above baseline following the first daily exposure to acute IH and 
remained significantly greater than baseline on the final night. Interestingly, they 
showed that the increase in AHI was correlated to the magnitude of the HVR but 
did not correlate to ventilatory LTF.  
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8.4.2 Separating respiratory LTF from progressive augmentation of the HVR 
Based on the aforementioned findings by (Yokhana et al., 2012), if respiratory LTF 
is going to be seriously considered as a therapeutic treatment option for OSA then 
scientists need to find a way of evoking respiratory LTF independently of 
progressive augmentation of the HVR. However, a potential stumbling block is that 
the two phenomena may in fact be the same form of respiratory plasticity 
demonstrated under different O2 tensions but mediated by the same mechanisms 
(Richerson, 2010).  
 
(Fregosi and Mitchell, 1994) previously showed that rats pre-treated systemically 
with a serotonin antagonist inhibited the development of phrenic and intercostal 
muscle LTF but not progressive augmentation of phrenic and intercostal muscle 
activity during intermittent carotid sinus nerve stimulation (i.e. progressive 
augmentation of the HVR). This strongly suggests that, in cats, different 
mechanisms might be responsible for the two forms of respiratory plasticity 
However, in every human study that has reported the manifestation of progressive 
augmentation of the HVR and ventilatory LTF, the existence of progressive 
augmentation of the HVR has been determined by simply comparing minute 
ventilation of hypoxic episodes at the end of the IH exposure to hypoxic episodes 
at the start (Harris et al., 2006, Lee et al., 2009, Gerst et al., 2011, Wadhwa et al., 
2008, Yokhana et al., 2012). It is possible that the greater minute ventilation during 
the late hypoxic episodes in these studies and also shown in our study in chapter 5 
is simply a result of the greater minute ventilation during euoxia (i.e. it is dependent 
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of ventilatory LTF). If LTF of phrenic motor nerve activity as mediated by serotonin 
caused increased ventilation during normoxia it will also cause increased 
ventilation during hypoxia. In chapter 4 where progressive augmentation of the 
HVR occurred following hypoxic airway occlusions and in chapter 5 where 
progressive augmentation of the HVR occurred after IH exposure, ventilatory LTF 
was also evident. Indeed, without the use of invasive techniques used in animal 
studies such as intermittent carotid sinus nerve stimulation and application of 
serotonin antagonists we are not aware of an appropriate study to investigate 
whether the responsible mechanisms for progressive augmentation of the HVR are 
different to those of respiratory LTF in humans.  
 
8.4.3 Future use of pharmaceutical aids to mimic IH-induced respiratory LTF 
As discussed throughout this thesis there exists strong evidence alluding to IH 
being the primary stimulus for the development of cardiovascular disease in OSA 
patients. Therefore, exposing patients to IH with the aim of inducing respiratory 
plasticity would negate any health benefits gained by alleviating upper airway 
collapse. However, an enhanced understanding of the cellular mechanisms 
involved in initiating and maintaining respiratory LTF following IH might enable the 
development of pharmaceutical aids that evoke respiratory LTF independent of IH 
exposure. If this is successful and can elicit respiratory LTF without a parallel 
activation of progressive augmentation of the HVR it could possibly benefit upper 
airway stability in OSA patients and other conditions associated with respiratory 
insufficiency. However, even if a pharmaceutical aid can be developed, its success 
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as a therapeutic treatment may still be dependent on PaCO2 levels being above the 
ventilatory threshold.  Because evidence already exists to show that IH is beneficial 
to chronic spinal injury patients without respiratory specific neuronal conditions a 
pharmaceutical aid mimicking the effects of IH may still be beneficial irrespective of 
PaCO2 levels (Dale-Nagle et al., 2010, Lovett-Barr et al., 2012, Trumbower et al., 
2012).  
 
Recent research has greatly expanded our understanding of the responsible 
mechanisms for IH-induced respiratory plasticity in animals. However, until the 
work performed in this thesis there had not been any studies undertaken to 
investigate if the same mechanisms are responsible for the development of 
respiratory LTF in humans. Furthermore, there is convincing evidence in animals 
that respiratory LTF is pattern sensitive and only IH but not CH can evoke 
respiratory LTF. However, since the first report of respiratory LTF in awake 
humans where the requirement for elevating PETCO2 was demonstrated (Harris et 
al., 2006) no study had been performed prior to this thesis to investigate whether 
acute CH also causes respiratory LTF under elevated PETCO2 conditions. 
Therefore, in chapter 5 we undertook a study to investigate whether a central or 
peripheral mechanism was responsible for maintaining ventilatory LTF in humans 
and whether ventilatory LTF was pattern sensitive in humans as it is in animals. 
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8.4.4 Hypoxic induced ventilatory LTF is neither pattern sensitive nor 
maintained by the CB in awake humans 
In chapter 5 we demonstrated that in awake humans, exposure to acute IH during 
sustained mild hypercapnia induced ventilatory LTF, as did an equivalent duration 
of acute CH. Future, studies are required to examine whether acute CH during 
sleep also induces ventilatory LTF and importantly whether acute CH induces LTF 
of upper airway dilator muscle activity.  
 
Evidence from animal studies clearly demonstrates that acute IH but not acute CH 
induces respiratory LTF and that the mediating mechanisms is serotonin 
dependent as intermittent but not continuous application of serotonin or 5-HT2 
receptor agonists evokes the same pattern of phrenic LTF (Lovett-Barr et al., 2006, 
MacFarlane and Mitchell, 2009) and hLTF (Bocchiaro and Feldman, 2004). Our 
finding that CH elicits ventilatory LTF in humans raises the important question 
whether different mechanisms may be responsible for respiratory LTF in humans 
than in animals. Because of this, potential therapeutic solutions that are based on 
our knowledge from animal research may not be successful in humans. However, 
in the same study we were able to demonstrate that the ventilatory LTF following 
acute IH and acute CH was not maintained by a change in CB activity as 
ventilatory LTF remained during transient exposures to hyperoxia. Therefore, a 
central mechanism must be responsible although the exact location remains to be 
determined.  
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8.5 Future research 
 
8.5.1 Future research into respiratory plasticity 
Although it is believed by many that ventilatory LTF might stabilise the upper 
airway in OSA patients, there is no evidence to support this theory and as shown in 
chapters 4 and 6, the expression of ventilatory LTF is restrained by low PaCO2 
levels and thus may not manifest in OSA patients. Furthermore, the expression of 
LTF of upper airway dilator muscle activity that has been shown to occur 
simultaneously to ventilatory LTF in humans is also restrained by low PaCO2 levels 
(Harris et al., 2006). Finally, as discussed previously it may not be possible to 
induce respiratory LTF without also inducing progressive augmentation of the HVR 
that was recently shown to augment OSA severity (Yokhana et al., 2012). 
Therefore, I suggest that future research should focus on a recently reported IH-
independent form of upper airway dilator muscle LTF. 
 
In addition to the upper airway muscles receiving neural activation in sync with the 
central respiratory pattern, they also receive neural activation from a 
mechanoreceptor reflex that responds to negative upper airway pressure (NUAP) 
(Akahoshi et al., 2001, Horner et al., 1991). (Ryan and Nolan, 2009b) recently 
demonstrated that LTF of this mechanoreceptor reflex manifests in rats exposed to 
modest intermittent UANP. Interestingly, the augmentation in upper airway dilator 
muscle activity was restricted to episodes of UANP as it was not present during 
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unrestricted breathing. Furthermore, the addition of IH did not further enhance LTF 
of the mechanoreceptor reflex or independently induce it. It would therefore appear 
that intermittent UANP and IH elicit very different forms of LTF. LTF of this 
mechanoreceptor reflex may have a better chance of evoking a clinical benefit in 
stabilising the upper airway in OSA patients for two reasons. Firstly, it is unlikely to 
occur simultaneously with progressive augmentation of the HVR and secondly it is 
unlikely to be restrained by low PaCO2 levels because it is not reliant on the 
chemoreflex. Future research should be performed to investigate the mechanistic 
pathways of this new form of LTF. 
 
8.5.2 Future research investigating the effects of IH on oxidative stress 
during hyperglycaemia 
In chapter 7 we showed that oxidative stress during IH is augmented following 
consumption of a high glucose and lipid meal in humans. Future research is 
required to determine the responsible mechanisms and what are the potential 
implications to the health of OSA patients with co-existing T2DM. 
 
Studies undertaken to investigate the responsible mechanisms should evoke 
postprandial hyperglycaemia and hyperlipidaemia separately, so that the stimuli 
responsible for augmenting oxidative stress during IH can be distinguished. We 
have previously (chapter 7) proposed a mechanistic pathway involving the enzyme 
xanthine oxidase that could theoretically mediate a synergistic interaction between 
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hyperglycaemia and IH. If future research was to show that hyperglycaemia does 
indeed cause an augmentation in IH-induced oxidative stress the drug allopurinol 
which inhibits xanthine oxidase activity could be used to investigate our proposed 
mechanistic pathway. Although human studies of this type would help to determine 
whether OSA patients with T2DM are at an increased risk of experiencing elevated 
levels of oxidative stress, animal research is required to determine what effect this 
may actually have on patients’ health. 
 
Although numerous animal studies have been performed to investigate the health 
effects of chronic exposures to hyperglycaemia or IH, to the best of our knowledge 
no study exists that has investigated the effects of combined exposures. Future 
studies using animal models of T2DM should investigate the effects on oxidative 
stress of simultaneous exposure to nightly IH. Furthermore, these studies could 
utilise antioxidant treatment to determine if there is a causal relationship between 
an increase in oxidative stress and the development of cardiovascular disease. In 
chapters 6 and 7 we only measured oxidative stress in the plasma of rats and 
humans that gives a whole body measurement of oxidative stress. Although ethical 
restraints of human research limit these measurements to be made in blood, future 
animal research should measure oxidative stress in specific tissues to give a better 
indication of the potential clinical implications of any synergistic interaction between 
hyperglycaemia and IH.  
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